id	sid	tid	token	lemma	pos
chd-116	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-116	1	2	e1	e1	NOUN
chd-116	1	3	cancer	cancer	NOUN
chd-116	1	4	health	health	NOUN
chd-116	1	5	disparities	disparity	NOUN
chd-116	1	6	research	research	NOUN
chd-116	1	7	cortisol	cortisol	NOUN
chd-116	1	8	and	and	CCONJ
chd-116	1	9	health	health	NOUN
chd-116	1	10	-	-	PUNCT
chd-116	1	11	related	relate	VERB
chd-116	1	12	quality	quality	NOUN
chd-116	1	13	of	of	ADP
chd-116	1	14	life	life	NOUN
chd-116	1	15	as	as	ADP
chd-116	1	16	prognostic	prognostic	ADJ
chd-116	1	17	indicators	indicator	NOUN
chd-116	1	18	for	for	ADP
chd-116	1	19	prostate	prostate	NOUN
chd-116	1	20	cancer	cancer	NOUN
chd-116	1	21	risk	risk	NOUN
chd-116	1	22	in	in	ADP
chd-116	1	23	west	west	ADJ
chd-116	1	24	african	african	ADJ
chd-116	1	25	black	black	ADJ
chd-116	1	26	men	man	NOUN
chd-116	1	27	in	in	ADP
chd-116	1	28	nigeria	nigeria	PROPN
chd-116	1	29	,	,	PUNCT
chd-116	1	30	cameroon	cameroon	PROPN
chd-116	1	31	and	and	CCONJ
chd-116	1	32	the	the	DET
chd-116	1	33	usa	usa	PROPN
chd-116	1	34	:	:	PUNCT
chd-116	1	35	the	the	DET
chd-116	1	36	captc	captc	ADJ
chd-116	1	37	cohort	cohort	NOUN
chd-116	1	38	study	study	NOUN
chd-116	1	39	mohammed	mohammed	PROPN
chd-116	1	40	faruk*1,2	faruk*1,2	PROPN
chd-116	1	41	,	,	PUNCT
chd-116	1	42	folakemi	folakemi	NOUN
chd-116	1	43	t.	t.	PROPN
chd-116	1	44	odedina1,3,4	odedina1,3,4	PROPN
chd-116	1	45	,	,	PUNCT
chd-116	1	46	sani	sani	PROPN
chd-116	1	47	ibrahim1,5	ibrahim1,5	PROPN
chd-116	1	48	,	,	PUNCT
chd-116	1	49	abdulmumini	abdulmumini	PROPN
chd-116	1	50	hassan	hassan	PROPN
chd-116	1	51	rafindadi1,2	rafindadi1,2	PROPN
chd-116	1	52	,	,	PUNCT
chd-116	1	53	ahmed	ahmed	PROPN
chd-116	1	54	adamu1,6	adamu1,6	PROPN
chd-116	1	55	,	,	PUNCT
chd-116	1	56	danladi	danladi	VERB
chd-116	1	57	amodu	amodu	PROPN
chd-116	2	1	ameh1,5	ameh1,5	PROPN
chd-116	2	2	,	,	PUNCT
chd-116	2	3	sirajo	sirajo	NOUN
chd-116	2	4	mohammed	mohammed	PROPN
chd-116	2	5	aminu1,7	aminu1,7	PROPN
chd-116	2	6	,	,	PUNCT
chd-116	2	7	abdullahi	abdullahi	PROPN
chd-116	2	8	adamu1,8	adamu1,8	PROPN
chd-116	2	9	,	,	PUNCT
chd-116	2	10	ahmad	ahmad	PROPN
chd-116	2	11	bello1,6	bello1,6	PROPN
chd-116	2	12	,	,	PUNCT
chd-116	2	13	ernie	ernie	PROPN
chd-116	2	14	kaninjing1,9	kaninjing1,9	PROPN
chd-116	2	15	,	,	PUNCT
chd-116	2	16	john	john	PROPN
chd-116	2	17	idoko1,10	idoko1,10	PROPN
chd-116	2	18	,	,	PUNCT
chd-116	2	19	aishatu	aishatu	ADJ
chd-116	2	20	maude	maude	PROPN
chd-116	2	21	suleiman1,7	suleiman1,7	PROPN
chd-116	2	22	,	,	PUNCT
chd-116	2	23	solomon	solomon	PROPN
chd-116	2	24	o.	o.	PROPN
chd-116	2	25	rotimi1,11	rotimi1,11	PROPN
chd-116	2	26	,	,	PUNCT
chd-116	2	27	,	,	PUNCT
chd-116	2	28	getachew	getachew	VERB
chd-116	2	29	a.	a.	NOUN
chd-116	2	30	dagne1,12	dagne1,12	PROPN
chd-116	2	31	,	,	PUNCT
chd-116	2	32	nissa	nissa	PROPN
chd-116	2	33	askins1,3,4	askins1,3,4	PROPN
chd-116	2	34	,	,	PUNCT
chd-116	2	35	clayton	clayton	PROPN
chd-116	2	36	c	c	PROPN
chd-116	2	37	yates1,13	yates1,13	PROPN
chd-116	2	38	,	,	PUNCT
chd-116	2	39	emeka	emeka	PROPN
chd-116	2	40	j.	j.	PROPN
chd-116	2	41	iweala1,11	iweala1,11	PROPN
chd-116	2	42	,	,	PUNCT
chd-116	2	43	yawale	yawale	NOUN
chd-116	2	44	iliyasu1,2	iliyasu1,2	PROPN
chd-116	2	45	,	,	PUNCT
chd-116	2	46	iya	iya	X
chd-116	2	47	eze	eze	X
chd-116	2	48	bassey1,14	bassey1,14	ADV
chd-116	2	49	,	,	PUNCT
chd-116	2	50	r.	r.	PROPN
chd-116	2	51	renee	renee	PROPN
chd-116	2	52	reams1,15	reams1,15	PROPN
chd-116	2	53	,	,	PUNCT
chd-116	2	54	abdullahi	abdullahi	PROPN
chd-116	2	55	mohammad1,2	mohammad1,2	PROPN
chd-116	2	56	,	,	PUNCT
chd-116	2	57	mohammed	mohammed	PROPN
chd-116	2	58	sani	sani	PROPN
chd-116	2	59	shehu1,2	shehu1,2	PROPN
chd-116	2	60	,	,	PUNCT
chd-116	3	1	abdullahi	abdullahi	PROPN
chd-116	3	2	jubril	jubril	PROPN
chd-116	3	3	randawa,1,16	randawa,1,16	PROPN
chd-116	3	4	hussaini	hussaini	PROPN
chd-116	3	5	yusuf	yusuf	PROPN
chd-116	3	6	maitama1,6	maitama1,6	PROPN
chd-116	3	7	,	,	PUNCT
chd-116	3	8	dauda	dauda	NOUN
chd-116	3	9	m.	m.	NOUN
chd-116	3	10	maigatari1,6	maigatari1,6	PROPN
chd-116	3	11	,	,	PUNCT
chd-116	3	12	abdulkadir	abdulkadir	ADJ
chd-116	3	13	lawal	lawal	NOUN
chd-116	3	14	rafinadadi1,17	rafinadadi1,17	NOUN
chd-116	3	15	,	,	PUNCT
chd-116	3	16	ahmad	ahmad	PROPN
chd-116	3	17	bello	bello	PROPN
chd-116	3	18	kumo1,18	kumo1,18	PROPN
chd-116	3	19	,	,	PUNCT
chd-116	3	20	haruna	haruna	PROPN
chd-116	3	21	a	a	DET
chd-116	3	22	nggada1,19	nggada1,19	PROPN
chd-116	3	23	rebecca	rebecca	NOUN
chd-116	3	24	gali1,20	gali1,20	PROPN
chd-116	3	25	,	,	PUNCT
chd-116	3	26	hassan	hassan	PROPN
chd-116	3	27	m.	m.	PROPN
chd-116	3	28	dogo1,21	dogo1,21	PROPN
chd-116	3	29	,	,	PUNCT
chd-116	3	30	ademola	ademola	NOUN
chd-116	3	31	popoola,1,22	popoola,1,22	PROPN
chd-116	3	32	serah	serah	PROPN
chd-116	3	33	adewumi1,22	adewumi1,22	PROPN
chd-116	3	34	,	,	PUNCT
chd-116	3	35	ruth	ruth	PROPN
chd-116	3	36	agaba1,11	agaba1,11	PROPN
chd-116	3	37	,	,	PUNCT
chd-116	3	38	kimberly	kimberly	ADV
chd-116	3	39	meza1,3,4	meza1,3,4	NUM
chd-116	3	40	,	,	PUNCT
chd-116	3	41	nkegoum	nkegoum	NOUN
chd-116	3	42	blaise1,23	blaise1,23	PROPN
chd-116	3	43	,	,	PUNCT
chd-116	3	44	paul	paul	PROPN
chd-116	3	45	jibrin1,24	jibrin1,24	PROPN
chd-116	3	46	,	,	PUNCT
chd-116	3	47	rakiya	rakiya	NOUN
chd-116	3	48	saidu,1,25,26	saidu,1,25,26	NOUN
chd-116	3	49	haruna	haruna	PROPN
chd-116	3	50	mohammad	mohammad	PROPN
chd-116	3	51	muktar1,7	muktar1,7	PROPN
chd-116	3	52	,	,	PUNCT
chd-116	3	53	ahmad	ahmad	PROPN
chd-116	3	54	mai1,6	mai1,6	PROPN
chd-116	3	55	,	,	PUNCT
chd-116	3	56	titilola	titilola	PROPN
chd-116	3	57	akinremi1,27	akinremi1,27	PROPN
chd-116	3	58	,	,	PUNCT
chd-116	3	59	sunday	sunday	PROPN
chd-116	3	60	ene	ene	PROPN
chd-116	3	61	-	-	PUNCT
chd-116	3	62	ojo	ojo	NOUN
chd-116	3	63	atawodi1,5	atawodi1,5	PROPN
chd-116	3	64	,	,	PUNCT
chd-116	3	65	saad	saad	PROPN
chd-116	3	66	aliyu	aliyu	PROPN
chd-116	3	67	ahmed1,2	ahmed1,2	PROPN
chd-116	3	68	,	,	PUNCT
chd-116	3	69	aliyu	aliyu	NOUN
chd-116	3	70	muhammad1,5	muhammad1,5	PROPN
chd-116	3	71	,	,	PUNCT
chd-116	3	72	kasimu	kasimu	PROPN
chd-116	3	73	umar	umar	PROPN
chd-116	3	74	adoke1,2	adoke1,2	PROPN
chd-116	3	75	,	,	PUNCT
chd-116	3	76	ahmad	ahmad	PROPN
chd-116	3	77	tijjani	tijjani	PROPN
chd-116	3	78	lawal1,6	lawal1,6	PROPN
chd-116	3	79	,	,	PUNCT
chd-116	3	80	jamilu	jamilu	NOUN
chd-116	3	81	ya’u,1,28	ya’u,1,28	PROPN
chd-116	3	82	ahmed	ahmed	PROPN
chd-116	3	83	muhammed1,6	muhammed1,6	PROPN
chd-116	3	84	,	,	PUNCT
chd-116	3	85	muhammad	muhammad	PROPN
chd-116	3	86	sa’idu	sa’idu	PROPN
chd-116	3	87	tanko1,29	tanko1,29	PROPN
chd-116	3	88	omolara	omolara	PROPN
chd-116	3	89	fatiregun1,30	fatiregun1,30	PROPN
chd-116	3	90	,	,	PUNCT
chd-116	3	91	aliyu	aliyu	VERB
chd-116	3	92	a	a	DET
chd-116	3	93	babadoko1,7	babadoko1,7	PROPN
chd-116	3	94	shehu	shehu	NOUN
chd-116	3	95	akuyam1,31	akuyam1,31	PROPN
chd-116	3	96	,	,	PUNCT
chd-116	3	97	yusuf	yusuf	PROPN
chd-116	3	98	rasheed1,31	rasheed1,31	PROPN
chd-116	3	99	,	,	PUNCT
chd-116	3	100	mubarak	mubarak	PROPN
chd-116	3	101	labaran	labaran	PROPN
chd-116	3	102	liman1,32	liman1,32	PROPN
chd-116	3	103	,	,	PUNCT
chd-116	3	104	abidemi	abidemi	NOUN
chd-116	3	105	e	e	NOUN
chd-116	3	106	omonisi1,33	omonisi1,33	PROPN
chd-116	3	107	,	,	PUNCT
chd-116	3	108	anthonia	anthonia	PROPN
chd-116	3	109	sowunmi1,34	sowunmi1,34	PROPN
chd-116	3	110	,	,	PUNCT
chd-116	3	111	jigo	jigo	PROPN
chd-116	3	112	dangude	dangude	NOUN
chd-116	3	113	yaro1,2	yaro1,2	PROPN
chd-116	3	114	,	,	PUNCT
chd-116	3	115	catherine	catherine	PROPN
chd-116	3	116	adebukola	adebukola	PROPN
chd-116	3	117	oladoyinbo1,35	oladoyinbo1,35	PROPN
chd-116	3	118	,	,	PUNCT
chd-116	3	119	faoziyat	faoziyat	NOUN
chd-116	3	120	adenike	adenike	VERB
chd-116	3	121	sulaiman,1,22	sulaiman,1,22	PROPN
chd-116	3	122	ogo	ogo	PROPN
chd-116	3	123	chidiebere	chidiebere	PROPN
chd-116	3	124	ndukwe,1,27	ndukwe,1,27	PROPN
chd-116	3	125	abdussamad	abdussamad	NOUN
chd-116	3	126	abdulrahaman,1,36	abdulrahaman,1,36	PROPN
chd-116	4	1	olubanke	olubanke	PROPN
chd-116	4	2	o.	o.	PROPN
chd-116	4	3	ogunlana,1,11	ogunlana,1,11	PROPN
chd-116	4	4	,	,	PUNCT
chd-116	4	5	ayo	ayo	VERB
chd-116	4	6	a	a	DET
chd-116	4	7	salako1,37	salako1,37	PROPN
chd-116	4	8	,	,	PUNCT
chd-116	4	9	frank	frank	PROPN
chd-116	4	10	chinegwundoh1,38	chinegwundoh1,38	PROPN
chd-116	4	11	,	,	PUNCT
chd-116	4	12	wole	wole	PROPN
chd-116	4	13	kukoyi,1,39	kukoyi,1,39	PROPN
chd-116	4	14	esther	esther	PROPN
chd-116	4	15	isaiah1,39	isaiah1,39	PROPN
chd-116	4	16	adenike	adenike	VERB
chd-116	4	17	onibokum	onibokum	PROPN
chd-116	4	18	1,40	1,40	NUM
chd-116	4	19	,	,	PUNCT
chd-116	4	20	ibrahim	ibrahim	PROPN
chd-116	4	21	suleiman1,41	suleiman1,41	PROPN
chd-116	4	22	,	,	PUNCT
chd-116	4	23	motolani	motolani	X
chd-116	4	24	e	e	X
chd-116	4	25	ogunsanya1,42	ogunsanya1,42	PROPN
chd-116	4	26	,	,	PUNCT
chd-116	4	27	fredrick	fredrick	PROPN
chd-116	4	28	ugwumba1,43	ugwumba1,43	PROPN
chd-116	4	29	,	,	PUNCT
chd-116	4	30	okezie	okezie	PROPN
chd-116	4	31	mbadiwe1,43	mbadiwe1,43	PROPN
chd-116	4	32	,	,	PUNCT
chd-116	4	33	kayode	kayode	PROPN
chd-116	4	34	adeniji,1,22	adeniji,1,22	PROPN
chd-116	4	35	,	,	PUNCT
chd-116	4	36	akinwumi	akinwumi	NOUN
chd-116	4	37	oluwole	oluwole	NOUN
chd-116	4	38	komolafe1,44	komolafe1,44	PROPN
chd-116	4	39	,	,	PUNCT
chd-116	4	40	suleiman	suleiman	PROPN
chd-116	4	41	alege	alege	PROPN
chd-116	4	42	kuranga,1,22	kuranga,1,22	PROPN
chd-116	4	43	iheanyi	iheanyi	PROPN
chd-116	5	1	okpala1,45	okpala1,45	X
chd-116	5	2	1	1	NUM
chd-116	5	3	prostate	prostate	NOUN
chd-116	5	4	cancer	cancer	NOUN
chd-116	5	5	transatlantic	transatlantic	NOUN
chd-116	5	6	consortium	consortium	NOUN
chd-116	5	7	(	(	PUNCT
chd-116	5	8	captc	captc	PROPN
chd-116	5	9	)	)	PUNCT
chd-116	5	10	;	;	PUNCT
chd-116	5	11	2	2	NUM
chd-116	5	12	department	department	NOUN
chd-116	5	13	of	of	ADP
chd-116	5	14	pathology	pathology	PROPN
chd-116	5	15	,	,	PUNCT
chd-116	5	16	college	college	PROPN
chd-116	5	17	of	of	ADP
chd-116	5	18	health	health	PROPN
chd-116	5	19	sciences	sciences	PROPN
chd-116	5	20	,	,	PUNCT
chd-116	5	21	faculty	faculty	NOUN
chd-116	5	22	of	of	ADP
chd-116	5	23	basic	basic	ADJ
chd-116	5	24	clinical	clinical	ADJ
chd-116	5	25	sciences	science	NOUN
chd-116	5	26	,	,	PUNCT
chd-116	5	27	ahmadu	ahmadu	PROPN
chd-116	5	28	bello	bello	PROPN
chd-116	5	29	university	university	NOUN
chd-116	5	30	,	,	PUNCT
chd-116	5	31	zaria	zaria	PROPN
chd-116	5	32	810001	810001	NUM
chd-116	5	33	,	,	PUNCT
chd-116	5	34	nigeria	nigeria	PRON
chd-116	5	35	;	;	PUNCT
chd-116	5	36	3department	3department	NUM
chd-116	5	37	of	of	ADP
chd-116	5	38	pharmacotherapy	pharmacotherapy	NOUN
chd-116	5	39	and	and	CCONJ
chd-116	5	40	translational	translational	ADJ
chd-116	5	41	research	research	NOUN
chd-116	5	42	,	,	PUNCT
chd-116	5	43	college	college	NOUN
chd-116	5	44	of	of	ADP
chd-116	5	45	pharmacy	pharmacy	NOUN
chd-116	5	46	,	,	PUNCT
chd-116	5	47	university	university	PROPN
chd-116	5	48	of	of	ADP
chd-116	5	49	florida	florida	PROPN
chd-116	5	50	,	,	PUNCT
chd-116	5	51	orlando	orlando	PROPN
chd-116	5	52	,	,	PUNCT
chd-116	5	53	florida	florida	PROPN
chd-116	5	54	32827	32827	NUM
chd-116	5	55	,	,	PUNCT
chd-116	5	56	usa	usa	PROPN
chd-116	5	57	;	;	PUNCT
chd-116	5	58	4minority	4minority	NUM
chd-116	5	59	cancer	cancer	NOUN
chd-116	5	60	research	research	NOUN
chd-116	5	61	and	and	CCONJ
chd-116	5	62	training	training	NOUN
chd-116	5	63	(	(	PUNCT
chd-116	5	64	micart	micart	ADJ
chd-116	5	65	)	)	PUNCT
chd-116	5	66	center	center	NOUN
chd-116	5	67	,	,	PUNCT
chd-116	5	68	university	university	PROPN
chd-116	5	69	of	of	ADP
chd-116	5	70	florida	florida	PROPN
chd-116	5	71	,	,	PUNCT
chd-116	5	72	orlando	orlando	PROPN
chd-116	5	73	,	,	PUNCT
chd-116	5	74	florida	florida	PROPN
chd-116	5	75	,	,	PUNCT
chd-116	5	76	usa	usa	PROPN
chd-116	5	77	;	;	PUNCT
chd-116	5	78	5department	5department	NUM
chd-116	5	79	of	of	ADP
chd-116	5	80	biochemistry	biochemistry	NOUN
chd-116	5	81	,	,	PUNCT
chd-116	5	82	faculty	faculty	NOUN
chd-116	5	83	of	of	ADP
chd-116	5	84	life	life	NOUN
chd-116	5	85	sciences	science	NOUN
chd-116	5	86	,	,	PUNCT
chd-116	5	87	ahmadu	ahmadu	PROPN
chd-116	5	88	bello	bello	PROPN
chd-116	5	89	university	university	PROPN
chd-116	5	90	,	,	PUNCT
chd-116	5	91	zaria	zaria	PROPN
chd-116	5	92	nigeria	nigeria	PROPN
chd-116	5	93	;	;	PUNCT
chd-116	5	94	6department	6department	NUM
chd-116	5	95	of	of	ADP
chd-116	5	96	surgery	surgery	NOUN
chd-116	5	97	,	,	PUNCT
chd-116	5	98	college	college	NOUN
chd-116	5	99	of	of	ADP
chd-116	5	100	health	health	PROPN
chd-116	5	101	sciences	sciences	PROPN
chd-116	5	102	,	,	PUNCT
chd-116	5	103	faculty	faculty	NOUN
chd-116	5	104	of	of	ADP
chd-116	5	105	clinical	clinical	ADJ
chd-116	5	106	sciences	science	NOUN
chd-116	5	107	,	,	PUNCT
chd-116	5	108	ahmadu	ahmadu	PROPN
chd-116	5	109	bello	bello	PROPN
chd-116	5	110	university	university	PROPN
chd-116	5	111	,	,	PUNCT
chd-116	5	112	zaria	zaria	PROPN
chd-116	5	113	nigeria	nigeria	PROPN
chd-116	5	114	;	;	PUNCT
chd-116	5	115	7department	7department	NUM
chd-116	5	116	of	of	ADP
chd-116	5	117	haematology	haematology	NOUN
chd-116	5	118	and	and	CCONJ
chd-116	5	119	blood	blood	NOUN
chd-116	5	120	transfusion	transfusion	NOUN
chd-116	5	121	,	,	PUNCT
chd-116	5	122	college	college	NOUN
chd-116	5	123	of	of	ADP
chd-116	5	124	health	health	PROPN
chd-116	5	125	sciences	sciences	PROPN
chd-116	5	126	,	,	PUNCT
chd-116	5	127	faculty	faculty	NOUN
chd-116	5	128	of	of	ADP
chd-116	5	129	basic	basic	ADJ
chd-116	5	130	clinical	clinical	ADJ
chd-116	5	131	sciences	science	NOUN
chd-116	5	132	,	,	PUNCT
chd-116	5	133	ahmadu	ahmadu	PROPN
chd-116	5	134	bello	bello	PROPN
chd-116	5	135	university	university	PROPN
chd-116	5	136	,	,	PUNCT
chd-116	5	137	zaria	zaria	PROPN
chd-116	5	138	,	,	PUNCT
chd-116	5	139	nigeria	nigeria	PROPN
chd-116	5	140	;	;	PUNCT
chd-116	5	141	8department	8department	NUM
chd-116	5	142	of	of	ADP
chd-116	5	143	radiology	radiology	NOUN
chd-116	5	144	and	and	CCONJ
chd-116	5	145	radiotherapy	radiotherapy	NOUN
chd-116	5	146	,	,	PUNCT
chd-116	5	147	college	college	NOUN
chd-116	5	148	of	of	ADP
chd-116	5	149	health	health	PROPN
chd-116	5	150	sciences	sciences	PROPN
chd-116	5	151	,	,	PUNCT
chd-116	5	152	faculty	faculty	NOUN
chd-116	5	153	of	of	ADP
chd-116	5	154	clinical	clinical	ADJ
chd-116	5	155	sciences	science	NOUN
chd-116	5	156	,	,	PUNCT
chd-116	5	157	ahmadu	ahmadu	PROPN
chd-116	5	158	bello	bello	PROPN
chd-116	5	159	university	university	PROPN
chd-116	5	160	,	,	PUNCT
chd-116	5	161	zaria	zaria	PROPN
chd-116	5	162	,	,	PUNCT
chd-116	5	163	nigeria	nigeria	PROPN
chd-116	5	164	,	,	PUNCT
chd-116	5	165	9school	9school	NUM
chd-116	5	166	of	of	ADP
chd-116	5	167	health	health	NOUN
chd-116	5	168	and	and	CCONJ
chd-116	5	169	human	human	ADJ
chd-116	5	170	performance	performance	NOUN
chd-116	5	171	,	,	PUNCT
chd-116	5	172	georgia	georgia	PROPN
chd-116	5	173	college	college	PROPN
chd-116	5	174	and	and	CCONJ
chd-116	5	175	state	state	PROPN
chd-116	5	176	university	university	PROPN
chd-116	5	177	,	,	PUNCT
chd-116	5	178	milledgeville	milledgeville	PROPN
chd-116	5	179	,	,	PUNCT
chd-116	5	180	georgia	georgia	PROPN
chd-116	5	181	31061	31061	NUM
chd-116	5	182	usa	usa	PROPN
chd-116	5	183	10department	10department	NUM
chd-116	5	184	of	of	ADP
chd-116	5	185	pathology	pathology	NOUN
chd-116	5	186	,	,	PUNCT
chd-116	5	187	ahmadu	ahmadu	PROPN
chd-116	5	188	bello	bello	PROPN
chd-116	5	189	university	university	NOUN
chd-116	5	190	teaching	teaching	NOUN
chd-116	5	191	hospital	hospital	NOUN
chd-116	5	192	shika	shika	PROPN
chd-116	5	193	zaria	zaria	PROPN
chd-116	5	194	,	,	PUNCT
chd-116	5	195	nigeria	nigeria	PROPN
chd-116	5	196	;	;	PUNCT
chd-116	5	197	11department	11department	NUM
chd-116	5	198	of	of	ADP
chd-116	5	199	biochemistry	biochemistry	NOUN
chd-116	5	200	,	,	PUNCT
chd-116	5	201	covenant	covenant	ADJ
chd-116	5	202	university	university	PROPN
chd-116	5	203	,	,	PUNCT
chd-116	5	204	ota	ota	PROPN
chd-116	5	205	,	,	PUNCT
chd-116	5	206	ogun	ogun	PROPN
chd-116	5	207	state	state	PROPN
chd-116	5	208	,	,	PUNCT
chd-116	5	209	nigeria	nigeria	PROPN
chd-116	5	210	;	;	PUNCT
chd-116	5	211	12department	12department	NUM
chd-116	5	212	of	of	ADP
chd-116	5	213	epidemiology	epidemiology	NOUN
chd-116	5	214	and	and	CCONJ
chd-116	5	215	biostatistics	biostatistic	NOUN
chd-116	5	216	,	,	PUNCT
chd-116	5	217	college	college	NOUN
chd-116	5	218	of	of	ADP
chd-116	5	219	public	public	ADJ
chd-116	5	220	health	health	NOUN
chd-116	5	221	,	,	PUNCT
chd-116	5	222	university	university	NOUN
chd-116	5	223	of	of	ADP
chd-116	5	224	south	south	PROPN
chd-116	5	225	florida	florida	PROPN
chd-116	5	226	,	,	PUNCT
chd-116	5	227	tampa	tampa	PROPN
chd-116	5	228	,	,	PUNCT
chd-116	5	229	florida	florida	PROPN
chd-116	5	230	usa	usa	PROPN
chd-116	5	231	;	;	PUNCT
chd-116	5	232	13department	13department	NUM
chd-116	5	233	of	of	ADP
chd-116	5	234	biology	biology	NOUN
chd-116	5	235	and	and	CCONJ
chd-116	5	236	center	center	NOUN
chd-116	5	237	for	for	ADP
chd-116	5	238	cancer	cancer	NOUN
chd-116	5	239	research	research	NOUN
chd-116	5	240	,	,	PUNCT
chd-116	5	241	tuskegee	tuskegee	PROPN
chd-116	5	242	university	university	PROPN
chd-116	5	243	,	,	PUNCT
chd-116	5	244	tuskegee	tuskegee	PROPN
chd-116	5	245	alabama	alabama	PROPN
chd-116	5	246	36088	36088	NUM
chd-116	5	247	,	,	PUNCT
chd-116	5	248	usa	usa	PROPN
chd-116	5	249	;	;	PUNCT
chd-116	5	250	14department	14department	NUM
chd-116	5	251	of	of	ADP
chd-116	5	252	medical	medical	ADJ
chd-116	5	253	laboratory	laboratory	NOUN
chd-116	5	254	science	science	NOUN
chd-116	5	255	,	,	PUNCT
chd-116	5	256	faculty	faculty	NOUN
chd-116	5	257	of	of	ADP
chd-116	5	258	allied	ally	VERB
chd-116	5	259	medical	medical	ADJ
chd-116	5	260	health	health	NOUN
chd-116	5	261	sciences	sciences	PROPN
chd-116	5	262	,	,	PUNCT
chd-116	5	263	college	college	NOUN
chd-116	5	264	of	of	ADP
chd-116	5	265	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-116	5	266	e2	e2	PROPN
chd-116	5	267	cancer	cancer	NOUN
chd-116	5	268	health	health	NOUN
chd-116	5	269	disparities	disparity	NOUN
chd-116	5	270	research	research	VERB
chd-116	5	271	medical	medical	ADJ
chd-116	5	272	sciences	sciences	PROPN
chd-116	5	273	,	,	PUNCT
chd-116	5	274	university	university	NOUN
chd-116	5	275	of	of	ADP
chd-116	5	276	calabar	calabar	PROPN
chd-116	5	277	,	,	PUNCT
chd-116	5	278	calabar	calabar	PROPN
chd-116	5	279	,	,	PUNCT
chd-116	5	280	nigeria.1,15college	nigeria.1,15college	NOUN
chd-116	5	281	of	of	ADP
chd-116	5	282	pharmacy	pharmacy	NOUN
chd-116	5	283	and	and	CCONJ
chd-116	5	284	pharmaceutical	pharmaceutical	NOUN
chd-116	5	285	sciences	science	NOUN
chd-116	5	286	,	,	PUNCT
chd-116	5	287	florida	florida	PROPN
chd-116	5	288	a&m	a&m	PROPN
chd-116	5	289	university	university	PROPN
chd-116	5	290	,	,	PUNCT
chd-116	5	291	tallahassee	tallahassee	PROPN
chd-116	5	292	,	,	PUNCT
chd-116	5	293	florida	florida	PROPN
chd-116	5	294	usa	usa	PROPN
chd-116	5	295	;	;	PUNCT
chd-116	5	296	16department	16department	NUM
chd-116	5	297	of	of	ADP
chd-116	5	298	obstetrics	obstetric	NOUN
chd-116	5	299	and	and	CCONJ
chd-116	5	300	gynaecology	gynaecology	NOUN
chd-116	5	301	,	,	PUNCT
chd-116	5	302	college	college	NOUN
chd-116	5	303	of	of	ADP
chd-116	5	304	health	health	PROPN
chd-116	5	305	sciences	sciences	PROPN
chd-116	5	306	,	,	PUNCT
chd-116	5	307	faculty	faculty	NOUN
chd-116	5	308	of	of	ADP
chd-116	5	309	basic	basic	ADJ
chd-116	5	310	clinical	clinical	ADJ
chd-116	5	311	sciences	science	NOUN
chd-116	5	312	,	,	PUNCT
chd-116	5	313	ahmadu	ahmadu	PROPN
chd-116	5	314	bello	bello	PROPN
chd-116	5	315	university	university	PROPN
chd-116	5	316	,	,	PUNCT
chd-116	5	317	zaria	zaria	PROPN
chd-116	5	318	,	,	PUNCT
chd-116	5	319	nigeria	nigeria	PROPN
chd-116	5	320	;	;	PUNCT
chd-116	5	321	17department	17department	NUM
chd-116	5	322	of	of	ADP
chd-116	5	323	ophthalmology	ophthalmology	NOUN
chd-116	5	324	,	,	PUNCT
chd-116	5	325	college	college	NOUN
chd-116	5	326	of	of	ADP
chd-116	5	327	health	health	PROPN
chd-116	5	328	sciences	sciences	PROPN
chd-116	5	329	,	,	PUNCT
chd-116	5	330	faculty	faculty	NOUN
chd-116	5	331	of	of	ADP
chd-116	5	332	basic	basic	ADJ
chd-116	5	333	clinical	clinical	ADJ
chd-116	5	334	sciences	science	NOUN
chd-116	5	335	,	,	PUNCT
chd-116	5	336	ahmadu	ahmadu	PROPN
chd-116	5	337	bello	bello	PROPN
chd-116	5	338	university	university	PROPN
chd-116	5	339	,	,	PUNCT
chd-116	5	340	zaria	zaria	PROPN
chd-116	5	341	,	,	PUNCT
chd-116	5	342	nigeria	nigeria	PROPN
chd-116	5	343	;	;	PUNCT
chd-116	5	344	18department	18department	NUM
chd-116	5	345	of	of	ADP
chd-116	5	346	medicine	medicine	NOUN
chd-116	5	347	,	,	PUNCT
chd-116	5	348	college	college	NOUN
chd-116	5	349	of	of	ADP
chd-116	5	350	health	health	PROPN
chd-116	5	351	sciences	sciences	PROPN
chd-116	5	352	,	,	PUNCT
chd-116	5	353	faculty	faculty	NOUN
chd-116	5	354	of	of	ADP
chd-116	5	355	basic	basic	ADJ
chd-116	5	356	clinical	clinical	ADJ
chd-116	5	357	sciences	science	NOUN
chd-116	5	358	,	,	PUNCT
chd-116	5	359	ahmadu	ahmadu	PROPN
chd-116	5	360	bello	bello	PROPN
chd-116	5	361	university	university	PROPN
chd-116	5	362	,	,	PUNCT
chd-116	5	363	zaria	zaria	PROPN
chd-116	5	364	,	,	PUNCT
chd-116	5	365	nigeria	nigeria	PROPN
chd-116	5	366	;	;	PUNCT
chd-116	5	367	19department	19department	NUM
chd-116	5	368	of	of	ADP
chd-116	5	369	pathology	pathology	NOUN
chd-116	5	370	,	,	PUNCT
chd-116	5	371	college	college	NOUN
chd-116	5	372	of	of	ADP
chd-116	5	373	medical	medical	ADJ
chd-116	5	374	sciences	sciences	PROPN
chd-116	5	375	,	,	PUNCT
chd-116	5	376	university	university	NOUN
chd-116	5	377	of	of	ADP
chd-116	5	378	maiduguri	maiduguri	PROPN
chd-116	5	379	,	,	PUNCT
chd-116	5	380	maiduguri	maiduguri	PROPN
chd-116	5	381	,	,	PUNCT
chd-116	5	382	nigeria	nigeria	PROPN
chd-116	5	383	;	;	PUNCT
chd-116	5	384	20department	20department	NUM
chd-116	5	385	of	of	ADP
chd-116	5	386	medical	medical	ADJ
chd-116	5	387	laboratory	laboratory	NOUN
chd-116	5	388	science	science	NOUN
chd-116	5	389	,	,	PUNCT
chd-116	5	390	college	college	NOUN
chd-116	5	391	of	of	ADP
chd-116	5	392	medical	medical	ADJ
chd-116	5	393	sciences	sciences	PROPN
chd-116	5	394	,	,	PUNCT
chd-116	5	395	university	university	NOUN
chd-116	5	396	of	of	ADP
chd-116	5	397	maiduguri	maiduguri	PROPN
chd-116	5	398	,	,	PUNCT
chd-116	5	399	maiduguri	maiduguri	PROPN
chd-116	5	400	,	,	PUNCT
chd-116	5	401	nigeria	nigeria	PROPN
chd-116	5	402	;	;	PUNCT
chd-116	5	403	21department	21department	NUM
chd-116	5	404	of	of	ADP
chd-116	5	405	surgery	surgery	NOUN
chd-116	5	406	,	,	PUNCT
chd-116	5	407	college	college	NOUN
chd-116	5	408	of	of	ADP
chd-116	5	409	medical	medical	ADJ
chd-116	5	410	sciences	sciences	PROPN
chd-116	5	411	,	,	PUNCT
chd-116	5	412	university	university	NOUN
chd-116	5	413	of	of	ADP
chd-116	5	414	maiduguri	maiduguri	PROPN
chd-116	5	415	,	,	PUNCT
chd-116	5	416	maiduguri	maiduguri	PROPN
chd-116	5	417	,	,	PUNCT
chd-116	5	418	nigeria	nigeria	PROPN
chd-116	5	419	;	;	PUNCT
chd-116	5	420	22faculty	22faculty	NUM
chd-116	5	421	of	of	ADP
chd-116	5	422	basic	basic	ADJ
chd-116	5	423	clinical	clinical	ADJ
chd-116	5	424	sciences	science	NOUN
chd-116	5	425	,	,	PUNCT
chd-116	5	426	college	college	NOUN
chd-116	5	427	of	of	ADP
chd-116	5	428	health	health	PROPN
chd-116	5	429	sciences	sciences	PROPN
chd-116	5	430	,	,	PUNCT
chd-116	5	431	university	university	NOUN
chd-116	5	432	of	of	ADP
chd-116	5	433	ilorin	ilorin	PROPN
chd-116	5	434	,	,	PUNCT
chd-116	5	435	ilorin	ilorin	NOUN
chd-116	5	436	,	,	PUNCT
chd-116	5	437	nigeria	nigeria	PROPN
chd-116	5	438	;	;	PUNCT
chd-116	5	439	23university	23university	NUM
chd-116	5	440	hospital	hospital	NOUN
chd-116	5	441	center	center	NOUN
chd-116	5	442	,	,	PUNCT
chd-116	5	443	yaounde	yaounde	PROPN
chd-116	5	444	,	,	PUNCT
chd-116	5	445	cameroon	cameroon	PROPN
chd-116	5	446	;	;	PUNCT
chd-116	5	447	24department	24department	NUM
chd-116	5	448	of	of	ADP
chd-116	5	449	pathology	pathology	PROPN
chd-116	5	450	,	,	PUNCT
chd-116	5	451	national	national	ADJ
chd-116	5	452	hospital	hospital	NOUN
chd-116	5	453	,	,	PUNCT
chd-116	5	454	abuja	abuja	PROPN
chd-116	5	455	,	,	PUNCT
chd-116	5	456	nigeria	nigeria	PROPN
chd-116	5	457	;	;	PUNCT
chd-116	5	458	25department	25department	NUM
chd-116	5	459	of	of	ADP
chd-116	5	460	obstetrics	obstetric	NOUN
chd-116	5	461	and	and	CCONJ
chd-116	5	462	gynaecology	gynaecology	NOUN
chd-116	5	463	,	,	PUNCT
chd-116	5	464	faculty	faculty	NOUN
chd-116	5	465	of	of	ADP
chd-116	5	466	medicine	medicine	NOUN
chd-116	5	467	,	,	PUNCT
chd-116	5	468	university	university	NOUN
chd-116	5	469	of	of	ADP
chd-116	5	470	ilorin	ilorin	PROPN
chd-116	5	471	,	,	PUNCT
chd-116	5	472	ilorin	ilorin	NOUN
chd-116	5	473	,	,	PUNCT
chd-116	5	474	nigeria	nigeria	PROPN
chd-116	5	475	;	;	PUNCT
chd-116	5	476	26department	26department	NUM
chd-116	5	477	of	of	ADP
chd-116	5	478	obstetrics	obstetric	NOUN
chd-116	5	479	and	and	CCONJ
chd-116	5	480	gynaecology	gynaecology	NOUN
chd-116	5	481	,	,	PUNCT
chd-116	5	482	university	university	NOUN
chd-116	5	483	of	of	ADP
chd-116	5	484	cape	cape	NOUN
chd-116	5	485	town	town	NOUN
chd-116	5	486	,	,	PUNCT
chd-116	5	487	south	south	PROPN
chd-116	5	488	africa	africa	PROPN
chd-116	5	489	;	;	PUNCT
chd-116	5	490	27federal	27federal	NUM
chd-116	5	491	medical	medical	ADJ
chd-116	5	492	center	center	NOUN
chd-116	5	493	,	,	PUNCT
chd-116	5	494	abeokuta	abeokuta	PROPN
chd-116	5	495	,	,	PUNCT
chd-116	5	496	nigeria	nigeria	PROPN
chd-116	5	497	;	;	PUNCT
chd-116	5	498	28department	28department	NUM
chd-116	5	499	of	of	ADP
chd-116	5	500	pharmacology	pharmacology	NOUN
chd-116	5	501	and	and	CCONJ
chd-116	5	502	therapeutics	therapeutic	NOUN
chd-116	5	503	,	,	PUNCT
chd-116	5	504	faculty	faculty	NOUN
chd-116	5	505	of	of	ADP
chd-116	5	506	pharmaceutical	pharmaceutical	NOUN
chd-116	5	507	sciences	science	NOUN
chd-116	5	508	,	,	PUNCT
chd-116	5	509	ahmadu	ahmadu	PROPN
chd-116	5	510	bello	bello	PROPN
chd-116	5	511	university	university	PROPN
chd-116	5	512	,	,	PUNCT
chd-116	5	513	zaria	zaria	PROPN
chd-116	5	514	nigeria	nigeria	PROPN
chd-116	5	515	;	;	PUNCT
chd-116	5	516	29veterinary	29veterinary	NUM
chd-116	5	517	teaching	teaching	NOUN
chd-116	5	518	hospital	hospital	NOUN
chd-116	5	519	,	,	PUNCT
chd-116	5	520	ahmadu	ahmadu	PROPN
chd-116	5	521	bello	bello	PROPN
chd-116	5	522	university	university	PROPN
chd-116	5	523	zaria	zaria	PROPN
chd-116	5	524	,	,	PUNCT
chd-116	5	525	nigeria	nigeria	PROPN
chd-116	5	526	30department	30department	NUM
chd-116	5	527	of	of	ADP
chd-116	5	528	radiotherapy	radiotherapy	NOUN
chd-116	5	529	and	and	CCONJ
chd-116	5	530	oncology	oncology	NOUN
chd-116	5	531	,	,	PUNCT
chd-116	5	532	lagos	lagos	NOUN
chd-116	5	533	state	state	NOUN
chd-116	5	534	university	university	PROPN
chd-116	5	535	teaching	teaching	NOUN
chd-116	5	536	hospital	hospital	NOUN
chd-116	5	537	,	,	PUNCT
chd-116	5	538	lagos	lago	NOUN
chd-116	5	539	,	,	PUNCT
chd-116	5	540	nigeria	nigeria	PROPN
chd-116	5	541	;	;	PUNCT
chd-116	5	542	31department	31department	NUM
chd-116	5	543	of	of	ADP
chd-116	5	544	chemical	chemical	PROPN
chd-116	5	545	pathology	pathology	PROPN
chd-116	5	546	,	,	PUNCT
chd-116	5	547	college	college	PROPN
chd-116	5	548	of	of	ADP
chd-116	5	549	health	health	PROPN
chd-116	5	550	sciences	sciences	PROPN
chd-116	5	551	,	,	PUNCT
chd-116	5	552	faculty	faculty	NOUN
chd-116	5	553	of	of	ADP
chd-116	5	554	basic	basic	ADJ
chd-116	5	555	clinical	clinical	ADJ
chd-116	5	556	sciences	science	NOUN
chd-116	5	557	,	,	PUNCT
chd-116	5	558	ahmadu	ahmadu	PROPN
chd-116	5	559	bello	bello	PROPN
chd-116	5	560	university	university	PROPN
chd-116	5	561	,	,	PUNCT
chd-116	5	562	zaria	zaria	PROPN
chd-116	5	563	,	,	PUNCT
chd-116	5	564	nigeria	nigeria	PROPN
chd-116	5	565	;	;	PUNCT
chd-116	5	566	32department	32department	NUM
chd-116	5	567	of	of	ADP
chd-116	5	568	science	science	NOUN
chd-116	5	569	laboratory	laboratory	NOUN
chd-116	5	570	technology	technology	NOUN
chd-116	5	571	,	,	PUNCT
chd-116	5	572	nuhu	nuhu	NOUN
chd-116	5	573	bamalli	bamalli	PROPN
chd-116	5	574	polytechnic	polytechnic	PROPN
chd-116	5	575	,	,	PUNCT
chd-116	5	576	zaria	zaria	PROPN
chd-116	5	577	,	,	PUNCT
chd-116	5	578	nigeria	nigeria	PROPN
chd-116	5	579	;	;	PUNCT
chd-116	5	580	33department	33department	NUM
chd-116	5	581	of	of	ADP
chd-116	5	582	anatomic	anatomic	ADJ
chd-116	5	583	pathology	pathology	NOUN
chd-116	5	584	,	,	PUNCT
chd-116	5	585	faculty	faculty	NOUN
chd-116	5	586	of	of	ADP
chd-116	5	587	basic	basic	ADJ
chd-116	5	588	clinical	clinical	ADJ
chd-116	5	589	sciences	science	NOUN
chd-116	5	590	,	,	PUNCT
chd-116	5	591	ekiti	ekiti	PROPN
chd-116	5	592	state	state	PROPN
chd-116	5	593	university	university	PROPN
chd-116	5	594	,	,	PUNCT
chd-116	5	595	ado	ado	NOUN
chd-116	5	596	-	-	PUNCT
chd-116	5	597	ekiti	ekiti	PROPN
chd-116	5	598	,	,	PUNCT
chd-116	5	599	nigeria	nigeria	PROPN
chd-116	5	600	;	;	PUNCT
chd-116	5	601	34department	34department	NUM
chd-116	5	602	of	of	ADP
chd-116	5	603	radiotherapy	radiotherapy	NOUN
chd-116	5	604	,	,	PUNCT
chd-116	5	605	lagos	lagos	NOUN
chd-116	5	606	university	university	NOUN
chd-116	5	607	teaching	teaching	NOUN
chd-116	5	608	hospital	hospital	NOUN
chd-116	5	609	,	,	PUNCT
chd-116	5	610	lagos	lago	NOUN
chd-116	5	611	,	,	PUNCT
chd-116	5	612	nigeria	nigeria	PROPN
chd-116	5	613	;	;	PUNCT
chd-116	5	614	35department	35department	NUM
chd-116	5	615	of	of	ADP
chd-116	5	616	nutrition	nutrition	NOUN
chd-116	5	617	and	and	CCONJ
chd-116	5	618	dietetics	dietetics	PROPN
chd-116	5	619	federal	federal	PROPN
chd-116	5	620	university	university	PROPN
chd-116	5	621	of	of	ADP
chd-116	5	622	agriculture	agriculture	PROPN
chd-116	5	623	,	,	PUNCT
chd-116	5	624	abeokuta	abeokuta	PROPN
chd-116	5	625	,	,	PUNCT
chd-116	5	626	nigeria	nigeria	PROPN
chd-116	5	627	;	;	PUNCT
chd-116	5	628	36department	36department	NUM
chd-116	5	629	of	of	ADP
chd-116	5	630	pharmaceutics	pharmaceutic	NOUN
chd-116	5	631	and	and	CCONJ
chd-116	5	632	pharmaceutical	pharmaceutical	NOUN
chd-116	5	633	microbiology	microbiology	NOUN
chd-116	5	634	,	,	PUNCT
chd-116	5	635	faculty	faculty	NOUN
chd-116	5	636	of	of	ADP
chd-116	5	637	pharmaceutical	pharmaceutical	NOUN
chd-116	5	638	sciences	science	NOUN
chd-116	5	639	,	,	PUNCT
chd-116	5	640	ahmadu	ahmadu	PROPN
chd-116	5	641	bello	bello	PROPN
chd-116	5	642	university	university	PROPN
chd-116	5	643	,	,	PUNCT
chd-116	5	644	zaria	zaria	PROPN
chd-116	5	645	nigeria	nigeria	PROPN
chd-116	5	646	;	;	PUNCT
chd-116	5	647	37department	37department	NUM
chd-116	5	648	of	of	ADP
chd-116	5	649	surgery	surgery	NOUN
chd-116	5	650	,	,	PUNCT
chd-116	5	651	obafemi	obafemi	ADP
chd-116	5	652	awolowo	awolowo	PROPN
chd-116	5	653	university	university	PROPN
chd-116	5	654	,	,	PUNCT
chd-116	5	655	ile	ile	PROPN
chd-116	5	656	-	-	PUNCT
chd-116	5	657	ife	ife	PROPN
chd-116	5	658	,	,	PUNCT
chd-116	5	659	nigeria	nigeria	PROPN
chd-116	5	660	;	;	PUNCT
chd-116	5	661	38barts	38barts	NUM
chd-116	5	662	health	health	NOUN
chd-116	5	663	nhs	nhs	PROPN
chd-116	5	664	trust/	trust/	NUM
chd-116	5	665	school	school	NOUN
chd-116	5	666	of	of	ADP
chd-116	5	667	health	health	NOUN
chd-116	5	668	sciences	sciences	PROPN
chd-116	5	669	,	,	PUNCT
chd-116	5	670	city	city	PROPN
chd-116	5	671	university	university	PROPN
chd-116	5	672	london	london	PROPN
chd-116	5	673	,	,	PUNCT
chd-116	5	674	uk	uk	PROPN
chd-116	5	675	;	;	PUNCT
chd-116	5	676	39ace	39ace	NOUN
chd-116	5	677	medicare	medicare	PROPN
chd-116	5	678	clinics	clinic	NOUN
chd-116	5	679	limited	limit	VERB
chd-116	5	680	ota	ota	PROPN
chd-116	5	681	,	,	PUNCT
chd-116	5	682	nigeria	nigeria	PROPN
chd-116	5	683	;	;	PUNCT
chd-116	5	684	40department	40department	NUM
chd-116	5	685	of	of	ADP
chd-116	5	686	nursing	nursing	NOUN
chd-116	5	687	sciences	science	NOUN
chd-116	5	688	,	,	PUNCT
chd-116	5	689	university	university	NOUN
chd-116	5	690	of	of	ADP
chd-116	5	691	ibadan	ibadan	PROPN
chd-116	5	692	,	,	PUNCT
chd-116	5	693	ibadan	ibadan	PROPN
chd-116	5	694	nigeria	nigeria	PROPN
chd-116	5	695	;	;	PUNCT
chd-116	5	696	41department	41department	NUM
chd-116	5	697	of	of	ADP
chd-116	5	698	physiology	physiology	NOUN
chd-116	5	699	,	,	PUNCT
chd-116	5	700	ahmadu	ahmadu	PROPN
chd-116	5	701	bello	bello	PROPN
chd-116	5	702	university	university	PROPN
chd-116	5	703	,	,	PUNCT
chd-116	5	704	zaria	zaria	PROPN
chd-116	5	705	,	,	PUNCT
chd-116	5	706	nigeria	nigeria	PROPN
chd-116	5	707	;	;	PUNCT
chd-116	5	708	42college	42college	NUM
chd-116	5	709	of	of	ADP
chd-116	5	710	pharmacy	pharmacy	NOUN
chd-116	5	711	,	,	PUNCT
chd-116	5	712	health	health	NOUN
chd-116	5	713	science	science	NOUN
chd-116	5	714	center	center	NOUN
chd-116	5	715	,	,	PUNCT
chd-116	5	716	university	university	PROPN
chd-116	5	717	of	of	ADP
chd-116	5	718	oklahoma	oklahoma	PROPN
chd-116	5	719	health	health	PROPN
chd-116	5	720	science	science	PROPN
chd-116	5	721	center	center	PROPN
chd-116	5	722	,	,	PUNCT
chd-116	5	723	oklahoma	oklahoma	PROPN
chd-116	5	724	city	city	PROPN
chd-116	5	725	,	,	PUNCT
chd-116	5	726	ok	ok	ADJ
chd-116	5	727	73117	73117	NUM
chd-116	5	728	,	,	PUNCT
chd-116	5	729	usa	usa	PROPN
chd-116	5	730	;	;	PUNCT
chd-116	5	731	43department	43department	NUM
chd-116	5	732	of	of	ADP
chd-116	5	733	surgery	surgery	NOUN
chd-116	5	734	,	,	PUNCT
chd-116	5	735	university	university	NOUN
chd-116	5	736	of	of	ADP
chd-116	5	737	nigeria	nigeria	PROPN
chd-116	5	738	,	,	PUNCT
chd-116	5	739	nsuka	nsuka	PROPN
chd-116	5	740	,	,	PUNCT
chd-116	5	741	nigeria	nigeria	PROPN
chd-116	5	742	;	;	PUNCT
chd-116	5	743	44department	44department	NUM
chd-116	5	744	of	of	ADP
chd-116	5	745	pathology	pathology	PROPN
chd-116	5	746	,	,	PUNCT
chd-116	5	747	obafemi	obafemi	PROPN
chd-116	5	748	awolowo	awolowo	PROPN
chd-116	5	749	university	university	PROPN
chd-116	5	750	,	,	PUNCT
chd-116	5	751	ile	ile	PROPN
chd-116	5	752	-	-	PUNCT
chd-116	5	753	ife	ife	PROPN
chd-116	5	754	,	,	PUNCT
chd-116	5	755	nigeria	nigeria	PROPN
chd-116	5	756	;	;	PUNCT
chd-116	5	757	45institute	45institute	NUM
chd-116	5	758	of	of	ADP
chd-116	5	759	human	human	ADJ
chd-116	5	760	genomics	genomic	NOUN
chd-116	5	761	and	and	CCONJ
chd-116	5	762	infectious	infectious	ADJ
chd-116	5	763	diseases	disease	NOUN
chd-116	5	764	,	,	PUNCT
chd-116	5	765	university	university	NOUN
chd-116	5	766	of	of	ADP
chd-116	5	767	nigeria	nigeria	PROPN
chd-116	5	768	,	,	PUNCT
chd-116	5	769	nsukka	nsukka	PROPN
chd-116	5	770	,	,	PUNCT
chd-116	5	771	nigeria	nigeria	PROPN
chd-116	5	772	*	*	PUNCT
chd-116	5	773	corresponding	correspond	VERB
chd-116	5	774	author	author	NOUN
chd-116	5	775	:	:	PUNCT
chd-116	5	776	mohammed	mohammed	PROPN
chd-116	5	777	faruk	faruk	PROPN
chd-116	5	778	,	,	PUNCT
chd-116	5	779	e	e	NOUN
chd-116	5	780	-	-	NOUN
chd-116	5	781	mail	mail	NOUN
chd-116	5	782	:	:	PUNCT
chd-116	5	783	fmohammed@abu.edu.ng	fmohammed@abu.edu.ng	PROPN
chd-116	5	784	mailto:fmohammed@abu.edu.ng	mailto:fmohammed@abu.edu.ng	ADV
chd-116	5	785	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	5	786	e3	e3	NOUN
chd-116	5	787	cancer	cancer	NOUN
chd-116	5	788	health	health	NOUN
chd-116	5	789	disparities	disparity	NOUN
chd-116	5	790	research	research	VERB
chd-116	5	791	abstract	abstract	ADJ
chd-116	5	792	poor	poor	ADJ
chd-116	5	793	understanding	understanding	NOUN
chd-116	5	794	of	of	ADP
chd-116	5	795	the	the	DET
chd-116	5	796	clinicopathological	clinicopathological	ADJ
chd-116	5	797	features	feature	NOUN
chd-116	5	798	of	of	ADP
chd-116	5	799	prostate	prostate	NOUN
chd-116	5	800	cancer	cancer	NOUN
chd-116	5	801	(	(	PUNCT
chd-116	5	802	cap	cap	NOUN
chd-116	5	803	)	)	PUNCT
chd-116	5	804	in	in	ADP
chd-116	5	805	black	black	ADJ
chd-116	5	806	men	man	NOUN
chd-116	5	807	(	(	PUNCT
chd-116	5	808	bm	bm	PROPN
chd-116	5	809	)	)	PUNCT
chd-116	5	810	is	be	AUX
chd-116	5	811	one	one	NUM
chd-116	5	812	of	of	ADP
chd-116	5	813	the	the	DET
chd-116	5	814	major	major	ADJ
chd-116	5	815	challenges	challenge	NOUN
chd-116	5	816	implicated	implicate	VERB
chd-116	5	817	in	in	ADP
chd-116	5	818	the	the	DET
chd-116	5	819	management	management	NOUN
chd-116	5	820	and	and	CCONJ
chd-116	5	821	prevention	prevention	NOUN
chd-116	5	822	of	of	ADP
chd-116	5	823	the	the	DET
chd-116	5	824	disease	disease	NOUN
chd-116	5	825	.	.	PUNCT
chd-116	6	1	the	the	DET
chd-116	6	2	development	development	NOUN
chd-116	6	3	of	of	ADP
chd-116	6	4	cap	cap	NOUN
chd-116	6	5	involves	involve	VERB
chd-116	6	6	an	an	DET
chd-116	6	7	accumulation	accumulation	NOUN
chd-116	6	8	of	of	ADP
chd-116	6	9	multiple	multiple	ADJ
chd-116	6	10	oncogenic	oncogenic	ADJ
chd-116	6	11	events	event	NOUN
chd-116	6	12	with	with	ADP
chd-116	6	13	associated	associated	ADJ
chd-116	6	14	increase	increase	NOUN
chd-116	6	15	in	in	ADP
chd-116	6	16	prostate	prostate	NOUN
chd-116	6	17	specific	specific	ADJ
chd-116	6	18	antigen	antigen	NOUN
chd-116	6	19	(	(	PUNCT
chd-116	6	20	psa	psa	NOUN
chd-116	6	21	)	)	PUNCT
chd-116	6	22	and	and	CCONJ
chd-116	6	23	stress	stress	NOUN
chd-116	6	24	related	relate	VERB
chd-116	6	25	hormones	hormone	NOUN
chd-116	6	26	such	such	ADJ
chd-116	6	27	as	as	ADP
chd-116	6	28	cortisol	cortisol	ADJ
chd-116	6	29	.	.	PUNCT
chd-116	7	1	this	this	DET
chd-116	7	2	research	research	NOUN
chd-116	7	3	aims	aim	VERB
chd-116	7	4	to	to	PART
chd-116	7	5	examine	examine	VERB
chd-116	7	6	the	the	DET
chd-116	7	7	role	role	NOUN
chd-116	7	8	of	of	ADP
chd-116	7	9	cortisol	cortisol	NOUN
chd-116	7	10	and	and	CCONJ
chd-116	7	11	health	health	NOUN
chd-116	7	12	-	-	PUNCT
chd-116	7	13	related	relate	VERB
chd-116	7	14	quality	quality	NOUN
chd-116	7	15	of	of	ADP
chd-116	7	16	life	life	NOUN
chd-116	7	17	(	(	PUNCT
chd-116	7	18	hrqol	hrqol	NOUN
chd-116	7	19	)	)	PUNCT
chd-116	7	20	in	in	ADP
chd-116	7	21	cap	cap	NOUN
chd-116	7	22	development	development	NOUN
chd-116	7	23	.	.	PUNCT
chd-116	8	1	data	datum	NOUN
chd-116	8	2	was	be	AUX
chd-116	8	3	collected	collect	VERB
chd-116	8	4	as	as	ADP
chd-116	8	5	part	part	NOUN
chd-116	8	6	of	of	ADP
chd-116	8	7	a	a	DET
chd-116	8	8	large	large	ADJ
chd-116	8	9	captc	captc	ADJ
chd-116	8	10	familial	familial	ADJ
chd-116	8	11	cap	cap	NOUN
chd-116	8	12	cohort	cohort	NOUN
chd-116	8	13	study	study	NOUN
chd-116	8	14	.	.	PUNCT
chd-116	9	1	the	the	DET
chd-116	9	2	hrqol	hrqol	NOUN
chd-116	9	3	indicators	indicator	NOUN
chd-116	9	4	were	be	AUX
chd-116	9	5	measured	measure	VERB
chd-116	9	6	and	and	CCONJ
chd-116	9	7	salivary	salivary	ADJ
chd-116	9	8	cortisol	cortisol	ADJ
chd-116	9	9	levels	level	NOUN
chd-116	9	10	evaluated	evaluate	VERB
chd-116	9	11	by	by	ADP
chd-116	9	12	enzyme	enzyme	NOUN
chd-116	9	13	immunoassay	immunoassay	NOUN
chd-116	9	14	.	.	PUNCT
chd-116	10	1	cap	cap	NOUN
chd-116	10	2	tissue	tissue	NOUN
chd-116	10	3	expression	expression	NOUN
chd-116	10	4	patterns	pattern	NOUN
chd-116	10	5	of	of	ADP
chd-116	10	6	cortisol	cortisol	NOUN
chd-116	10	7	and	and	CCONJ
chd-116	10	8	annexin	annexin	NOUN
chd-116	10	9	v	v	NUM
chd-116	10	10	were	be	AUX
chd-116	10	11	also	also	ADV
chd-116	10	12	studied	study	VERB
chd-116	10	13	by	by	ADP
chd-116	10	14	immunohistochemistry	immunohistochemistry	NOUN
chd-116	10	15	.	.	PUNCT
chd-116	11	1	the	the	DET
chd-116	11	2	hrqol	hrqol	NOUN
chd-116	11	3	indicators	indicator	NOUN
chd-116	11	4	showed	show	VERB
chd-116	11	5	a	a	DET
chd-116	11	6	significant	significant	ADJ
chd-116	11	7	difference	difference	NOUN
chd-116	11	8	between	between	ADP
chd-116	11	9	participants	participant	NOUN
chd-116	11	10	with	with	ADP
chd-116	11	11	and	and	CCONJ
chd-116	11	12	without	without	ADP
chd-116	11	13	physical	physical	ADJ
chd-116	11	14	activity	activity	NOUN
chd-116	11	15	(	(	PUNCT
chd-116	11	16	p	p	X
chd-116	11	17	=	=	NOUN
chd-116	11	18	0.025	0.025	NUM
chd-116	11	19	)	)	PUNCT
chd-116	11	20	,	,	PUNCT
chd-116	11	21	stress	stress	NOUN
chd-116	11	22	(	(	PUNCT
chd-116	11	23	p	p	NOUN
chd-116	11	24	=	=	NOUN
chd-116	11	25	0.008	0.008	NUM
chd-116	11	26	)	)	PUNCT
chd-116	11	27	and	and	CCONJ
chd-116	11	28	self	self	NOUN
chd-116	11	29	-	-	PUNCT
chd-116	11	30	care	care	NOUN
chd-116	11	31	(	(	PUNCT
chd-116	11	32	p	p	NOUN
chd-116	11	33	=	=	NOUN
chd-116	11	34	0.005	0.005	NUM
chd-116	11	35	)	)	PUNCT
chd-116	11	36	.	.	PUNCT
chd-116	12	1	there	there	PRON
chd-116	12	2	was	be	VERB
chd-116	12	3	significant	significant	ADJ
chd-116	12	4	increase	increase	NOUN
chd-116	12	5	in	in	ADP
chd-116	12	6	salivary	salivary	ADJ
chd-116	12	7	cortisol	cortisol	ADJ
chd-116	12	8	levels	level	NOUN
chd-116	12	9	in	in	ADP
chd-116	12	10	the	the	DET
chd-116	12	11	cap	cap	NOUN
chd-116	12	12	patients	patient	NOUN
chd-116	12	13	compared	compare	VERB
chd-116	12	14	to	to	ADP
chd-116	12	15	cap	cap	NOUN
chd-116	12	16	-	-	PUNCT
chd-116	12	17	free	free	ADJ
chd-116	12	18	participants	participant	NOUN
chd-116	12	19	(	(	PUNCT
chd-116	12	20	p	p	X
chd-116	12	21	=	=	NOUN
chd-116	12	22	0.003	0.003	NUM
chd-116	12	23	)	)	PUNCT
chd-116	12	24	.	.	PUNCT
chd-116	13	1	the	the	DET
chd-116	13	2	salivary	salivary	ADJ
chd-116	13	3	cortisol	cortisol	ADJ
chd-116	13	4	level	level	NOUN
chd-116	13	5	for	for	ADP
chd-116	13	6	the	the	DET
chd-116	13	7	cap	cap	NOUN
chd-116	13	8	patients	patient	NOUN
chd-116	13	9	ranged	range	VERB
chd-116	13	10	from	from	ADP
chd-116	13	11	1.029	1.029	NUM
chd-116	13	12	µg	µg	NOUN
chd-116	13	13	/	/	SYM
chd-116	13	14	dl	dl	NOUN
chd-116	13	15	to	to	ADP
chd-116	13	16	0.037	0.037	NUM
chd-116	13	17	µg	µg	NOUN
chd-116	13	18	/	/	SYM
chd-116	13	19	dl	dl	PROPN
chd-116	13	20	while	while	SCONJ
chd-116	13	21	the	the	DET
chd-116	13	22	range	range	NOUN
chd-116	13	23	for	for	ADP
chd-116	13	24	the	the	DET
chd-116	13	25	cap	cap	NOUN
chd-116	13	26	-	-	PUNCT
chd-116	13	27	free	free	ADJ
chd-116	13	28	participants	participant	NOUN
chd-116	13	29	was	be	AUX
chd-116	13	30	from	from	ADP
chd-116	13	31	0.139	0.139	NUM
chd-116	13	32	µg	µg	NOUN
chd-116	13	33	/	/	SYM
chd-116	13	34	dl	dl	NOUN
chd-116	13	35	to	to	ADP
chd-116	13	36	0.026	0.026	NUM
chd-116	13	37	µg	µg	NOUN
chd-116	13	38	/	/	SYM
chd-116	13	39	dl	dl	PROPN
chd-116	13	40	.	.	PROPN
chd-116	14	1	in	in	ADP
chd-116	14	2	addition	addition	NOUN
chd-116	14	3	,	,	PUNCT
chd-116	14	4	we	we	PRON
chd-116	14	5	found	find	VERB
chd-116	14	6	increased	increase	VERB
chd-116	14	7	expression	expression	NOUN
chd-116	14	8	of	of	ADP
chd-116	14	9	the	the	DET
chd-116	14	10	cortisol	cortisol	ADJ
chd-116	14	11	protein	protein	NOUN
chd-116	14	12	in	in	ADP
chd-116	14	13	cap	cap	NOUN
chd-116	14	14	patients	patient	NOUN
chd-116	14	15	with	with	ADP
chd-116	14	16	gleason	gleason	PROPN
chd-116	14	17	score	score	PROPN
chd-116	14	18	8	8	NUM
chd-116	14	19	compared	compare	VERB
chd-116	14	20	to	to	ADP
chd-116	14	21	those	those	PRON
chd-116	14	22	with	with	ADP
chd-116	14	23	lower	low	ADJ
chd-116	14	24	scores	score	NOUN
chd-116	14	25	and	and	CCONJ
chd-116	14	26	the	the	DET
chd-116	14	27	cap	cap	NOUN
chd-116	14	28	tissues	tissue	NOUN
chd-116	14	29	showed	show	VERB
chd-116	14	30	overexpression	overexpression	NOUN
chd-116	14	31	of	of	ADP
chd-116	14	32	annexin	annexin	NOUN
chd-116	14	33	v	v	ADP
chd-116	14	34	protein	protein	NOUN
chd-116	14	35	.	.	PUNCT
chd-116	15	1	salivary	salivary	VERB
chd-116	15	2	and	and	CCONJ
chd-116	15	3	tissue	tissue	NOUN
chd-116	15	4	cortisol	cortisol	NOUN
chd-116	15	5	levels	level	NOUN
chd-116	15	6	with	with	ADP
chd-116	15	7	an	an	DET
chd-116	15	8	accompanying	accompany	VERB
chd-116	15	9	annexin	annexin	NOUN
chd-116	15	10	v	v	ADP
chd-116	15	11	expression	expression	NOUN
chd-116	15	12	may	may	AUX
chd-116	15	13	serve	serve	VERB
chd-116	15	14	as	as	ADP
chd-116	15	15	important	important	ADJ
chd-116	15	16	biomarkers	biomarker	NOUN
chd-116	15	17	for	for	ADP
chd-116	15	18	cap	cap	NOUN
chd-116	15	19	diagnosis	diagnosis	NOUN
chd-116	15	20	and	and	CCONJ
chd-116	15	21	prognosis	prognosis	NOUN
chd-116	15	22	in	in	ADP
chd-116	15	23	west	west	ADJ
chd-116	15	24	african	african	ADJ
chd-116	15	25	black	black	ADJ
chd-116	15	26	men	man	NOUN
chd-116	15	27	.	.	PUNCT
chd-116	16	1	keywords	keyword	NOUN
chd-116	16	2	:	:	PUNCT
chd-116	16	3	prostate	prostate	NOUN
chd-116	16	4	cancer	cancer	NOUN
chd-116	16	5	,	,	PUNCT
chd-116	16	6	african	african	ADJ
chd-116	16	7	black	black	ADJ
chd-116	16	8	men	man	NOUN
chd-116	16	9	,	,	PUNCT
chd-116	16	10	nigerian	nigerian	ADJ
chd-116	16	11	men	man	NOUN
chd-116	16	12	,	,	PUNCT
chd-116	16	13	cameroonian	cameroonian	ADJ
chd-116	16	14	men	man	NOUN
chd-116	16	15	,	,	PUNCT
chd-116	16	16	cortisol	cortisol	NOUN
chd-116	16	17	,	,	PUNCT
chd-116	16	18	health	health	NOUN
chd-116	16	19	related	relate	VERB
chd-116	16	20	quality	quality	NOUN
chd-116	16	21	of	of	ADP
chd-116	16	22	life	life	NOUN
chd-116	16	23	citation	citation	NOUN
chd-116	16	24	:	:	PUNCT
chd-116	16	25	faruk	faruk	PROPN
chd-116	16	26	et	et	PROPN
chd-116	16	27	al	al	PROPN
chd-116	16	28	(	(	PUNCT
chd-116	16	29	2019	2019	NUM
chd-116	16	30	)	)	PUNCT
chd-116	16	31	cortisol	cortisol	NOUN
chd-116	16	32	and	and	CCONJ
chd-116	16	33	health	health	NOUN
chd-116	16	34	-	-	PUNCT
chd-116	16	35	related	relate	VERB
chd-116	16	36	quality	quality	NOUN
chd-116	16	37	of	of	ADP
chd-116	16	38	life	life	NOUN
chd-116	16	39	as	as	ADP
chd-116	16	40	prognostic	prognostic	ADJ
chd-116	16	41	indicators	indicator	NOUN
chd-116	16	42	for	for	ADP
chd-116	16	43	prostate	prostate	NOUN
chd-116	16	44	cancer	cancer	NOUN
chd-116	16	45	risk	risk	NOUN
chd-116	16	46	in	in	ADP
chd-116	16	47	west	west	ADJ
chd-116	16	48	african	african	ADJ
chd-116	16	49	black	black	ADJ
chd-116	16	50	men	man	NOUN
chd-116	16	51	in	in	ADP
chd-116	16	52	nigeria	nigeria	PROPN
chd-116	16	53	,	,	PUNCT
chd-116	16	54	cameroon	cameroon	PROPN
chd-116	16	55	and	and	CCONJ
chd-116	16	56	the	the	DET
chd-116	16	57	usa	usa	PROPN
chd-116	16	58	:	:	PUNCT
chd-116	16	59	the	the	DET
chd-116	16	60	captc	captc	ADJ
chd-116	16	61	cohort	cohort	NOUN
chd-116	16	62	study	study	NOUN
chd-116	16	63	.	.	PUNCT
chd-116	17	1	cancer	cancer	NOUN
chd-116	17	2	health	health	NOUN
chd-116	17	3	disparities	disparity	NOUN
chd-116	17	4	4	4	NUM
chd-116	17	5	:	:	PUNCT
chd-116	17	6	e1	e1	NOUN
chd-116	17	7	-	-	PUNCT
chd-116	17	8	17	17	NUM
chd-116	17	9	.	.	PUNCT
chd-116	18	1	doi:10.9777	doi:10.9777	VERB
chd-116	18	2	/	/	SYM
chd-116	18	3	chd.2019.1009	chd.2019.1009	NOUN
chd-116	18	4	.	.	NOUN
chd-116	18	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	18	6	e4	e4	PROPN
chd-116	18	7	cancer	cancer	NOUN
chd-116	18	8	health	health	NOUN
chd-116	18	9	disparities	disparity	NOUN
chd-116	18	10	research	research	NOUN
chd-116	18	11	introduction	introduction	NOUN
chd-116	18	12	prostate	prostate	NOUN
chd-116	18	13	cancer	cancer	NOUN
chd-116	18	14	(	(	PUNCT
chd-116	18	15	cap	cap	NOUN
chd-116	18	16	)	)	PUNCT
chd-116	18	17	is	be	AUX
chd-116	18	18	a	a	DET
chd-116	18	19	significant	significant	ADJ
chd-116	18	20	public	public	ADJ
chd-116	18	21	health	health	NOUN
chd-116	18	22	challenge	challenge	NOUN
chd-116	18	23	that	that	PRON
chd-116	18	24	has	have	AUX
chd-116	18	25	disproportionately	disproportionately	ADV
chd-116	18	26	overburdened	overburden	VERB
chd-116	18	27	black	black	ADJ
chd-116	18	28	men	man	NOUN
chd-116	18	29	of	of	ADP
chd-116	18	30	african	african	ADJ
chd-116	18	31	ancestry	ancestry	NOUN
chd-116	18	32	with	with	ADP
chd-116	18	33	increased	increase	VERB
chd-116	18	34	prevalence	prevalence	NOUN
chd-116	18	35	,	,	PUNCT
chd-116	18	36	poor	poor	ADJ
chd-116	18	37	prognosis	prognosis	NOUN
chd-116	18	38	and	and	CCONJ
chd-116	18	39	heavy	heavy	ADJ
chd-116	18	40	mortality	mortality	NOUN
chd-116	18	41	rates	rate	NOUN
chd-116	18	42	(	(	PUNCT
chd-116	18	43	odedina	odedina	PROPN
chd-116	18	44	et	et	PROPN
chd-116	18	45	al	al	PROPN
chd-116	18	46	.	.	PROPN
chd-116	18	47	,	,	PUNCT
chd-116	18	48	2009	2009	NUM
chd-116	18	49	(	(	PUNCT
chd-116	18	50	a	a	X
chd-116	18	51	)	)	PUNCT
chd-116	18	52	;	;	PUNCT
chd-116	19	1	bray	bray	PROPN
chd-116	19	2	et	et	PROPN
chd-116	19	3	al	al	PROPN
chd-116	19	4	.	.	PROPN
chd-116	19	5	,	,	PUNCT
chd-116	19	6	2013	2013	NUM
chd-116	19	7	)	)	PUNCT
chd-116	19	8	.	.	PUNCT
chd-116	20	1	a	a	DET
chd-116	20	2	number	number	NOUN
chd-116	20	3	of	of	ADP
chd-116	20	4	studies	study	NOUN
chd-116	20	5	have	have	AUX
chd-116	20	6	documented	document	VERB
chd-116	20	7	significant	significant	ADJ
chd-116	20	8	cap	cap	NOUN
chd-116	20	9	burden	burden	NOUN
chd-116	20	10	among	among	ADP
chd-116	20	11	nigerian	nigerian	ADJ
chd-116	20	12	and	and	CCONJ
chd-116	20	13	cameroonian	cameroonian	ADJ
chd-116	20	14	black	black	ADJ
chd-116	20	15	men	man	NOUN
chd-116	20	16	in	in	ADP
chd-116	20	17	west	west	PROPN
chd-116	20	18	africa	africa	PROPN
chd-116	20	19	and	and	CCONJ
chd-116	20	20	the	the	DET
chd-116	20	21	diaspora	diaspora	PROPN
chd-116	20	22	(	(	PUNCT
chd-116	20	23	odedina	odedina	PROPN
chd-116	20	24	et	et	PROPN
chd-116	20	25	al	al	PROPN
chd-116	20	26	.	.	PROPN
chd-116	20	27	,	,	PUNCT
chd-116	20	28	2009	2009	NUM
chd-116	20	29	(	(	PUNCT
chd-116	20	30	b	b	NOUN
chd-116	20	31	)	)	PUNCT
chd-116	20	32	;	;	PUNCT
chd-116	21	1	kumar	kumar	PROPN
chd-116	21	2	et	et	PROPN
chd-116	21	3	al	al	PROPN
chd-116	21	4	.	.	PROPN
chd-116	21	5	,	,	PUNCT
chd-116	21	6	2009	2009	NUM
chd-116	21	7	;	;	PUNCT
chd-116	21	8	akinremi	akinremi	ADV
chd-116	21	9	et	et	PROPN
chd-116	21	10	al	al	PROPN
chd-116	21	11	.	.	PROPN
chd-116	21	12	,	,	PUNCT
chd-116	21	13	2011	2011	NUM
chd-116	21	14	;	;	PUNCT
chd-116	21	15	odedina	odedina	PROPN
chd-116	21	16	et	et	PROPN
chd-116	21	17	al	al	PROPN
chd-116	21	18	.	.	PROPN
chd-116	21	19	,	,	PUNCT
chd-116	21	20	2011(a	2011(a	NUM
chd-116	21	21	)	)	PUNCT
chd-116	21	22	;	;	PUNCT
chd-116	21	23	odedina	odedina	PROPN
chd-116	21	24	et	et	PROPN
chd-116	21	25	al	al	PROPN
chd-116	21	26	.	.	PROPN
chd-116	21	27	,	,	PUNCT
chd-116	21	28	2011	2011	NUM
chd-116	21	29	(	(	PUNCT
chd-116	21	30	b	b	NOUN
chd-116	21	31	)	)	PUNCT
chd-116	21	32	;	;	PUNCT
chd-116	21	33	enow	enow	PROPN
chd-116	21	34	orock	orock	PROPN
chd-116	21	35	et	et	PROPN
chd-116	21	36	al	al	PROPN
chd-116	21	37	.	.	PROPN
chd-116	21	38	,	,	PUNCT
chd-116	21	39	2012	2012	NUM
chd-116	21	40	;	;	PUNCT
chd-116	21	41	ferlay	ferlay	NOUN
chd-116	21	42	et	et	PROPN
chd-116	21	43	al	al	PROPN
chd-116	21	44	.	.	PROPN
chd-116	21	45	,	,	PUNCT
chd-116	21	46	2015	2015	NUM
chd-116	21	47	;	;	PUNCT
chd-116	21	48	kaninjing	kaninje	VERB
chd-116	21	49	et	et	PROPN
chd-116	21	50	al	al	PROPN
chd-116	21	51	.	.	PROPN
chd-116	21	52	,	,	PUNCT
chd-116	21	53	2017	2017	NUM
chd-116	21	54	;	;	PUNCT
chd-116	21	55	odedina	odedina	PROPN
chd-116	21	56	et	et	PROPN
chd-116	21	57	al	al	PROPN
chd-116	21	58	.	.	PROPN
chd-116	21	59	,	,	PUNCT
chd-116	21	60	2017	2017	NUM
chd-116	21	61	)	)	PUNCT
chd-116	21	62	.	.	PUNCT
chd-116	22	1	in	in	ADP
chd-116	22	2	african	african	PROPN
chd-116	22	3	americans	americans	PROPN
chd-116	22	4	,	,	PUNCT
chd-116	22	5	the	the	DET
chd-116	22	6	incidence	incidence	NOUN
chd-116	22	7	and	and	CCONJ
chd-116	22	8	mortality	mortality	NOUN
chd-116	22	9	rates	rate	NOUN
chd-116	22	10	of	of	ADP
chd-116	22	11	cap	cap	NOUN
chd-116	22	12	are	be	AUX
chd-116	22	13	disproportionately	disproportionately	ADV
chd-116	22	14	higher	high	ADJ
chd-116	22	15	than	than	ADP
chd-116	22	16	in	in	ADP
chd-116	22	17	caucasians	caucasian	NOUN
chd-116	22	18	,	,	PUNCT
chd-116	22	19	and	and	CCONJ
chd-116	22	20	the	the	DET
chd-116	22	21	prognosis	prognosis	NOUN
chd-116	22	22	worse	worse	ADV
chd-116	22	23	,	,	PUNCT
chd-116	22	24	due	due	ADJ
chd-116	22	25	largely	largely	ADV
chd-116	22	26	to	to	ADP
chd-116	22	27	genetic	genetic	ADJ
chd-116	22	28	factors	factor	NOUN
chd-116	22	29	(	(	PUNCT
chd-116	22	30	odedina	odedina	NOUN
chd-116	22	31	et	et	PROPN
chd-116	22	32	al	al	PROPN
chd-116	22	33	.	.	PROPN
chd-116	22	34	,	,	PUNCT
chd-116	22	35	2009	2009	NUM
chd-116	22	36	(	(	PUNCT
chd-116	22	37	b	b	NOUN
chd-116	22	38	)	)	PUNCT
chd-116	22	39	;	;	PUNCT
chd-116	22	40	american	american	ADJ
chd-116	22	41	cancer	cancer	NOUN
chd-116	22	42	society	society	NOUN
chd-116	22	43	,	,	PUNCT
chd-116	22	44	2013	2013	NUM
chd-116	22	45	)	)	PUNCT
chd-116	22	46	.	.	PUNCT
chd-116	23	1	personal	personal	ADJ
chd-116	23	2	factors	factor	NOUN
chd-116	23	3	(	(	PUNCT
chd-116	23	4	such	such	ADJ
chd-116	23	5	as	as	ADP
chd-116	23	6	lack	lack	NOUN
chd-116	23	7	of	of	ADP
chd-116	23	8	awareness	awareness	NOUN
chd-116	23	9	)	)	PUNCT
chd-116	23	10	,	,	PUNCT
chd-116	23	11	provider	provider	NOUN
chd-116	23	12	factors	factor	NOUN
chd-116	23	13	(	(	PUNCT
chd-116	23	14	such	such	ADJ
chd-116	23	15	as	as	ADP
chd-116	23	16	shortage	shortage	NOUN
chd-116	23	17	of	of	ADP
chd-116	23	18	human	human	ADJ
chd-116	23	19	resources	resource	NOUN
chd-116	23	20	)	)	PUNCT
chd-116	23	21	and	and	CCONJ
chd-116	23	22	healthcare	healthcare	PROPN
chd-116	23	23	systems	system	NOUN
chd-116	23	24	factors	factor	NOUN
chd-116	23	25	(	(	PUNCT
chd-116	23	26	such	such	ADJ
chd-116	23	27	as	as	ADP
chd-116	23	28	limited	limited	ADJ
chd-116	23	29	access	access	NOUN
chd-116	23	30	to	to	ADP
chd-116	23	31	appropriate	appropriate	ADJ
chd-116	23	32	treatment	treatment	NOUN
chd-116	23	33	)	)	PUNCT
chd-116	23	34	contribute	contribute	VERB
chd-116	23	35	to	to	ADP
chd-116	23	36	the	the	DET
chd-116	23	37	late	late	ADJ
chd-116	23	38	cap	cap	NOUN
chd-116	23	39	presentation	presentation	NOUN
chd-116	23	40	with	with	ADP
chd-116	23	41	metastatic	metastatic	ADJ
chd-116	23	42	disease	disease	NOUN
chd-116	23	43	as	as	ADP
chd-116	23	44	the	the	DET
chd-116	23	45	first	first	ADJ
chd-116	23	46	presenting	presenting	NOUN
chd-116	23	47	features	feature	NOUN
chd-116	23	48	at	at	ADP
chd-116	23	49	diagnosis	diagnosis	NOUN
chd-116	23	50	in	in	ADP
chd-116	23	51	black	black	ADJ
chd-116	23	52	men	man	NOUN
chd-116	23	53	of	of	ADP
chd-116	23	54	african	african	ADJ
chd-116	23	55	ancestry	ancestry	NOUN
chd-116	23	56	(	(	PUNCT
chd-116	23	57	farré	farré	NOUN
chd-116	23	58	and	and	CCONJ
chd-116	23	59	kibera	kibera	PROPN
chd-116	23	60	,	,	PUNCT
chd-116	23	61	2018	2018	NUM
chd-116	23	62	)	)	PUNCT
chd-116	23	63	.	.	PUNCT
chd-116	24	1	it	it	PRON
chd-116	24	2	is	be	AUX
chd-116	24	3	pertinent	pertinent	ADJ
chd-116	24	4	to	to	PART
chd-116	24	5	note	note	VERB
chd-116	24	6	that	that	SCONJ
chd-116	24	7	available	available	ADJ
chd-116	24	8	diagnostic	diagnostic	ADJ
chd-116	24	9	and	and	CCONJ
chd-116	24	10	prognostic	prognostic	ADJ
chd-116	24	11	tools	tool	NOUN
chd-116	24	12	for	for	ADP
chd-116	24	13	cap	cap	NOUN
chd-116	24	14	which	which	PRON
chd-116	24	15	includes	include	VERB
chd-116	24	16	prostate	prostate	NOUN
chd-116	24	17	specific	specific	ADJ
chd-116	24	18	antigen	antigen	NOUN
chd-116	24	19	(	(	PUNCT
chd-116	24	20	psa	psa	NOUN
chd-116	24	21	)	)	PUNCT
chd-116	24	22	lack	lack	NOUN
chd-116	24	23	specificity	specificity	NOUN
chd-116	24	24	and	and	CCONJ
chd-116	24	25	sensitivity	sensitivity	NOUN
chd-116	24	26	.	.	PUNCT
chd-116	25	1	this	this	PRON
chd-116	25	2	makes	make	VERB
chd-116	25	3	it	it	PRON
chd-116	25	4	difficult	difficult	ADJ
chd-116	25	5	to	to	PART
chd-116	25	6	distinguish	distinguish	VERB
chd-116	25	7	between	between	ADP
chd-116	25	8	aggressive	aggressive	ADJ
chd-116	25	9	and	and	CCONJ
chd-116	25	10	nonaggressive	nonaggressive	ADJ
chd-116	25	11	state	state	NOUN
chd-116	25	12	of	of	ADP
chd-116	25	13	the	the	DET
chd-116	25	14	disease	disease	NOUN
chd-116	25	15	for	for	ADP
chd-116	25	16	proper	proper	ADJ
chd-116	25	17	stratification	stratification	NOUN
chd-116	25	18	,	,	PUNCT
chd-116	25	19	further	further	ADJ
chd-116	25	20	evaluation	evaluation	NOUN
chd-116	25	21	and	and	CCONJ
chd-116	25	22	therapeutic	therapeutic	ADJ
chd-116	25	23	intervention	intervention	NOUN
chd-116	25	24	(	(	PUNCT
chd-116	25	25	farran	farran	NOUN
chd-116	25	26	et	et	PROPN
chd-116	25	27	al	al	PROPN
chd-116	25	28	.	.	PROPN
chd-116	25	29	,	,	PUNCT
chd-116	25	30	2018	2018	NUM
chd-116	25	31	)	)	PUNCT
chd-116	25	32	.	.	PUNCT
chd-116	26	1	to	to	PART
chd-116	26	2	explore	explore	VERB
chd-116	26	3	the	the	DET
chd-116	26	4	distinct	distinct	ADJ
chd-116	26	5	biological	biological	ADJ
chd-116	26	6	and	and	CCONJ
chd-116	26	7	environmental	environmental	ADJ
chd-116	26	8	etiology	etiology	NOUN
chd-116	26	9	of	of	ADP
chd-116	26	10	cap	cap	NOUN
chd-116	26	11	,	,	PUNCT
chd-116	26	12	the	the	DET
chd-116	26	13	prostate	prostate	NOUN
chd-116	26	14	cancer	cancer	NOUN
chd-116	26	15	transatlantic	transatlantic	ADJ
chd-116	26	16	consortium	consortium	NOUN
chd-116	26	17	(	(	PUNCT
chd-116	26	18	captc	captc	VERB
chd-116	26	19	https://epi.grants.cancer.gov/captc/	https://epi.grants.cancer.gov/captc/	NOUN
chd-116	26	20	)	)	PUNCT
chd-116	26	21	,	,	PUNCT
chd-116	26	22	a	a	DET
chd-116	26	23	us	us	PROPN
chd-116	26	24	national	national	PROPN
chd-116	26	25	institutes	institutes	PROPN
chd-116	26	26	of	of	ADP
chd-116	26	27	health	health	PROPN
chd-116	26	28	(	(	PUNCT
chd-116	26	29	nih)/	nih)/	PROPN
chd-116	26	30	national	national	PROPN
chd-116	26	31	cancer	cancer	PROPN
chd-116	26	32	institute	institute	PROPN
chd-116	26	33	(	(	PUNCT
chd-116	26	34	nci	nci	PROPN
chd-116	26	35	)	)	PUNCT
chd-116	26	36	–	–	PUNCT
chd-116	26	37	epidemiology	epidemiology	NOUN
chd-116	26	38	and	and	CCONJ
chd-116	26	39	genomics	genomics	NOUN
chd-116	26	40	research	research	NOUN
chd-116	26	41	program	program	NOUN
chd-116	26	42	(	(	PUNCT
chd-116	26	43	egrp	egrp	PROPN
chd-116	26	44	)	)	PUNCT
chd-116	26	45	approved	approve	VERB
chd-116	26	46	consortium	consortium	NOUN
chd-116	26	47	,	,	PUNCT
chd-116	26	48	utilizes	utilize	VERB
chd-116	26	49	multilevel	multilevel	NOUN
chd-116	26	50	,	,	PUNCT
chd-116	26	51	collaborative	collaborative	ADJ
chd-116	26	52	,	,	PUNCT
chd-116	26	53	transdisciplinary	transdisciplinary	ADJ
chd-116	26	54	,	,	PUNCT
chd-116	26	55	translational	translational	ADJ
chd-116	26	56	,	,	PUNCT
chd-116	26	57	and	and	CCONJ
chd-116	26	58	global	global	ADJ
chd-116	26	59	team	team	NOUN
chd-116	26	60	science	science	NOUN
chd-116	26	61	research	research	NOUN
chd-116	26	62	approach	approach	NOUN
chd-116	26	63	to	to	PART
chd-116	26	64	study	study	VERB
chd-116	26	65	black	black	ADJ
chd-116	26	66	men	man	NOUN
chd-116	26	67	globally	globally	ADV
chd-116	26	68	.	.	PUNCT
chd-116	27	1	specifically	specifically	ADV
chd-116	27	2	,	,	PUNCT
chd-116	27	3	captc	captc	ADJ
chd-116	27	4	investigators	investigator	NOUN
chd-116	27	5	address	address	VERB
chd-116	27	6	the	the	DET
chd-116	27	7	complexity	complexity	NOUN
chd-116	27	8	of	of	ADP
chd-116	27	9	cap	cap	NOUN
chd-116	27	10	taking	take	VERB
chd-116	27	11	into	into	ADP
chd-116	27	12	consideration	consideration	NOUN
chd-116	27	13	the	the	DET
chd-116	27	14	ethnic	ethnic	ADJ
chd-116	27	15	heterogeneity	heterogeneity	NOUN
chd-116	27	16	and	and	CCONJ
chd-116	27	17	geographical	geographical	ADJ
chd-116	27	18	classifications	classification	NOUN
chd-116	27	19	of	of	ADP
chd-116	27	20	black	black	ADJ
chd-116	27	21	men	man	NOUN
chd-116	27	22	with	with	ADP
chd-116	27	23	african	african	ADJ
chd-116	27	24	ancestry	ancestry	NOUN
chd-116	27	25	.	.	PUNCT
chd-116	28	1	this	this	DET
chd-116	28	2	approach	approach	NOUN
chd-116	28	3	is	be	AUX
chd-116	28	4	pertinent	pertinent	ADJ
chd-116	28	5	to	to	ADP
chd-116	28	6	understanding	understand	VERB
chd-116	28	7	the	the	DET
chd-116	28	8	etiology	etiology	NOUN
chd-116	28	9	of	of	ADP
chd-116	28	10	african	african	ADJ
chd-116	28	11	-	-	PUNCT
chd-116	28	12	associated	associate	VERB
chd-116	28	13	cap	cap	NOUN
chd-116	28	14	risk	risk	NOUN
chd-116	28	15	and	and	CCONJ
chd-116	28	16	utilizing	utilize	VERB
chd-116	28	17	the	the	DET
chd-116	28	18	diverse	diverse	ADJ
chd-116	28	19	west	west	ADJ
chd-116	28	20	african	african	ADJ
chd-116	28	21	population	population	NOUN
chd-116	28	22	will	will	AUX
chd-116	28	23	be	be	AUX
chd-116	28	24	of	of	ADP
chd-116	28	25	immense	immense	ADJ
chd-116	28	26	benefit	benefit	NOUN
chd-116	28	27	.	.	PUNCT
chd-116	29	1	the	the	DET
chd-116	29	2	initial	initial	ADJ
chd-116	29	3	state	state	NOUN
chd-116	29	4	of	of	ADP
chd-116	29	5	cap	cap	NOUN
chd-116	29	6	and	and	CCONJ
chd-116	29	7	its	its	PRON
chd-116	29	8	progression	progression	NOUN
chd-116	29	9	involves	involve	VERB
chd-116	29	10	an	an	DET
chd-116	29	11	accumulation	accumulation	NOUN
chd-116	29	12	of	of	ADP
chd-116	29	13	multiple	multiple	ADJ
chd-116	29	14	oncogenic	oncogenic	ADJ
chd-116	29	15	events	event	NOUN
chd-116	29	16	resulting	result	VERB
chd-116	29	17	in	in	ADP
chd-116	29	18	gene	gene	NOUN
chd-116	29	19	amplification	amplification	NOUN
chd-116	29	20	,	,	PUNCT
chd-116	29	21	which	which	PRON
chd-116	29	22	is	be	AUX
chd-116	29	23	associated	associate	VERB
chd-116	29	24	with	with	ADP
chd-116	29	25	increased	increase	VERB
chd-116	29	26	levels	level	NOUN
chd-116	29	27	of	of	ADP
chd-116	29	28	androgens	androgen	NOUN
chd-116	29	29	and	and	CCONJ
chd-116	29	30	prostatespecific	prostatespecific	ADJ
chd-116	29	31	antigen	antigen	NOUN
chd-116	29	32	(	(	PUNCT
chd-116	29	33	psa	psa	NOUN
chd-116	29	34	)	)	PUNCT
chd-116	29	35	.	.	PUNCT
chd-116	30	1	the	the	DET
chd-116	30	2	psa	psa	NOUN
chd-116	30	3	has	have	AUX
chd-116	30	4	been	be	AUX
chd-116	30	5	reported	report	VERB
chd-116	30	6	to	to	PART
chd-116	30	7	be	be	AUX
chd-116	30	8	higher	high	ADJ
chd-116	30	9	in	in	ADP
chd-116	30	10	black	black	ADJ
chd-116	30	11	men	man	NOUN
chd-116	30	12	compared	compare	VERB
chd-116	30	13	to	to	ADP
chd-116	30	14	caucasians	caucasian	NOUN
chd-116	30	15	,	,	PUNCT
chd-116	30	16	however	however	ADV
chd-116	30	17	,	,	PUNCT
chd-116	30	18	this	this	PRON
chd-116	30	19	has	have	AUX
chd-116	30	20	been	be	AUX
chd-116	30	21	associated	associate	VERB
chd-116	30	22	with	with	ADP
chd-116	30	23	complications	complication	NOUN
chd-116	30	24	and	and	CCONJ
chd-116	30	25	controversies	controversy	NOUN
chd-116	30	26	(	(	PUNCT
chd-116	30	27	visakorpi	visakorpi	NOUN
chd-116	30	28	et	et	PROPN
chd-116	30	29	al	al	PROPN
chd-116	30	30	.	.	PROPN
chd-116	30	31	,	,	PUNCT
chd-116	30	32	1995	1995	NUM
chd-116	30	33	;	;	PUNCT
chd-116	31	1	moul	moul	X
chd-116	31	2	et	et	PROPN
chd-116	31	3	al	al	PROPN
chd-116	31	4	..	..	PROPN
chd-116	31	5	,	,	PUNCT
chd-116	31	6	1996	1996	NUM
chd-116	31	7	;	;	PUNCT
chd-116	31	8	us	us	PROPN
chd-116	31	9	preventive	preventive	ADJ
chd-116	31	10	services	service	NOUN
chd-116	31	11	task	task	PROPN
chd-116	31	12	force	force	PROPN
chd-116	31	13	recommendation	recommendation	NOUN
chd-116	31	14	statement	statement	NOUN
chd-116	31	15	,	,	PUNCT
chd-116	31	16	2018	2018	NUM
chd-116	31	17	)	)	PUNCT
chd-116	31	18	.	.	PUNCT
chd-116	32	1	the	the	DET
chd-116	32	2	complications	complication	NOUN
chd-116	32	3	with	with	ADP
chd-116	32	4	increase	increase	NOUN
chd-116	32	5	in	in	ADP
chd-116	32	6	psa	psa	NOUN
chd-116	32	7	level	level	NOUN
chd-116	32	8	are	be	AUX
chd-116	32	9	aggravated	aggravate	VERB
chd-116	32	10	by	by	ADP
chd-116	32	11	several	several	ADJ
chd-116	32	12	abnormal	abnormal	ADJ
chd-116	32	13	mutations	mutation	NOUN
chd-116	32	14	that	that	PRON
chd-116	32	15	make	make	VERB
chd-116	32	16	cap	cap	NOUN
chd-116	32	17	cells	cell	NOUN
chd-116	32	18	more	more	ADV
chd-116	32	19	aggressive	aggressive	ADJ
chd-116	32	20	via	via	ADP
chd-116	32	21	the	the	DET
chd-116	32	22	stress	stress	NOUN
chd-116	32	23	and	and	CCONJ
chd-116	32	24	cortisol	cortisol	ADJ
chd-116	32	25	axis	axis	NOUN
chd-116	32	26	mechanisms	mechanism	NOUN
chd-116	32	27	and	and	CCONJ
chd-116	32	28	an	an	DET
chd-116	32	29	increase	increase	NOUN
chd-116	32	30	in	in	ADP
chd-116	32	31	the	the	DET
chd-116	32	32	amino	amino	NOUN
chd-116	32	33	acid	acid	NOUN
chd-116	32	34	content	content	NOUN
chd-116	32	35	within	within	ADP
chd-116	32	36	the	the	DET
chd-116	32	37	cancer	cancer	NOUN
chd-116	32	38	microenvironment	microenvironment	NOUN
chd-116	32	39	(	(	PUNCT
chd-116	32	40	gaddipati	gaddipati	PROPN
chd-116	32	41	et	et	PROPN
chd-116	32	42	al	al	PROPN
chd-116	32	43	.	.	PROPN
chd-116	32	44	,	,	PUNCT
chd-116	32	45	1994	1994	NUM
chd-116	32	46	;	;	PUNCT
chd-116	32	47	zhao	zhao	PROPN
chd-116	32	48	et	et	PROPN
chd-116	32	49	al	al	PROPN
chd-116	32	50	.	.	PROPN
chd-116	32	51	,	,	PUNCT
chd-116	32	52	2000	2000	NUM
chd-116	32	53	;	;	PUNCT
chd-116	32	54	wang	wang	PROPN
chd-116	32	55	et	et	PROPN
chd-116	32	56	al	al	PROPN
chd-116	32	57	.	.	PROPN
chd-116	32	58	,	,	PUNCT
chd-116	32	59	2013	2013	NUM
chd-116	32	60	;	;	PUNCT
chd-116	32	61	tee	tee	NOUN
chd-116	32	62	,	,	PUNCT
chd-116	32	63	2013	2013	NUM
chd-116	32	64	;	;	PUNCT
chd-116	32	65	huang	huang	PROPN
chd-116	32	66	et	et	PROPN
chd-116	32	67	al	al	PROPN
chd-116	32	68	.	.	PROPN
chd-116	32	69	,	,	PUNCT
chd-116	32	70	2018	2018	NUM
chd-116	32	71	)	)	PUNCT
chd-116	32	72	.	.	PUNCT
chd-116	33	1	in	in	ADP
chd-116	33	2	addition	addition	NOUN
chd-116	33	3	,	,	PUNCT
chd-116	33	4	amino	amino	ADJ
chd-116	33	5	acids	acid	NOUN
chd-116	33	6	via	via	ADP
chd-116	33	7	anabolic	anabolic	NOUN
chd-116	33	8	pathways	pathway	NOUN
chd-116	33	9	generate	generate	VERB
chd-116	33	10	nucleotide	nucleotide	NOUN
chd-116	33	11	and	and	CCONJ
chd-116	33	12	membrane	membrane	NOUN
chd-116	33	13	biomolecule	biomolecule	NOUN
chd-116	33	14	precursors	precursor	NOUN
chd-116	33	15	for	for	ADP
chd-116	33	16	aggressive	aggressive	ADJ
chd-116	33	17	cap	cap	NOUN
chd-116	33	18	cells	cell	NOUN
chd-116	33	19	(	(	PUNCT
chd-116	33	20	andrew	andrew	PROPN
chd-116	33	21	et	et	PROPN
chd-116	33	22	al	al	PROPN
chd-116	33	23	.	.	PROPN
chd-116	33	24	,	,	PUNCT
chd-116	33	25	2013	2013	NUM
chd-116	33	26	)	)	PUNCT
chd-116	33	27	.	.	PUNCT
chd-116	34	1	perhaps	perhaps	ADV
chd-116	34	2	,	,	PUNCT
chd-116	34	3	this	this	PRON
chd-116	34	4	explains	explain	VERB
chd-116	34	5	why	why	SCONJ
chd-116	34	6	leucine	leucine	NOUN
chd-116	34	7	may	may	AUX
chd-116	34	8	serve	serve	VERB
chd-116	34	9	as	as	ADP
chd-116	34	10	a	a	DET
chd-116	34	11	source	source	NOUN
chd-116	34	12	of	of	ADP
chd-116	34	13	fuel	fuel	NOUN
chd-116	34	14	for	for	ADP
chd-116	34	15	aggressive	aggressive	ADJ
chd-116	34	16	prostate	prostate	NOUN
chd-116	34	17	cancer	cancer	NOUN
chd-116	34	18	cells	cell	NOUN
chd-116	34	19	.	.	PUNCT
chd-116	35	1	however	however	ADV
chd-116	35	2	,	,	PUNCT
chd-116	35	3	it	it	PRON
chd-116	35	4	has	have	AUX
chd-116	35	5	not	not	PART
chd-116	35	6	been	be	AUX
chd-116	35	7	unequivocally	unequivocally	ADV
chd-116	35	8	demonstrated	demonstrate	VERB
chd-116	35	9	that	that	SCONJ
chd-116	35	10	leucine	leucine	NOUN
chd-116	35	11	is	be	AUX
chd-116	35	12	secreted	secrete	VERB
chd-116	35	13	mostly	mostly	ADV
chd-116	35	14	by	by	ADP
chd-116	35	15	cortisol	cortisol	ADJ
chd-116	35	16	overexpression	overexpression	NOUN
chd-116	35	17	.	.	PUNCT
chd-116	36	1	the	the	DET
chd-116	36	2	cortisol	cortisol	NOUN
chd-116	36	3	,	,	PUNCT
chd-116	36	4	an	an	DET
chd-116	36	5	important	important	ADJ
chd-116	36	6	glucocorticoid	glucocorticoid	ADJ
chd-116	36	7	hormone	hormone	NOUN
chd-116	36	8	,	,	PUNCT
chd-116	36	9	is	be	AUX
chd-116	36	10	synthesized	synthesize	VERB
chd-116	36	11	in	in	ADP
chd-116	36	12	the	the	DET
chd-116	36	13	body	body	NOUN
chd-116	36	14	by	by	ADP
chd-116	36	15	adrenal	adrenal	ADJ
chd-116	36	16	https://epi.grants.cancer.gov/captc/	https://epi.grants.cancer.gov/captc/	NOUN
chd-116	36	17	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	ADP
chd-116	36	18	e5	e5	PROPN
chd-116	36	19	cancer	cancer	NOUN
chd-116	36	20	health	health	NOUN
chd-116	36	21	disparities	disparity	NOUN
chd-116	36	22	research	research	VERB
chd-116	36	23	cortex	cortex	NOUN
chd-116	36	24	via	via	ADP
chd-116	36	25	adrenocorticotropin	adrenocorticotropin	NOUN
chd-116	36	26	stimulation	stimulation	NOUN
chd-116	36	27	.	.	PUNCT
chd-116	37	1	therefore	therefore	ADV
chd-116	37	2	,	,	PUNCT
chd-116	37	3	cortisol	cortisol	ADJ
chd-116	37	4	fluctuation	fluctuation	NOUN
chd-116	37	5	as	as	ADP
chd-116	37	6	a	a	DET
chd-116	37	7	result	result	NOUN
chd-116	37	8	of	of	ADP
chd-116	37	9	stress	stress	NOUN
chd-116	37	10	has	have	AUX
chd-116	37	11	been	be	AUX
chd-116	37	12	linked	link	VERB
chd-116	37	13	to	to	ADP
chd-116	37	14	allostatic	allostatic	ADJ
chd-116	37	15	load	load	NOUN
chd-116	37	16	-	-	PUNCT
chd-116	37	17	associated	associate	VERB
chd-116	37	18	diseases	disease	NOUN
chd-116	37	19	including	include	VERB
chd-116	37	20	immune	immune	ADJ
chd-116	37	21	suppression	suppression	NOUN
chd-116	37	22	(	(	PUNCT
chd-116	37	23	kirschbaum	kirschbaum	PROPN
chd-116	37	24	and	and	CCONJ
chd-116	37	25	hellhammer	hellhammer	PROPN
chd-116	37	26	,	,	PUNCT
chd-116	37	27	1999	1999	NUM
chd-116	37	28	)	)	PUNCT
chd-116	37	29	.	.	PUNCT
chd-116	38	1	only	only	ADV
chd-116	38	2	about	about	ADV
chd-116	38	3	5	5	NUM
chd-116	38	4	%	%	NOUN
chd-116	38	5	of	of	ADP
chd-116	38	6	cortisol	cortisol	NOUN
chd-116	38	7	is	be	AUX
chd-116	38	8	unbound	unbound	ADJ
chd-116	38	9	and	and	CCONJ
chd-116	38	10	freely	freely	ADV
chd-116	38	11	circulate	circulate	VERB
chd-116	38	12	to	to	ADP
chd-116	38	13	the	the	DET
chd-116	38	14	tissues	tissue	NOUN
chd-116	38	15	including	include	VERB
chd-116	38	16	salivary	salivary	ADJ
chd-116	38	17	gland	gland	NOUN
chd-116	38	18	for	for	ADP
chd-116	38	19	biological	biological	ADJ
chd-116	38	20	activity	activity	NOUN
chd-116	38	21	,	,	PUNCT
chd-116	38	22	whereas	whereas	SCONJ
chd-116	38	23	the	the	DET
chd-116	38	24	remaining	remain	VERB
chd-116	38	25	95	95	NUM
chd-116	38	26	%	%	NOUN
chd-116	38	27	is	be	AUX
chd-116	38	28	bound	bind	VERB
chd-116	38	29	to	to	ADP
chd-116	38	30	several	several	ADJ
chd-116	38	31	components	component	NOUN
chd-116	38	32	of	of	ADP
chd-116	38	33	the	the	DET
chd-116	38	34	blood	blood	NOUN
chd-116	38	35	including	include	VERB
chd-116	38	36	corticosteroid	corticosteroid	NOUN
chd-116	38	37	-	-	PUNCT
chd-116	38	38	binding	bind	VERB
chd-116	38	39	globulin	globulin	NOUN
chd-116	38	40	(	(	PUNCT
chd-116	38	41	ekins	ekin	NOUN
chd-116	38	42	,	,	PUNCT
chd-116	38	43	1990	1990	NUM
chd-116	38	44	;	;	PUNCT
chd-116	38	45	walker	walker	PROPN
chd-116	38	46	et	et	PROPN
chd-116	38	47	al	al	PROPN
chd-116	38	48	.	.	PROPN
chd-116	38	49	,	,	PUNCT
chd-116	38	50	1978	1978	NUM
chd-116	38	51	)	)	PUNCT
chd-116	38	52	.	.	PUNCT
chd-116	39	1	thus	thus	ADV
chd-116	39	2	,	,	PUNCT
chd-116	39	3	saliva	saliva	NOUN
chd-116	39	4	provides	provide	VERB
chd-116	39	5	a	a	DET
chd-116	39	6	simple	simple	ADJ
chd-116	39	7	and	and	CCONJ
chd-116	39	8	non	non	ADJ
chd-116	39	9	-	-	ADJ
chd-116	39	10	invasive	invasive	ADJ
chd-116	39	11	means	mean	NOUN
chd-116	39	12	of	of	ADP
chd-116	39	13	assessing	assess	VERB
chd-116	39	14	unbound	unbound	ADJ
chd-116	39	15	cortisol	cortisol	NOUN
chd-116	39	16	level	level	NOUN
chd-116	39	17	because	because	SCONJ
chd-116	39	18	blood	blood	NOUN
chd-116	39	19	cortisol	cortisol	NOUN
chd-116	39	20	levels	level	NOUN
chd-116	39	21	may	may	AUX
chd-116	39	22	be	be	AUX
chd-116	39	23	affected	affect	VERB
chd-116	39	24	by	by	ADP
chd-116	39	25	the	the	DET
chd-116	39	26	corticosteroid	corticosteroid	NOUN
chd-116	39	27	-	-	PUNCT
chd-116	39	28	binding	bind	VERB
chd-116	39	29	globulin	globulin	NOUN
chd-116	39	30	activity	activity	NOUN
chd-116	39	31	(	(	PUNCT
chd-116	39	32	walker	walker	PROPN
chd-116	39	33	et	et	PROPN
chd-116	39	34	al	al	PROPN
chd-116	39	35	.	.	PROPN
chd-116	39	36	,	,	PUNCT
chd-116	39	37	1978	1978	NUM
chd-116	39	38	)	)	PUNCT
chd-116	39	39	.	.	PUNCT
chd-116	40	1	health	health	NOUN
chd-116	40	2	-	-	PUNCT
chd-116	40	3	related	relate	VERB
chd-116	40	4	quality	quality	NOUN
chd-116	40	5	of	of	ADP
chd-116	40	6	life	life	NOUN
chd-116	40	7	(	(	PUNCT
chd-116	40	8	hrqol	hrqol	NOUN
chd-116	40	9	)	)	PUNCT
chd-116	40	10	has	have	AUX
chd-116	40	11	also	also	ADV
chd-116	40	12	been	be	AUX
chd-116	40	13	reported	report	VERB
chd-116	40	14	to	to	PART
chd-116	40	15	be	be	AUX
chd-116	40	16	associated	associate	VERB
chd-116	40	17	with	with	ADP
chd-116	40	18	psa	psa	NOUN
chd-116	40	19	status	status	NOUN
chd-116	40	20	in	in	ADP
chd-116	40	21	men	man	NOUN
chd-116	40	22	with	with	ADP
chd-116	40	23	cap	cap	NOUN
chd-116	40	24	(	(	PUNCT
chd-116	40	25	gidron	gidron	NOUN
chd-116	40	26	et	et	PROPN
chd-116	40	27	al	al	PROPN
chd-116	40	28	.	.	PROPN
chd-116	40	29	,	,	PUNCT
chd-116	40	30	2011	2011	NUM
chd-116	40	31	)	)	PUNCT
chd-116	40	32	.	.	PUNCT
chd-116	41	1	since	since	SCONJ
chd-116	41	2	a	a	DET
chd-116	41	3	deficiency	deficiency	NOUN
chd-116	41	4	in	in	ADP
chd-116	41	5	cortisol	cortisol	ADJ
chd-116	41	6	secretion	secretion	NOUN
chd-116	41	7	results	result	NOUN
chd-116	41	8	to	to	ADP
chd-116	41	9	quiescent	quiescent	ADJ
chd-116	41	10	immune	immune	ADJ
chd-116	41	11	system	system	NOUN
chd-116	41	12	and	and	CCONJ
chd-116	41	13	overexpression	overexpression	NOUN
chd-116	41	14	of	of	ADP
chd-116	41	15	cortisol	cortisol	NOUN
chd-116	41	16	contribute	contribute	VERB
chd-116	41	17	to	to	ADP
chd-116	41	18	suppression	suppression	NOUN
chd-116	41	19	of	of	ADP
chd-116	41	20	immune	immune	ADJ
chd-116	41	21	responses	response	NOUN
chd-116	41	22	and	and	CCONJ
chd-116	41	23	possible	possible	ADJ
chd-116	41	24	tumorigenesis	tumorigenesis	NOUN
chd-116	41	25	(	(	PUNCT
chd-116	41	26	munck	munck	NOUN
chd-116	41	27	and	and	CCONJ
chd-116	41	28	narayfejes	narayfejes	NOUN
chd-116	41	29	-	-	PUNCT
chd-116	41	30	toth	toth	NOUN
chd-116	41	31	,	,	PUNCT
chd-116	41	32	1995	1995	NUM
chd-116	41	33	;	;	PUNCT
chd-116	41	34	coussens	coussen	NOUN
chd-116	41	35	and	and	CCONJ
chd-116	41	36	werb	werb	ADJ
chd-116	41	37	,	,	PUNCT
chd-116	41	38	2002	2002	NUM
chd-116	41	39	)	)	PUNCT
chd-116	41	40	,	,	PUNCT
chd-116	41	41	our	our	PRON
chd-116	41	42	study	study	NOUN
chd-116	41	43	focused	focus	VERB
chd-116	41	44	on	on	ADP
chd-116	41	45	the	the	DET
chd-116	41	46	expression	expression	NOUN
chd-116	41	47	pattern	pattern	NOUN
chd-116	41	48	of	of	ADP
chd-116	41	49	cortisol	cortisol	NOUN
chd-116	41	50	in	in	ADP
chd-116	41	51	cap	cap	NOUN
chd-116	41	52	tissue	tissue	NOUN
chd-116	41	53	cells	cell	NOUN
chd-116	41	54	,	,	PUNCT
chd-116	41	55	taking	take	VERB
chd-116	41	56	into	into	ADP
chd-116	41	57	considerations	consideration	NOUN
chd-116	41	58	the	the	DET
chd-116	41	59	gleason	gleason	PROPN
chd-116	41	60	score	score	NOUN
chd-116	41	61	by	by	ADP
chd-116	41	62	immunohistochemistry	immunohistochemistry	NOUN
chd-116	41	63	.	.	PUNCT
chd-116	42	1	the	the	DET
chd-116	42	2	ability	ability	NOUN
chd-116	42	3	of	of	ADP
chd-116	42	4	cortisol	cortisol	NOUN
chd-116	42	5	to	to	PART
chd-116	42	6	regulate	regulate	VERB
chd-116	42	7	immunological	immunological	ADJ
chd-116	42	8	and	and	CCONJ
chd-116	42	9	inflammatory	inflammatory	ADJ
chd-116	42	10	processes	process	NOUN
chd-116	42	11	prompted	prompt	VERB
chd-116	42	12	us	we	PRON
chd-116	42	13	to	to	PART
chd-116	42	14	explore	explore	VERB
chd-116	42	15	the	the	DET
chd-116	42	16	expression	expression	NOUN
chd-116	42	17	pattern	pattern	NOUN
chd-116	42	18	of	of	ADP
chd-116	42	19	annexin	annexin	NOUN
chd-116	42	20	v	v	NOUN
chd-116	42	21	,	,	PUNCT
chd-116	42	22	an	an	DET
chd-116	42	23	intracellular	intracellular	ADJ
chd-116	42	24	protein	protein	NOUN
chd-116	42	25	with	with	ADP
chd-116	42	26	affinity	affinity	NOUN
chd-116	42	27	to	to	PART
chd-116	42	28	phosphatidylserine	phosphatidylserine	VERB
chd-116	42	29	,	,	PUNCT
chd-116	42	30	which	which	PRON
chd-116	42	31	is	be	AUX
chd-116	42	32	expressed	express	VERB
chd-116	42	33	on	on	ADP
chd-116	42	34	the	the	DET
chd-116	42	35	surface	surface	NOUN
chd-116	42	36	of	of	ADP
chd-116	42	37	physiologically	physiologically	ADV
chd-116	42	38	stressed	stress	VERB
chd-116	42	39	cells	cell	NOUN
chd-116	42	40	and	and	CCONJ
chd-116	42	41	functions	function	NOUN
chd-116	42	42	in	in	ADP
chd-116	42	43	inhibition	inhibition	NOUN
chd-116	42	44	of	of	ADP
chd-116	42	45	cancer	cancer	NOUN
chd-116	42	46	angiogenesis	angiogenesis	NOUN
chd-116	42	47	(	(	PUNCT
chd-116	42	48	blankenberg	blankenberg	PROPN
chd-116	42	49	,	,	PUNCT
chd-116	42	50	2009	2009	NUM
chd-116	42	51	)	)	PUNCT
chd-116	42	52	.	.	PUNCT
chd-116	43	1	in	in	ADP
chd-116	43	2	line	line	NOUN
chd-116	43	3	with	with	ADP
chd-116	43	4	our	our	PRON
chd-116	43	5	long	long	ADJ
chd-116	43	6	-	-	PUNCT
chd-116	43	7	term	term	NOUN
chd-116	43	8	goal	goal	NOUN
chd-116	43	9	of	of	ADP
chd-116	43	10	addressing	address	VERB
chd-116	43	11	the	the	DET
chd-116	43	12	burden	burden	NOUN
chd-116	43	13	of	of	ADP
chd-116	43	14	cap	cap	NOUN
chd-116	43	15	in	in	ADP
chd-116	43	16	west	west	ADJ
chd-116	43	17	african	african	ADJ
chd-116	43	18	men	man	NOUN
chd-116	43	19	,	,	PUNCT
chd-116	43	20	the	the	DET
chd-116	43	21	primary	primary	ADJ
chd-116	43	22	objective	objective	NOUN
chd-116	43	23	of	of	ADP
chd-116	43	24	this	this	DET
chd-116	43	25	study	study	NOUN
chd-116	43	26	was	be	AUX
chd-116	43	27	to	to	PART
chd-116	43	28	examine	examine	VERB
chd-116	43	29	the	the	DET
chd-116	43	30	role	role	NOUN
chd-116	43	31	of	of	ADP
chd-116	43	32	cortisol	cortisol	NOUN
chd-116	43	33	and	and	CCONJ
chd-116	43	34	hrqol	hrqol	NOUN
chd-116	43	35	in	in	ADP
chd-116	43	36	the	the	DET
chd-116	43	37	development	development	NOUN
chd-116	43	38	of	of	ADP
chd-116	43	39	cap	cap	NOUN
chd-116	43	40	among	among	ADP
chd-116	43	41	nigerian	nigerian	ADJ
chd-116	43	42	and	and	CCONJ
chd-116	43	43	cameroonian	cameroonian	ADJ
chd-116	43	44	men	man	NOUN
chd-116	43	45	living	live	VERB
chd-116	43	46	in	in	ADP
chd-116	43	47	nigeria	nigeria	PROPN
chd-116	43	48	,	,	PUNCT
chd-116	43	49	cameroon	cameroon	PROPN
chd-116	43	50	and	and	CCONJ
chd-116	43	51	united	united	PROPN
chd-116	43	52	states	states	PROPN
chd-116	43	53	.	.	PUNCT
chd-116	44	1	findings	finding	NOUN
chd-116	44	2	from	from	ADP
chd-116	44	3	this	this	DET
chd-116	44	4	study	study	NOUN
chd-116	44	5	show	show	VERB
chd-116	44	6	significant	significant	ADJ
chd-116	44	7	differences	difference	NOUN
chd-116	44	8	in	in	ADP
chd-116	44	9	hrqol	hrqol	NOUN
chd-116	44	10	,	,	PUNCT
chd-116	44	11	salivary	salivary	ADJ
chd-116	44	12	cortisol	cortisol	ADJ
chd-116	44	13	level	level	NOUN
chd-116	44	14	and	and	CCONJ
chd-116	44	15	tissue	tissue	NOUN
chd-116	44	16	cortisol	cortisol	ADJ
chd-116	44	17	expression	expression	NOUN
chd-116	44	18	pattern	pattern	NOUN
chd-116	44	19	in	in	ADP
chd-116	44	20	the	the	DET
chd-116	44	21	cap	cap	NOUN
chd-116	44	22	patients	patient	NOUN
chd-116	44	23	compared	compare	VERB
chd-116	44	24	to	to	ADP
chd-116	44	25	cap	cap	NOUN
chd-116	44	26	-	-	PUNCT
chd-116	44	27	free	free	ADJ
chd-116	44	28	participants	participant	NOUN
chd-116	44	29	.	.	PUNCT
chd-116	45	1	these	these	DET
chd-116	45	2	findings	finding	NOUN
chd-116	45	3	may	may	AUX
chd-116	45	4	have	have	VERB
chd-116	45	5	a	a	DET
chd-116	45	6	significant	significant	ADJ
chd-116	45	7	impact	impact	NOUN
chd-116	45	8	on	on	ADP
chd-116	45	9	cap	cap	NOUN
chd-116	45	10	risk	risk	NOUN
chd-116	45	11	and	and	CCONJ
chd-116	45	12	prognosis	prognosis	NOUN
chd-116	45	13	,	,	PUNCT
chd-116	45	14	and	and	CCONJ
chd-116	45	15	may	may	AUX
chd-116	45	16	contribute	contribute	VERB
chd-116	45	17	to	to	ADP
chd-116	45	18	the	the	DET
chd-116	45	19	understanding	understanding	NOUN
chd-116	45	20	of	of	ADP
chd-116	45	21	the	the	DET
chd-116	45	22	genetic	genetic	ADJ
chd-116	45	23	,	,	PUNCT
chd-116	45	24	environmental	environmental	ADJ
chd-116	45	25	and	and	CCONJ
chd-116	45	26	behavioral	behavioral	ADJ
chd-116	45	27	etiological	etiological	ADJ
chd-116	45	28	factors	factor	NOUN
chd-116	45	29	associated	associate	VERB
chd-116	45	30	with	with	ADP
chd-116	45	31	the	the	DET
chd-116	45	32	disease	disease	NOUN
chd-116	45	33	in	in	ADP
chd-116	45	34	black	black	ADJ
chd-116	45	35	men	man	NOUN
chd-116	45	36	.	.	PUNCT
chd-116	46	1	methods	method	NOUN
chd-116	46	2	study	study	VERB
chd-116	46	3	participants	participant	NOUN
chd-116	46	4	and	and	CCONJ
chd-116	46	5	recruitment	recruitment	NOUN
chd-116	46	6	the	the	DET
chd-116	46	7	participants	participant	NOUN
chd-116	46	8	recruited	recruit	VERB
chd-116	46	9	for	for	ADP
chd-116	46	10	this	this	DET
chd-116	46	11	pilot	pilot	NOUN
chd-116	46	12	study	study	NOUN
chd-116	46	13	were	be	AUX
chd-116	46	14	nigerian	nigerian	ADJ
chd-116	46	15	and	and	CCONJ
chd-116	46	16	cameroonian	cameroonian	ADJ
chd-116	46	17	black	black	ADJ
chd-116	46	18	men	man	NOUN
chd-116	46	19	within	within	ADP
chd-116	46	20	the	the	DET
chd-116	46	21	age	age	NOUN
chd-116	46	22	bracket	bracket	NOUN
chd-116	46	23	of	of	ADP
chd-116	46	24	35	35	NUM
chd-116	46	25	to	to	PART
chd-116	46	26	70	70	NUM
chd-116	46	27	years	year	NOUN
chd-116	46	28	and	and	CCONJ
chd-116	46	29	residing	reside	VERB
chd-116	46	30	in	in	ADP
chd-116	46	31	nigeria	nigeria	PROPN
chd-116	46	32	,	,	PUNCT
chd-116	46	33	the	the	DET
chd-116	46	34	republic	republic	NOUN
chd-116	46	35	of	of	ADP
chd-116	46	36	cameroon	cameroon	PROPN
chd-116	46	37	and	and	CCONJ
chd-116	46	38	the	the	DET
chd-116	46	39	united	united	PROPN
chd-116	46	40	states	states	PROPN
chd-116	46	41	of	of	ADP
chd-116	46	42	america	america	PROPN
chd-116	46	43	(	(	PUNCT
chd-116	46	44	us	us	PROPN
chd-116	46	45	)	)	PUNCT
chd-116	46	46	participants	participant	NOUN
chd-116	46	47	were	be	AUX
chd-116	46	48	recruited	recruit	VERB
chd-116	46	49	as	as	ADP
chd-116	46	50	part	part	NOUN
chd-116	46	51	of	of	ADP
chd-116	46	52	the	the	DET
chd-116	46	53	large	large	ADJ
chd-116	46	54	-	-	PUNCT
chd-116	46	55	scale	scale	NOUN
chd-116	46	56	captc	captc	NOUN
chd-116	46	57	study	study	NOUN
chd-116	46	58	focused	focus	VERB
chd-116	46	59	on	on	ADP
chd-116	46	60	studying	study	VERB
chd-116	46	61	a	a	DET
chd-116	46	62	familial	familial	ADJ
chd-116	46	63	cohort	cohort	NOUN
chd-116	46	64	of	of	ADP
chd-116	46	65	west	west	ADJ
chd-116	46	66	african	african	ADJ
chd-116	46	67	men	man	NOUN
chd-116	46	68	in	in	ADP
chd-116	46	69	multiple	multiple	ADJ
chd-116	46	70	countries	country	NOUN
chd-116	46	71	.	.	PUNCT
chd-116	47	1	the	the	DET
chd-116	47	2	captc	captc	ADJ
chd-116	47	3	study	study	NOUN
chd-116	47	4	(	(	PUNCT
chd-116	47	5	which	which	PRON
chd-116	47	6	is	be	AUX
chd-116	47	7	ongoing	ongoing	ADJ
chd-116	47	8	)	)	PUNCT
chd-116	47	9	is	be	AUX
chd-116	47	10	using	use	VERB
chd-116	47	11	the	the	DET
chd-116	47	12	heterogeneity	heterogeneity	NOUN
chd-116	47	13	of	of	ADP
chd-116	47	14	the	the	DET
chd-116	47	15	study	study	NOUN
chd-116	47	16	participants	participant	NOUN
chd-116	47	17	,	,	PUNCT
chd-116	47	18	including	include	VERB
chd-116	47	19	geographical	geographical	ADJ
chd-116	47	20	locations	location	NOUN
chd-116	47	21	,	,	PUNCT
chd-116	47	22	to	to	PART
chd-116	47	23	explore	explore	VERB
chd-116	47	24	the	the	DET
chd-116	47	25	genetic	genetic	ADJ
chd-116	47	26	,	,	PUNCT
chd-116	47	27	environmental	environmental	ADJ
chd-116	47	28	and	and	CCONJ
chd-116	47	29	behavioral	behavioral	ADJ
chd-116	47	30	etiological	etiological	ADJ
chd-116	47	31	factors	factor	NOUN
chd-116	47	32	associated	associate	VERB
chd-116	47	33	with	with	ADP
chd-116	47	34	cap	cap	NOUN
chd-116	47	35	.	.	PUNCT
chd-116	48	1	the	the	DET
chd-116	48	2	study	study	NOUN
chd-116	48	3	inclusion	inclusion	NOUN
chd-116	48	4	criteria	criterion	NOUN
chd-116	48	5	were	be	AUX
chd-116	48	6	:	:	PUNCT
chd-116	48	7	(	(	PUNCT
chd-116	48	8	1	1	X
chd-116	48	9	)	)	PUNCT
chd-116	48	10	west	west	ADJ
chd-116	48	11	african	african	ADJ
chd-116	48	12	men	man	NOUN
chd-116	48	13	regardless	regardless	ADV
chd-116	48	14	of	of	ADP
chd-116	48	15	the	the	DET
chd-116	48	16	history	history	NOUN
chd-116	48	17	of	of	ADP
chd-116	48	18	cap	cap	NOUN
chd-116	48	19	diagnosis	diagnosis	NOUN
chd-116	48	20	;	;	PUNCT
chd-116	48	21	(	(	PUNCT
chd-116	48	22	2	2	X
chd-116	48	23	)	)	PUNCT
chd-116	48	24	men	man	NOUN
chd-116	48	25	between	between	ADP
chd-116	48	26	the	the	DET
chd-116	48	27	age	age	NOUN
chd-116	48	28	of	of	ADP
chd-116	48	29	35	35	NUM
chd-116	48	30	and	and	CCONJ
chd-116	48	31	70	70	NUM
chd-116	48	32	years	year	NOUN
chd-116	48	33	;	;	PUNCT
chd-116	48	34	and	and	CCONJ
chd-116	48	35	(	(	PUNCT
chd-116	48	36	3	3	X
chd-116	48	37	)	)	PUNCT
chd-116	48	38	men	man	NOUN
chd-116	48	39	who	who	PRON
chd-116	48	40	consented	consent	VERB
chd-116	48	41	to	to	PART
chd-116	48	42	complete	complete	VERB
chd-116	48	43	the	the	DET
chd-116	48	44	study	study	NOUN
chd-116	48	45	survey	survey	NOUN
chd-116	48	46	.	.	PUNCT
chd-116	49	1	participants	participant	NOUN
chd-116	49	2	were	be	AUX
chd-116	49	3	recruited	recruit	VERB
chd-116	49	4	from	from	ADP
chd-116	49	5	multiple	multiple	ADJ
chd-116	49	6	settings	setting	NOUN
chd-116	49	7	using	use	VERB
chd-116	49	8	a	a	DET
chd-116	49	9	flyer	flyer	NOUN
chd-116	49	10	,	,	PUNCT
chd-116	49	11	including	include	VERB
chd-116	49	12	at	at	ADP
chd-116	49	13	clinics	clinic	NOUN
chd-116	49	14	and	and	CCONJ
chd-116	49	15	diverse	diverse	ADJ
chd-116	49	16	community	community	NOUN
chd-116	49	17	settings	setting	NOUN
chd-116	49	18	such	such	ADJ
chd-116	49	19	as	as	ADP
chd-116	49	20	social	social	ADJ
chd-116	49	21	organizations	organization	NOUN
chd-116	49	22	,	,	PUNCT
chd-116	49	23	churches	church	NOUN
chd-116	49	24	,	,	PUNCT
chd-116	49	25	mosques	mosque	NOUN
chd-116	49	26	,	,	PUNCT
chd-116	49	27	health	health	NOUN
chd-116	49	28	events	event	NOUN
chd-116	49	29	and	and	CCONJ
chd-116	49	30	also	also	ADV
chd-116	49	31	business	business	NOUN
chd-116	49	32	facilities	facility	NOUN
chd-116	49	33	.	.	PUNCT
chd-116	50	1	study	study	NOUN
chd-116	50	2	variables	variable	NOUN
chd-116	50	3	and	and	CCONJ
chd-116	50	4	measures	measure	NOUN
chd-116	50	5	the	the	DET
chd-116	50	6	study	study	NOUN
chd-116	50	7	variables	variable	NOUN
chd-116	50	8	were	be	AUX
chd-116	50	9	:	:	PUNCT
chd-116	50	10	(	(	PUNCT
chd-116	50	11	1	1	X
chd-116	50	12	)	)	PUNCT
chd-116	50	13	health	health	NOUN
chd-116	50	14	-	-	PUNCT
chd-116	50	15	related	relate	VERB
chd-116	50	16	quality	quality	NOUN
chd-116	50	17	of	of	ADP
chd-116	50	18	life	life	NOUN
chd-116	50	19	indicators	indicator	NOUN
chd-116	50	20	including	include	VERB
chd-116	50	21	exercise	exercise	NOUN
chd-116	50	22	,	,	PUNCT
chd-116	50	23	stress	stress	NOUN
chd-116	50	24	,	,	PUNCT
chd-116	50	25	ability	ability	NOUN
chd-116	50	26	to	to	PART
chd-116	50	27	self	self	NOUN
chd-116	50	28	-	-	PUNCT
chd-116	50	29	care	care	NOUN
chd-116	50	30	and	and	CCONJ
chd-116	50	31	perceived	perceive	VERB
chd-116	50	32	emotional	emotional	ADJ
chd-116	50	33	health	health	NOUN
chd-116	50	34	status,-	status,-	NOUN
chd-116	50	35	;	;	PUNCT
chd-116	50	36	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	50	37	e6	e6	VERB
chd-116	50	38	cancer	cancer	NOUN
chd-116	50	39	health	health	NOUN
chd-116	50	40	disparities	disparity	NOUN
chd-116	50	41	research	research	NOUN
chd-116	50	42	(	(	PUNCT
chd-116	50	43	2	2	NUM
chd-116	50	44	)	)	PUNCT
chd-116	50	45	personal	personal	ADJ
chd-116	50	46	history	history	NOUN
chd-116	50	47	of	of	ADP
chd-116	50	48	cap,-	cap,-	NOUN
chd-116	50	49	;	;	PUNCT
chd-116	50	50	and	and	CCONJ
chd-116	50	51	(	(	PUNCT
chd-116	50	52	3	3	X
chd-116	50	53	)	)	PUNCT
chd-116	50	54	demographic	demographic	ADJ
chd-116	50	55	information	information	NOUN
chd-116	50	56	,	,	PUNCT
chd-116	50	57	including	include	VERB
chd-116	50	58	age	age	NOUN
chd-116	50	59	,	,	PUNCT
chd-116	50	60	religion	religion	NOUN
chd-116	50	61	,	,	PUNCT
chd-116	50	62	ethnicity	ethnicity	NOUN
chd-116	50	63	,	,	PUNCT
chd-116	50	64	education	education	NOUN
chd-116	50	65	,	,	PUNCT
chd-116	50	66	income	income	NOUN
chd-116	50	67	,	,	PUNCT
chd-116	50	68	employment	employment	NOUN
chd-116	50	69	,	,	PUNCT
chd-116	50	70	country	country	NOUN
chd-116	50	71	of	of	ADP
chd-116	50	72	residence	residence	NOUN
chd-116	50	73	,	,	PUNCT
chd-116	50	74	and	and	CCONJ
chd-116	50	75	previous	previous	ADJ
chd-116	50	76	history	history	NOUN
chd-116	50	77	of	of	ADP
chd-116	50	78	cancer	cancer	NOUN
chd-116	50	79	.	.	PUNCT
chd-116	51	1	these	these	DET
chd-116	51	2	variables	variable	NOUN
chd-116	51	3	were	be	AUX
chd-116	51	4	assessed	assess	VERB
chd-116	51	5	using	use	VERB
chd-116	51	6	the	the	DET
chd-116	51	7	standardized	standardized	ADJ
chd-116	51	8	global	global	ADJ
chd-116	51	9	prostate	prostate	NOUN
chd-116	51	10	cancer	cancer	NOUN
chd-116	51	11	measure	measure	NOUN
chd-116	51	12	for	for	ADP
chd-116	51	13	black	black	ADJ
chd-116	51	14	men	man	NOUN
chd-116	51	15	that	that	PRON
chd-116	51	16	was	be	AUX
chd-116	51	17	developed	develop	VERB
chd-116	51	18	by	by	ADP
chd-116	51	19	captc	captc	NOUN
chd-116	51	20	and	and	CCONJ
chd-116	51	21	the	the	DET
chd-116	51	22	african	african	ADJ
chd-116	51	23	caribbean	caribbean	ADJ
chd-116	51	24	cancer	cancer	NOUN
chd-116	51	25	consortium	consortium	NOUN
chd-116	51	26	(	(	PUNCT
chd-116	51	27	ac3	ac3	PROPN
chd-116	51	28	)	)	PUNCT
chd-116	51	29	.	.	PUNCT
chd-116	52	1	data	datum	NOUN
chd-116	52	2	collection	collection	PROPN
chd-116	52	3	ethical	ethical	ADJ
chd-116	52	4	approval	approval	NOUN
chd-116	52	5	was	be	AUX
chd-116	52	6	obtained	obtain	VERB
chd-116	52	7	at	at	ADP
chd-116	52	8	each	each	DET
chd-116	52	9	study	study	NOUN
chd-116	52	10	site	site	NOUN
chd-116	52	11	prior	prior	ADV
chd-116	52	12	to	to	ADP
chd-116	52	13	data	data	NOUN
chd-116	52	14	collection	collection	NOUN
chd-116	52	15	.	.	PUNCT
chd-116	53	1	the	the	DET
chd-116	53	2	ethics	ethic	NOUN
chd-116	53	3	approval	approval	NOUN
chd-116	53	4	include	include	VERB
chd-116	53	5	implementing	implement	VERB
chd-116	53	6	informed	inform	VERB
chd-116	53	7	consent	consent	NOUN
chd-116	53	8	process	process	NOUN
chd-116	53	9	for	for	ADP
chd-116	53	10	each	each	DET
chd-116	53	11	participant	participant	NOUN
chd-116	53	12	.	.	PUNCT
chd-116	54	1	following	follow	VERB
chd-116	54	2	informed	informed	ADJ
chd-116	54	3	consent	consent	NOUN
chd-116	54	4	approval	approval	NOUN
chd-116	54	5	by	by	ADP
chd-116	54	6	participants	participant	NOUN
chd-116	54	7	,	,	PUNCT
chd-116	54	8	the	the	DET
chd-116	54	9	key	key	ADJ
chd-116	54	10	study	study	NOUN
chd-116	54	11	personnel	personnel	NOUN
chd-116	54	12	in	in	ADP
chd-116	54	13	charge	charge	NOUN
chd-116	54	14	of	of	ADP
chd-116	54	15	data	datum	NOUN
chd-116	54	16	collection	collection	NOUN
chd-116	54	17	administered	administer	VERB
chd-116	54	18	the	the	DET
chd-116	54	19	survey	survey	NOUN
chd-116	54	20	and	and	CCONJ
chd-116	54	21	collected	collect	VERB
chd-116	54	22	saliva	saliva	NOUN
chd-116	54	23	drool	drool	NOUN
chd-116	54	24	using	use	VERB
chd-116	54	25	a	a	DET
chd-116	54	26	saliva	saliva	NOUN
chd-116	54	27	kit	kit	NOUN
chd-116	54	28	.	.	PUNCT
chd-116	55	1	the	the	DET
chd-116	55	2	salivary	salivary	ADJ
chd-116	55	3	samples	sample	NOUN
chd-116	55	4	were	be	AUX
chd-116	55	5	collected	collect	VERB
chd-116	55	6	from	from	ADP
chd-116	55	7	8	8	NUM
chd-116	55	8	am	am	NOUN
chd-116	55	9	to	to	ADP
chd-116	55	10	12	12	NUM
chd-116	55	11	noon	noon	NOUN
chd-116	55	12	.	.	PUNCT
chd-116	56	1	participants	participant	NOUN
chd-116	56	2	were	be	AUX
chd-116	56	3	provided	provide	VERB
chd-116	56	4	a	a	DET
chd-116	56	5	monetary	monetary	ADJ
chd-116	56	6	incentive	incentive	NOUN
chd-116	56	7	or	or	CCONJ
chd-116	56	8	a	a	DET
chd-116	56	9	t	t	NOUN
chd-116	56	10	-	-	PUNCT
chd-116	56	11	shirt	shirt	NOUN
chd-116	56	12	for	for	ADP
chd-116	56	13	the	the	DET
chd-116	56	14	time	time	NOUN
chd-116	56	15	taken	take	VERB
chd-116	56	16	to	to	PART
chd-116	56	17	participate	participate	VERB
chd-116	56	18	in	in	ADP
chd-116	56	19	the	the	DET
chd-116	56	20	study	study	NOUN
chd-116	56	21	.	.	PUNCT
chd-116	57	1	statistical	statistical	ADJ
chd-116	57	2	considerations	consideration	NOUN
chd-116	57	3	and	and	CCONJ
chd-116	57	4	data	datum	NOUN
chd-116	57	5	analyses	analyse	VERB
chd-116	57	6	the	the	DET
chd-116	57	7	study	study	NOUN
chd-116	57	8	data	data	NOUN
chd-116	57	9	entry	entry	NOUN
chd-116	57	10	and	and	CCONJ
chd-116	57	11	management	management	NOUN
chd-116	57	12	was	be	AUX
chd-116	57	13	conducted	conduct	VERB
chd-116	57	14	using	use	VERB
chd-116	57	15	the	the	DET
chd-116	57	16	research	research	NOUN
chd-116	57	17	electronic	electronic	ADJ
chd-116	57	18	data	datum	NOUN
chd-116	57	19	capture	capture	NOUN
chd-116	57	20	(	(	PUNCT
chd-116	57	21	redcap	redcap	NOUN
chd-116	57	22	)	)	PUNCT
chd-116	57	23	software	software	NOUN
chd-116	57	24	.	.	PUNCT
chd-116	58	1	subsequently	subsequently	ADV
chd-116	58	2	,	,	PUNCT
chd-116	58	3	data	datum	NOUN
chd-116	58	4	were	be	AUX
chd-116	58	5	exported	export	VERB
chd-116	58	6	into	into	ADP
chd-116	58	7	the	the	DET
chd-116	58	8	pc	pc	NOUN
chd-116	58	9	-	-	PUNCT
chd-116	58	10	sas	sas	ADJ
chd-116	58	11	analytical	analytical	ADJ
chd-116	58	12	software	software	NOUN
chd-116	58	13	for	for	ADP
chd-116	58	14	data	datum	NOUN
chd-116	58	15	analysis	analysis	NOUN
chd-116	58	16	.	.	PUNCT
chd-116	59	1	frequency	frequency	NOUN
chd-116	59	2	analysis	analysis	NOUN
chd-116	59	3	of	of	ADP
chd-116	59	4	the	the	DET
chd-116	59	5	variables	variable	NOUN
chd-116	59	6	was	be	AUX
chd-116	59	7	conducted	conduct	VERB
chd-116	59	8	to	to	PART
chd-116	59	9	confirm	confirm	VERB
chd-116	59	10	responses	response	NOUN
chd-116	59	11	are	be	AUX
chd-116	59	12	appropriately	appropriately	ADV
chd-116	59	13	entered	enter	VERB
chd-116	59	14	and	and	CCONJ
chd-116	59	15	errors	error	NOUN
chd-116	59	16	corrected	correct	VERB
chd-116	59	17	.	.	PUNCT
chd-116	60	1	the	the	DET
chd-116	60	2	internal	internal	ADJ
chd-116	60	3	consistency	consistency	NOUN
chd-116	60	4	of	of	ADP
chd-116	60	5	the	the	DET
chd-116	60	6	study	study	NOUN
chd-116	60	7	scales	scale	NOUN
chd-116	60	8	was	be	AUX
chd-116	60	9	calculated	calculate	VERB
chd-116	60	10	to	to	PART
chd-116	60	11	establish	establish	VERB
chd-116	60	12	the	the	DET
chd-116	60	13	reliability	reliability	NOUN
chd-116	60	14	of	of	ADP
chd-116	60	15	the	the	DET
chd-116	60	16	scales	scale	NOUN
chd-116	60	17	.	.	PUNCT
chd-116	61	1	the	the	DET
chd-116	61	2	study	study	NOUN
chd-116	61	3	variables	variable	NOUN
chd-116	61	4	were	be	AUX
chd-116	61	5	evaluated	evaluate	VERB
chd-116	61	6	using	use	VERB
chd-116	61	7	descriptive	descriptive	ADJ
chd-116	61	8	statistics	statistic	NOUN
chd-116	61	9	of	of	ADP
chd-116	61	10	means	mean	NOUN
chd-116	61	11	procedure	procedure	NOUN
chd-116	61	12	for	for	ADP
chd-116	61	13	continuous	continuous	ADJ
chd-116	61	14	variables	variable	NOUN
chd-116	61	15	and	and	CCONJ
chd-116	61	16	frequency	frequency	NOUN
chd-116	61	17	analyses	analysis	NOUN
chd-116	61	18	for	for	ADP
chd-116	61	19	categorical	categorical	ADJ
chd-116	61	20	variables	variable	NOUN
chd-116	61	21	.	.	PUNCT
chd-116	62	1	microsoft	microsoft	PROPN
chd-116	62	2	excel	excel	PROPN
chd-116	62	3	(	(	PUNCT
chd-116	62	4	microsoft	microsoft	PROPN
chd-116	62	5	office	office	PROPN
chd-116	62	6	professional	professional	PROPN
chd-116	62	7	plus	plus	CCONJ
chd-116	62	8	2013	2013	NUM
chd-116	62	9	;	;	PUNCT
chd-116	62	10	microsoft	microsoft	PROPN
chd-116	62	11	corp	corp	PROPN
chd-116	62	12	.	.	PROPN
chd-116	62	13	,	,	PUNCT
chd-116	62	14	redmond	redmond	PROPN
chd-116	62	15	,	,	PUNCT
chd-116	62	16	wa	wa	PROPN
chd-116	62	17	,	,	PUNCT
chd-116	62	18	usa	usa	PROPN
chd-116	62	19	)	)	PUNCT
chd-116	62	20	was	be	AUX
chd-116	62	21	used	use	VERB
chd-116	62	22	to	to	PART
chd-116	62	23	produce	produce	VERB
chd-116	62	24	the	the	DET
chd-116	62	25	charts	chart	NOUN
chd-116	62	26	.	.	PUNCT
chd-116	63	1	subsequently	subsequently	PROPN
chd-116	63	2	t	t	NOUN
chd-116	63	3	-	-	PUNCT
chd-116	63	4	test	test	NOUN
chd-116	63	5	statistical	statistical	ADJ
chd-116	63	6	analysis	analysis	NOUN
chd-116	63	7	was	be	AUX
chd-116	63	8	used	use	VERB
chd-116	63	9	to	to	PART
chd-116	63	10	determine	determine	VERB
chd-116	63	11	the	the	DET
chd-116	63	12	differences	difference	NOUN
chd-116	63	13	in	in	ADP
chd-116	63	14	cortisol	cortisol	ADJ
chd-116	63	15	levels	level	NOUN
chd-116	63	16	and	and	CCONJ
chd-116	63	17	expression	expression	NOUN
chd-116	63	18	using	use	VERB
chd-116	63	19	the	the	DET
chd-116	63	20	spss	spss	PROPN
chd-116	63	21	software	software	NOUN
chd-116	63	22	,	,	PUNCT
chd-116	63	23	version	version	NOUN
chd-116	63	24	20.0	20.0	NUM
chd-116	63	25	(	(	PUNCT
chd-116	63	26	ibm	ibm	PROPN
chd-116	63	27	corp	corp	PROPN
chd-116	63	28	.	.	PROPN
chd-116	63	29	,	,	PUNCT
chd-116	63	30	armonk	armonk	PROPN
chd-116	63	31	,	,	PUNCT
chd-116	63	32	ny	ny	PROPN
chd-116	63	33	,	,	PUNCT
chd-116	63	34	usa	usa	PROPN
chd-116	63	35	)	)	PUNCT
chd-116	63	36	.	.	PUNCT
chd-116	64	1	a	a	DET
chd-116	64	2	p	p	NOUN
chd-116	64	3	-value	-value	NOUN
chd-116	64	4	of	of	ADP
chd-116	64	5	<	<	NOUN
chd-116	64	6	0.05	0.05	NUM
chd-116	64	7	was	be	AUX
chd-116	64	8	considered	consider	VERB
chd-116	64	9	statistically	statistically	ADV
chd-116	64	10	significant	significant	ADJ
chd-116	64	11	.	.	PUNCT
chd-116	65	1	salivary	salivary	VERB
chd-116	65	2	cortisol	cortisol	ADJ
chd-116	65	3	analysis	analysis	NOUN
chd-116	65	4	by	by	ADP
chd-116	65	5	enzyme	enzyme	NOUN
chd-116	65	6	-	-	PUNCT
chd-116	65	7	linked	link	VERB
chd-116	65	8	immunosorbent	immunosorbent	NOUN
chd-116	65	9	assay	assay	ADV
chd-116	65	10	the	the	DET
chd-116	65	11	salivary	salivary	ADJ
chd-116	65	12	cortisol	cortisol	NOUN
chd-116	65	13	was	be	AUX
chd-116	65	14	quantified	quantify	VERB
chd-116	65	15	using	use	VERB
chd-116	65	16	an	an	DET
chd-116	65	17	enzyme	enzyme	NOUN
chd-116	65	18	-	-	PUNCT
chd-116	65	19	linked	link	VERB
chd-116	65	20	immunosorbent	immunosorbent	NOUN
chd-116	65	21	assay	assay	PROPN
chd-116	65	22	(	(	PUNCT
chd-116	65	23	elisa	elisa	NOUN
chd-116	65	24	)	)	PUNCT
chd-116	65	25	kit	kit	NOUN
chd-116	65	26	(	(	PUNCT
chd-116	65	27	salimetric	salimetric	PROPN
chd-116	65	28	inc	inc	PROPN
chd-116	65	29	,	,	PUNCT
chd-116	65	30	college	college	NOUN
chd-116	65	31	park	park	NOUN
chd-116	65	32	,	,	PUNCT
chd-116	65	33	pa	pa	PROPN
chd-116	65	34	)	)	PUNCT
chd-116	65	35	as	as	ADP
chd-116	65	36	per	per	ADP
chd-116	65	37	manufacturer	manufacturer	NOUN
chd-116	65	38	’s	’s	PART
chd-116	65	39	procedure	procedure	NOUN
chd-116	65	40	.	.	PUNCT
chd-116	66	1	all	all	DET
chd-116	66	2	elisa	elisa	NOUN
chd-116	66	3	experiments	experiment	NOUN
chd-116	66	4	were	be	AUX
chd-116	66	5	performed	perform	VERB
chd-116	66	6	in	in	ADP
chd-116	66	7	duplicate	duplicate	ADJ
chd-116	66	8	analysis	analysis	NOUN
chd-116	66	9	.	.	PUNCT
chd-116	67	1	tissue	tissue	NOUN
chd-116	67	2	cortisol	cortisol	ADJ
chd-116	67	3	analysis	analysis	NOUN
chd-116	67	4	by	by	ADP
chd-116	67	5	immunohistochemistry	immunohistochemistry	NOUN
chd-116	67	6	immunohistochemistry	immunohistochemistry	NOUN
chd-116	67	7	(	(	PUNCT
chd-116	67	8	ihc	ihc	PROPN
chd-116	67	9	)	)	PUNCT
chd-116	67	10	was	be	AUX
chd-116	67	11	performed	perform	VERB
chd-116	67	12	on	on	ADP
chd-116	67	13	5μm	5μm	ADJ
chd-116	67	14	cap	cap	NOUN
chd-116	67	15	formalin	formalin	NOUN
chd-116	67	16	fixed	fix	VERB
chd-116	67	17	paraffin	paraffin	NOUN
chd-116	67	18	embedded	embed	VERB
chd-116	67	19	(	(	PUNCT
chd-116	67	20	ffpe	ffpe	NOUN
chd-116	67	21	)	)	PUNCT
chd-116	67	22	tissue	tissue	NOUN
chd-116	67	23	and	and	CCONJ
chd-116	67	24	non	non	ADJ
chd-116	67	25	-	-	ADJ
chd-116	67	26	malignant	malignant	ADJ
chd-116	67	27	prostatic	prostatic	ADJ
chd-116	67	28	ffpe	ffpe	NOUN
chd-116	67	29	tissues	tissue	NOUN
chd-116	67	30	for	for	ADP
chd-116	67	31	cortisol	cortisol	NOUN
chd-116	67	32	and	and	CCONJ
chd-116	67	33	annexin	annexin	NOUN
chd-116	67	34	v	v	ADP
chd-116	67	35	protein	protein	NOUN
chd-116	67	36	expression	expression	NOUN
chd-116	67	37	using	use	VERB
chd-116	67	38	anti	anti	ADJ
chd-116	67	39	-	-	ADJ
chd-116	67	40	cortisol	cortisol	ADJ
chd-116	67	41	(	(	PUNCT
chd-116	67	42	abin3208586	abin3208586	PROPN
chd-116	67	43	)	)	PUNCT
chd-116	67	44	and	and	CCONJ
chd-116	67	45	anti	anti	ADJ
chd-116	67	46	-	-	NOUN
chd-116	67	47	annexin	annexin	ADJ
chd-116	67	48	v	v	NOUN
chd-116	67	49	(	(	PUNCT
chd-116	67	50	bin4964891	bin4964891	NOUN
chd-116	67	51	)	)	PUNCT
chd-116	67	52	antibodies	antibodie	VERB
chd-116	67	53	(	(	PUNCT
chd-116	67	54	antibodies	antibody	NOUN
chd-116	67	55	-	-	PUNCT
chd-116	67	56	online	online	ADJ
chd-116	67	57	aachen	aachen	PROPN
chd-116	67	58	,	,	PUNCT
chd-116	67	59	germany	germany	PROPN
chd-116	67	60	)	)	PUNCT
chd-116	67	61	.	.	PUNCT
chd-116	68	1	briefly	briefly	ADV
chd-116	68	2	,	,	PUNCT
chd-116	68	3	the	the	DET
chd-116	68	4	slides	slide	NOUN
chd-116	68	5	containing	contain	VERB
chd-116	68	6	tissue	tissue	NOUN
chd-116	68	7	sections	section	NOUN
chd-116	68	8	were	be	AUX
chd-116	68	9	baked	bake	VERB
chd-116	68	10	for	for	ADP
chd-116	68	11	1	1	NUM
chd-116	68	12	hour	hour	NOUN
chd-116	68	13	,	,	PUNCT
chd-116	68	14	then	then	ADV
chd-116	68	15	deparaffinized	deparaffinize	VERB
chd-116	68	16	with	with	ADP
chd-116	68	17	100	100	NUM
chd-116	68	18	%	%	NOUN
chd-116	68	19	xylene	xylene	NOUN
chd-116	68	20	at	at	ADP
chd-116	68	21	room	room	NOUN
chd-116	68	22	temperature	temperature	NOUN
chd-116	68	23	for	for	ADP
chd-116	68	24	1	1	NUM
chd-116	68	25	minute	minute	NOUN
chd-116	68	26	,	,	PUNCT
chd-116	68	27	and	and	CCONJ
chd-116	68	28	hydrated	hydrate	VERB
chd-116	68	29	in	in	ADP
chd-116	68	30	a	a	DET
chd-116	68	31	graded	grade	VERB
chd-116	68	32	alcohol	alcohol	NOUN
chd-116	68	33	stages	stage	NOUN
chd-116	68	34	consisting	consist	VERB
chd-116	68	35	of	of	ADP
chd-116	68	36	30	30	NUM
chd-116	68	37	-	-	PUNCT
chd-116	68	38	second	second	NOUN
chd-116	68	39	dips	dip	NOUN
chd-116	68	40	each	each	PRON
chd-116	68	41	in	in	ADP
chd-116	68	42	100	100	NUM
chd-116	68	43	%	%	NOUN
chd-116	68	44	and	and	CCONJ
chd-116	68	45	95	95	NUM
chd-116	68	46	%	%	NOUN
chd-116	68	47	ethyl	ethyl	PROPN
chd-116	68	48	alcohol	alcohol	NOUN
chd-116	68	49	diluted	dilute	VERB
chd-116	68	50	in	in	ADP
chd-116	68	51	water	water	NOUN
chd-116	68	52	(	(	PUNCT
chd-116	68	53	total	total	ADJ
chd-116	68	54	volume	volume	NOUN
chd-116	68	55	is	be	AUX
chd-116	68	56	5	5	NUM
chd-116	68	57	ml	ml	NOUN
chd-116	68	58	)	)	PUNCT
chd-116	68	59	at	at	ADP
chd-116	68	60	room	room	NOUN
chd-116	68	61	temperature	temperature	NOUN
chd-116	68	62	,	,	PUNCT
chd-116	68	63	and	and	CCONJ
chd-116	68	64	finally	finally	ADV
chd-116	68	65	hydrated	hydrate	VERB
chd-116	68	66	in	in	ADP
chd-116	68	67	water	water	NOUN
chd-116	68	68	.	.	PUNCT
chd-116	69	1	sections	section	NOUN
chd-116	69	2	were	be	AUX
chd-116	69	3	incubated	incubate	VERB
chd-116	69	4	in	in	ADP
chd-116	69	5	3	3	NUM
chd-116	69	6	%	%	NOUN
chd-116	69	7	hydrogen	hydrogen	NOUN
chd-116	69	8	peroxidase	peroxidase	NOUN
chd-116	69	9	in	in	ADP
chd-116	69	10	water	water	NOUN
chd-116	69	11	at	at	ADP
chd-116	69	12	room	room	NOUN
chd-116	69	13	temperature	temperature	NOUN
chd-116	69	14	for	for	ADP
chd-116	69	15	10	10	NUM
chd-116	69	16	minutes	minute	NOUN
chd-116	69	17	to	to	PART
chd-116	69	18	block	block	VERB
chd-116	69	19	endogenous	endogenous	ADJ
chd-116	69	20	peroxidase	peroxidase	NOUN
chd-116	69	21	activity	activity	NOUN
chd-116	69	22	.	.	PUNCT
chd-116	70	1	the	the	DET
chd-116	70	2	slides	slide	NOUN
chd-116	70	3	were	be	AUX
chd-116	70	4	then	then	ADV
chd-116	70	5	washed	wash	VERB
chd-116	70	6	,	,	PUNCT
chd-116	70	7	blocked	block	VERB
chd-116	70	8	and	and	CCONJ
chd-116	70	9	incubated	incubate	VERB
chd-116	70	10	at	at	ADP
chd-116	70	11	room	room	NOUN
chd-116	70	12	temperature	temperature	NOUN
chd-116	70	13	for	for	ADP
chd-116	70	14	30	30	NUM
chd-116	70	15	minutes	minute	NOUN
chd-116	70	16	.	.	PUNCT
chd-116	71	1	the	the	DET
chd-116	71	2	slides	slide	NOUN
chd-116	71	3	were	be	AUX
chd-116	71	4	incubated	incubate	VERB
chd-116	71	5	with	with	ADP
chd-116	71	6	the	the	DET
chd-116	71	7	anti	anti	ADJ
chd-116	71	8	-	-	ADJ
chd-116	71	9	cortisol	cortisol	ADJ
chd-116	71	10	antibody	antibody	NOUN
chd-116	71	11	and	and	CCONJ
chd-116	71	12	in	in	ADP
chd-116	71	13	5	5	NUM
chd-116	71	14	µg	µg	ADJ
chd-116	71	15	/	/	SYM
chd-116	71	16	ml	ml	NOUN
chd-116	71	17	dilutions	dilution	NOUN
chd-116	71	18	and	and	CCONJ
chd-116	71	19	with	with	ADP
chd-116	71	20	hrp	hrp	NOUN
chd-116	71	21	-	-	PUNCT
chd-116	71	22	linked	link	VERB
chd-116	71	23	secondary	secondary	ADJ
chd-116	71	24	antibody	antibody	NOUN
chd-116	71	25	in	in	ADP
chd-116	71	26	blocking	block	VERB
chd-116	71	27	buffer	buffer	NOUN
chd-116	71	28	.	.	PUNCT
chd-116	72	1	the	the	DET
chd-116	72	2	same	same	ADJ
chd-116	72	3	protocol	protocol	NOUN
chd-116	72	4	was	be	AUX
chd-116	72	5	used	use	VERB
chd-116	72	6	for	for	ADP
chd-116	72	7	anti	anti	ADJ
chd-116	72	8	-	-	ADJ
chd-116	72	9	annexin	annexin	ADJ
chd-116	72	10	v	v	NOUN
chd-116	72	11	(	(	PUNCT
chd-116	72	12	bin4964891	bin4964891	NOUN
chd-116	72	13	)	)	PUNCT
chd-116	72	14	antibody	antibody	NOUN
chd-116	72	15	staining	stain	VERB
chd-116	72	16	using	use	VERB
chd-116	72	17	2.5	2.5	NUM
chd-116	72	18	µg	µg	NOUN
chd-116	72	19	/	/	SYM
chd-116	72	20	ml	ml	NOUN
chd-116	72	21	.	.	PUNCT
chd-116	73	1	the	the	DET
chd-116	73	2	nuclei	nucleus	NOUN
chd-116	73	3	of	of	ADP
chd-116	73	4	the	the	DET
chd-116	73	5	cells	cell	NOUN
chd-116	73	6	were	be	AUX
chd-116	73	7	counterstained	counterstaine	VERB
chd-116	73	8	with	with	ADP
chd-116	73	9	haematoxylin	haematoxylin	NOUN
chd-116	73	10	(	(	PUNCT
chd-116	73	11	blue	blue	ADJ
chd-116	73	12	)	)	PUNCT
chd-116	73	13	.	.	PUNCT
chd-116	74	1	the	the	DET
chd-116	74	2	expression	expression	NOUN
chd-116	74	3	level	level	NOUN
chd-116	74	4	was	be	AUX
chd-116	74	5	categorized	categorize	VERB
chd-116	74	6	as	as	ADP
chd-116	74	7	low	low	ADJ
chd-116	74	8	and	and	CCONJ
chd-116	74	9	high	high	ADJ
chd-116	74	10	based	base	VERB
chd-116	74	11	on	on	ADP
chd-116	74	12	a	a	DET
chd-116	74	13	combined	combine	VERB
chd-116	74	14	score	score	NOUN
chd-116	74	15	of	of	ADP
chd-116	74	16	intensity	intensity	NOUN
chd-116	74	17	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-116	74	18	e7	e7	PROPN
chd-116	74	19	cancer	cancer	NOUN
chd-116	74	20	health	health	NOUN
chd-116	74	21	disparities	disparity	NOUN
chd-116	74	22	research	research	NOUN
chd-116	74	23	and	and	CCONJ
chd-116	74	24	distribution	distribution	NOUN
chd-116	74	25	.	.	PUNCT
chd-116	75	1	the	the	DET
chd-116	75	2	expression	expression	NOUN
chd-116	75	3	was	be	AUX
chd-116	75	4	categorised	categorise	VERB
chd-116	75	5	base	base	NOUN
chd-116	75	6	on	on	ADP
chd-116	75	7	intensity	intensity	NOUN
chd-116	75	8	of	of	ADP
chd-116	75	9	the	the	DET
chd-116	75	10	stain	stain	NOUN
chd-116	75	11	(	(	PUNCT
chd-116	75	12	0	0	NUM
chd-116	75	13	=	=	SYM
chd-116	75	14	absent	absent	ADJ
chd-116	75	15	;	;	PUNCT
chd-116	75	16	1	1	NUM
chd-116	75	17	=	=	SYM
chd-116	75	18	weak	weak	ADJ
chd-116	75	19	;	;	PUNCT
chd-116	75	20	2	2	NUM
chd-116	75	21	=	=	SYM
chd-116	75	22	moderate	moderate	ADJ
chd-116	75	23	;	;	PUNCT
chd-116	75	24	3	3	NUM
chd-116	75	25	=	=	SYM
chd-116	75	26	strong	strong	ADJ
chd-116	75	27	)	)	PUNCT
chd-116	75	28	and	and	CCONJ
chd-116	75	29	distribution	distribution	NOUN
chd-116	75	30	(	(	PUNCT
chd-116	75	31	per	per	ADP
chd-116	75	32	cent	cent	NOUN
chd-116	75	33	of	of	ADP
chd-116	75	34	tumour	tumour	NOUN
chd-116	75	35	positive	positive	ADJ
chd-116	75	36	)	)	PUNCT
chd-116	75	37	.	.	PUNCT
chd-116	76	1	results	result	VERB
chd-116	76	2	a	a	DET
chd-116	76	3	total	total	NOUN
chd-116	76	4	of	of	ADP
chd-116	76	5	500	500	NUM
chd-116	76	6	black	black	ADJ
chd-116	76	7	men	man	NOUN
chd-116	76	8	of	of	ADP
chd-116	76	9	west	west	ADJ
chd-116	76	10	african	african	ADJ
chd-116	76	11	descent	descent	NOUN
chd-116	76	12	participated	participate	VERB
chd-116	76	13	in	in	ADP
chd-116	76	14	the	the	DET
chd-116	76	15	study	study	NOUN
chd-116	76	16	.	.	PUNCT
chd-116	77	1	of	of	ADP
chd-116	77	2	the	the	DET
chd-116	77	3	500	500	NUM
chd-116	77	4	black	black	ADJ
chd-116	77	5	men	man	NOUN
chd-116	77	6	,	,	PUNCT
chd-116	77	7	85	85	NUM
chd-116	77	8	%	%	NOUN
chd-116	77	9	are	be	AUX
chd-116	77	10	resident	resident	ADJ
chd-116	77	11	in	in	ADP
chd-116	77	12	nigeria	nigeria	PROPN
chd-116	77	13	,	,	PUNCT
chd-116	77	14	8	8	NUM
chd-116	77	15	%	%	NOUN
chd-116	77	16	in	in	ADP
chd-116	77	17	the	the	DET
chd-116	77	18	usa	usa	PROPN
chd-116	77	19	and	and	CCONJ
chd-116	77	20	7	7	NUM
chd-116	77	21	%	%	NOUN
chd-116	77	22	in	in	ADP
chd-116	77	23	the	the	DET
chd-116	77	24	republic	republic	NOUN
chd-116	77	25	of	of	ADP
chd-116	77	26	cameroon	cameroon	PROPN
chd-116	77	27	.	.	PUNCT
chd-116	78	1	demographic	demographic	ADJ
chd-116	78	2	characteristics	characteristic	NOUN
chd-116	78	3	of	of	ADP
chd-116	78	4	the	the	DET
chd-116	78	5	participants	participant	NOUN
chd-116	78	6	are	be	AUX
chd-116	78	7	displayed	display	VERB
chd-116	78	8	in	in	ADP
chd-116	78	9	table	table	NOUN
chd-116	78	10	1	1	NUM
chd-116	78	11	.	.	PUNCT
chd-116	79	1	the	the	DET
chd-116	79	2	results	result	NOUN
chd-116	79	3	revealed	reveal	VERB
chd-116	79	4	that	that	SCONJ
chd-116	79	5	8	8	NUM
chd-116	79	6	%	%	NOUN
chd-116	79	7	(	(	PUNCT
chd-116	79	8	40	40	NUM
chd-116	79	9	)	)	PUNCT
chd-116	79	10	of	of	ADP
chd-116	79	11	the	the	DET
chd-116	79	12	participants	participant	NOUN
chd-116	79	13	had	have	VERB
chd-116	79	14	previous	previous	ADJ
chd-116	79	15	diagnosis	diagnosis	NOUN
chd-116	79	16	of	of	ADP
chd-116	79	17	prostate	prostate	NOUN
chd-116	79	18	cancer	cancer	NOUN
chd-116	79	19	whereas	whereas	SCONJ
chd-116	79	20	1	1	NUM
chd-116	79	21	%	%	NOUN
chd-116	79	22	(	(	PUNCT
chd-116	79	23	4	4	NUM
chd-116	79	24	)	)	PUNCT
chd-116	79	25	had	have	AUX
chd-116	79	26	previously	previously	ADV
chd-116	79	27	been	be	AUX
chd-116	79	28	diagnosed	diagnose	VERB
chd-116	79	29	with	with	ADP
chd-116	79	30	other	other	ADJ
chd-116	79	31	malignancies	malignancy	NOUN
chd-116	79	32	such	such	ADJ
chd-116	79	33	as	as	ADP
chd-116	79	34	colorectal	colorectal	ADJ
chd-116	79	35	,	,	PUNCT
chd-116	79	36	liver	liver	NOUN
chd-116	79	37	,	,	PUNCT
chd-116	79	38	nasopharyngeal	nasopharyngeal	ADJ
chd-116	79	39	cancers	cancer	NOUN
chd-116	79	40	and	and	CCONJ
chd-116	79	41	sarcoma	sarcoma	NOUN
chd-116	79	42	.	.	PUNCT
chd-116	80	1	about	about	ADV
chd-116	80	2	82	82	NUM
chd-116	80	3	%	%	NOUN
chd-116	80	4	(	(	PUNCT
chd-116	80	5	401	401	NUM
chd-116	80	6	)	)	PUNCT
chd-116	80	7	of	of	ADP
chd-116	80	8	the	the	DET
chd-116	80	9	participants	participant	NOUN
chd-116	80	10	were	be	AUX
chd-116	80	11	non	non	NOUN
chd-116	80	12	-	-	NOUN
chd-116	80	13	smokers	smoker	NOUN
chd-116	80	14	and	and	CCONJ
chd-116	80	15	85	85	NUM
chd-116	80	16	%	%	NOUN
chd-116	80	17	(	(	PUNCT
chd-116	80	18	427	427	NUM
chd-116	80	19	)	)	PUNCT
chd-116	80	20	were	be	AUX
chd-116	80	21	employed	employ	VERB
chd-116	80	22	.	.	PUNCT
chd-116	81	1	table	table	NOUN
chd-116	81	2	1	1	NUM
chd-116	81	3	.	.	PUNCT
chd-116	82	1	demographic	demographic	ADJ
chd-116	82	2	characteristic	characteristic	NOUN
chd-116	82	3	for	for	ADP
chd-116	82	4	the	the	DET
chd-116	82	5	captc	captc	ADJ
chd-116	82	6	cohort	cohort	NOUN
chd-116	82	7	study	study	NOUN
chd-116	82	8	.	.	PUNCT
chd-116	83	1	characteristics	characteristic	NOUN
chd-116	83	2	frequency	frequency	NOUN
chd-116	83	3	percent	percent	NOUN
chd-116	83	4	demographic	demographic	ADJ
chd-116	83	5	characteristics	characteristic	NOUN
chd-116	83	6	,	,	PUNCT
chd-116	83	7	n	n	NOUN
chd-116	83	8	=	=	SYM
chd-116	83	9	500	500	NUM
chd-116	83	10	country	country	NOUN
chd-116	83	11	of	of	ADP
chd-116	83	12	resident	resident	NOUN
chd-116	83	13	nigeria	nigeria	PROPN
chd-116	83	14	428	428	NUM
chd-116	83	15	85.60	85.60	NUM
chd-116	83	16	cameroon	cameroon	NOUN
chd-116	83	17	34	34	NUM
chd-116	83	18	6.80	6.80	NUM
chd-116	83	19	usa	usa	PROPN
chd-116	83	20	38	38	NUM
chd-116	83	21	7.60	7.60	NUM
chd-116	83	22	age	age	NOUN
chd-116	83	23	range	range	NOUN
chd-116	83	24	of	of	ADP
chd-116	83	25	participants	participant	NOUN
chd-116	83	26	recruited	recruit	VERB
chd-116	83	27	35	35	NUM
chd-116	83	28	-	-	SYM
chd-116	83	29	44	44	NUM
chd-116	83	30	216	216	NUM
chd-116	83	31	43.20	43.20	NUM
chd-116	83	32	45	45	NUM
chd-116	83	33	-	-	SYM
chd-116	83	34	54	54	NUM
chd-116	83	35	160	160	NUM
chd-116	83	36	32.00	32.00	NUM
chd-116	83	37	55	55	NUM
chd-116	83	38	-	-	SYM
chd-116	83	39	64	64	NUM
chd-116	83	40	82	82	NUM
chd-116	83	41	16.40	16.40	NUM
chd-116	83	42	65	65	NUM
chd-116	83	43	and	and	CCONJ
chd-116	83	44	above	above	ADP
chd-116	83	45	42	42	NUM
chd-116	83	46	8.40	8.40	NUM
chd-116	83	47	personal	personal	ADJ
chd-116	83	48	history	history	NOUN
chd-116	83	49	of	of	ADP
chd-116	83	50	cancer	cancer	NOUN
chd-116	83	51	prostate	prostate	NOUN
chd-116	83	52	cancer	cancer	NOUN
chd-116	83	53	40	40	NUM
chd-116	83	54	8.00	8.00	NUM
chd-116	83	55	colorectal	colorectal	ADJ
chd-116	83	56	cancer	cancer	NOUN
chd-116	83	57	2	2	NUM
chd-116	83	58	0.40	0.40	NUM
chd-116	83	59	liver	liver	NOUN
chd-116	83	60	cancer	cancer	NOUN
chd-116	83	61	1	1	NUM
chd-116	83	62	0.20	0.20	NUM
chd-116	83	63	nasopharyngeal	nasopharyngeal	ADJ
chd-116	83	64	1	1	NUM
chd-116	83	65	0.20	0.20	NUM
chd-116	83	66	sarcoma	sarcoma	NOUN
chd-116	83	67	1	1	NUM
chd-116	83	68	0.20	0.20	NUM
chd-116	83	69	do	do	AUX
chd-116	83	70	not	not	PART
chd-116	83	71	know	know	VERB
chd-116	83	72	455	455	NUM
chd-116	83	73	91.00	91.00	NUM
chd-116	83	74	marital	marital	ADJ
chd-116	83	75	status	status	NOUN
chd-116	83	76	married	marry	VERB
chd-116	83	77	or	or	CCONJ
chd-116	83	78	living	live	VERB
chd-116	83	79	as	as	ADP
chd-116	83	80	married	marry	VERB
chd-116	83	81	460	460	NUM
chd-116	83	82	92.00	92.00	NUM
chd-116	83	83	never	never	ADV
chd-116	83	84	married	marry	VERB
chd-116	83	85	or	or	CCONJ
chd-116	83	86	divorced/	divorced/	NUM
chd-116	83	87	widowed	widow	VERB
chd-116	83	88	37	37	NUM
chd-116	83	89	7.40	7.40	NUM
chd-116	83	90	non	non	ADJ
chd-116	83	91	-	-	VERB
chd-116	83	92	disclosed	disclose	VERB
chd-116	83	93	3	3	NUM
chd-116	83	94	0.60	0.60	NUM
chd-116	83	95	smoking	smoking	NOUN
chd-116	83	96	status	status	NOUN
chd-116	83	97	at	at	ADP
chd-116	83	98	present	present	ADJ
chd-116	83	99	20	20	NUM
chd-116	83	100	4.00	4.00	NUM
chd-116	83	101	in	in	ADP
chd-116	83	102	the	the	DET
chd-116	83	103	past	past	ADJ
chd-116	83	104	72	72	NUM
chd-116	83	105	14.40	14.40	NUM
chd-116	83	106	never	never	ADV
chd-116	83	107	329	329	NUM
chd-116	83	108	68.80	68.80	NUM
chd-116	83	109	non	non	ADJ
chd-116	83	110	-	-	VERB
chd-116	83	111	disclosed	disclose	VERB
chd-116	83	112	79	79	NUM
chd-116	83	113	15.80	15.80	NUM
chd-116	83	114	education	education	NOUN
chd-116	83	115	8	8	NUM
chd-116	83	116	to	to	ADP
chd-116	83	117	11th	11th	ADJ
chd-116	83	118	grade	grade	NOUN
chd-116	83	119	87	87	NUM
chd-116	83	120	17.4	17.4	NUM
chd-116	83	121	high	high	ADJ
chd-116	83	122	school	school	NOUN
chd-116	83	123	108	108	NUM
chd-116	83	124	21.6	21.6	NUM
chd-116	83	125	university	university	NOUN
chd-116	83	126	294	294	NUM
chd-116	83	127	58.8	58.8	NUM
chd-116	83	128	non	non	ADJ
chd-116	83	129	-	-	ADJ
chd-116	83	130	disclosed	disclose	VERB
chd-116	83	131	11	11	NUM
chd-116	83	132	2.20	2.20	NUM
chd-116	83	133	employment	employment	NOUN
chd-116	83	134	status	status	NOUN
chd-116	83	135	employed	employ	VERB
chd-116	83	136	427	427	NUM
chd-116	83	137	85.40	85.40	NUM
chd-116	83	138	not	not	PART
chd-116	83	139	employed	employ	VERB
chd-116	83	140	63	63	NUM
chd-116	83	141	12.60	12.60	NUM
chd-116	83	142	non	non	ADJ
chd-116	83	143	-	-	VERB
chd-116	83	144	disclosed	disclose	VERB
chd-116	83	145	10	10	NUM
chd-116	83	146	2.00	2.00	NUM
chd-116	83	147	household	household	NOUN
chd-116	83	148	income	income	NOUN
chd-116	83	149	less	less	ADJ
chd-116	83	150	than	than	ADP
chd-116	83	151	$	$	SYM
chd-116	83	152	25,000	25,000	NUM
chd-116	83	153	419	419	NUM
chd-116	83	154	83.80	83.80	NUM
chd-116	83	155	$	$	SYM
chd-116	83	156	25,000	25,000	NUM
chd-116	83	157	to	to	PART
chd-116	83	158	$	$	SYM
chd-116	83	159	49,999	49,999	NUM
chd-116	83	160	10	10	NUM
chd-116	83	161	2.00	2.00	NUM
chd-116	83	162	$	$	SYM
chd-116	83	163	50,000	50,000	NUM
chd-116	83	164	to	to	PART
chd-116	83	165	$	$	SYM
chd-116	83	166	74,999	74,999	NUM
chd-116	83	167	9	9	NUM
chd-116	83	168	1.80	1.80	NUM
chd-116	83	169	$	$	SYM
chd-116	83	170	75,000	75,000	NUM
chd-116	83	171	and	and	CCONJ
chd-116	83	172	above	above	ADP
chd-116	83	173	15	15	NUM
chd-116	83	174	3.00	3.00	NUM
chd-116	83	175	non	non	ADJ
chd-116	83	176	-	-	VERB
chd-116	83	177	disclosed	disclose	VERB
chd-116	83	178	47	47	NUM
chd-116	83	179	9.40	9.40	NUM
chd-116	83	180	participant	participant	NOUN
chd-116	83	181	’s	’s	PART
chd-116	83	182	health	health	NOUN
chd-116	83	183	-	-	PUNCT
chd-116	83	184	related	relate	VERB
chd-116	83	185	quality	quality	NOUN
chd-116	83	186	of	of	ADP
chd-116	83	187	life	life	NOUN
chd-116	83	188	five	five	NUM
chd-116	83	189	relevant	relevant	ADJ
chd-116	83	190	factors	factor	NOUN
chd-116	83	191	associated	associate	VERB
chd-116	83	192	with	with	ADP
chd-116	83	193	hrqol	hrqol	NOUN
chd-116	83	194	indicators	indicator	NOUN
chd-116	83	195	were	be	AUX
chd-116	83	196	examined	examine	VERB
chd-116	83	197	in	in	ADP
chd-116	83	198	this	this	DET
chd-116	83	199	study	study	NOUN
chd-116	83	200	:	:	PUNCT
chd-116	83	201	exercise	exercise	NOUN
chd-116	83	202	,	,	PUNCT
chd-116	83	203	stress	stress	NOUN
chd-116	83	204	,	,	PUNCT
chd-116	83	205	ability	ability	NOUN
chd-116	83	206	to	to	PART
chd-116	83	207	self	self	NOUN
chd-116	83	208	-	-	PUNCT
chd-116	83	209	care	care	NOUN
chd-116	83	210	,	,	PUNCT
chd-116	83	211	health	health	NOUN
chd-116	83	212	status	status	NOUN
chd-116	83	213	perception	perception	NOUN
chd-116	83	214	and	and	CCONJ
chd-116	83	215	the	the	DET
chd-116	83	216	need	need	NOUN
chd-116	83	217	for	for	ADP
chd-116	83	218	specialized	specialized	ADJ
chd-116	83	219	equipment	equipment	NOUN
chd-116	83	220	towards	towards	ADP
chd-116	83	221	personal	personal	ADJ
chd-116	83	222	daily	daily	ADJ
chd-116	83	223	life	life	NOUN
chd-116	83	224	support	support	NOUN
chd-116	83	225	.	.	PUNCT
chd-116	84	1	results	result	NOUN
chd-116	84	2	show	show	VERB
chd-116	84	3	significant	significant	ADJ
chd-116	84	4	differences	difference	NOUN
chd-116	84	5	(	(	PUNCT
chd-116	84	6	p	p	X
chd-116	84	7	=	=	NOUN
chd-116	84	8	0.0353	0.0353	NUM
chd-116	84	9	)	)	PUNCT
chd-116	84	10	in	in	ADP
chd-116	84	11	participants	participant	NOUN
chd-116	84	12	physical	physical	ADJ
chd-116	84	13	activity	activity	NOUN
chd-116	84	14	levels	level	NOUN
chd-116	84	15	within	within	ADP
chd-116	84	16	the	the	DET
chd-116	84	17	last	last	ADJ
chd-116	84	18	month	month	NOUN
chd-116	84	19	,	,	PUNCT
chd-116	84	20	with	with	ADP
chd-116	84	21	57	57	NUM
chd-116	84	22	%	%	NOUN
chd-116	84	23	of	of	ADP
chd-116	84	24	participants	participant	NOUN
chd-116	84	25	reporting	report	VERB
chd-116	84	26	up	up	ADP
chd-116	84	27	to	to	PART
chd-116	84	28	30	30	NUM
chd-116	84	29	days	day	NOUN
chd-116	84	30	active	active	ADJ
chd-116	84	31	exercise	exercise	NOUN
chd-116	84	32	,	,	PUNCT
chd-116	84	33	19	19	NUM
chd-116	84	34	%	%	NOUN
chd-116	84	35	reporting	reporting	NOUN
chd-116	84	36	0	0	NUM
chd-116	84	37	to	to	ADP
chd-116	84	38	9	9	NUM
chd-116	84	39	days	day	NOUN
chd-116	84	40	of	of	ADP
chd-116	84	41	no	no	DET
chd-116	84	42	exercise	exercise	NOUN
chd-116	84	43	,	,	PUNCT
chd-116	84	44	3	3	NUM
chd-116	84	45	%	%	NOUN
chd-116	84	46	reporting	report	VERB
chd-116	84	47	10	10	NUM
chd-116	84	48	to	to	PART
chd-116	84	49	19	19	NUM
chd-116	84	50	days	day	NOUN
chd-116	84	51	of	of	ADP
chd-116	84	52	no	no	DET
chd-116	84	53	exercise	exercise	NOUN
chd-116	84	54	,	,	PUNCT
chd-116	84	55	and	and	CCONJ
chd-116	84	56	4	4	NUM
chd-116	84	57	%	%	NOUN
chd-116	84	58	reporting	report	VERB
chd-116	84	59	20	20	NUM
chd-116	84	60	to	to	PART
chd-116	84	61	30	30	NUM
chd-116	84	62	days	day	NOUN
chd-116	84	63	of	of	ADP
chd-116	84	64	no	no	DET
chd-116	84	65	exercise	exercise	NOUN
chd-116	84	66	within	within	ADP
chd-116	84	67	the	the	DET
chd-116	84	68	last	last	ADJ
chd-116	84	69	month	month	NOUN
chd-116	84	70	(	(	PUNCT
chd-116	84	71	see	see	VERB
chd-116	84	72	figure	figure	NOUN
chd-116	84	73	1	1	NUM
chd-116	84	74	)	)	PUNCT
chd-116	84	75	.	.	PUNCT
chd-116	85	1	there	there	PRON
chd-116	85	2	was	be	VERB
chd-116	85	3	also	also	ADV
chd-116	85	4	significance	significance	NOUN
chd-116	85	5	difference	difference	NOUN
chd-116	85	6	(	(	PUNCT
chd-116	85	7	p	p	NOUN
chd-116	85	8	=	=	NOUN
chd-116	85	9	0.0080	0.0080	NUM
chd-116	85	10	)	)	PUNCT
chd-116	85	11	across	across	ADP
chd-116	85	12	stress	stress	NOUN
chd-116	85	13	levels	level	NOUN
chd-116	85	14	of	of	ADP
chd-116	85	15	participants	participant	NOUN
chd-116	85	16	within	within	ADP
chd-116	85	17	the	the	DET
chd-116	85	18	last	last	ADJ
chd-116	85	19	month	month	NOUN
chd-116	85	20	.	.	PUNCT
chd-116	86	1	sixtyfour	sixtyfour	PROPN
chd-116	86	2	per	per	ADP
chd-116	86	3	cent	cent	NOUN
chd-116	86	4	(	(	PUNCT
chd-116	86	5	64	64	NUM
chd-116	86	6	%	%	NOUN
chd-116	86	7	)	)	PUNCT
chd-116	86	8	of	of	ADP
chd-116	86	9	participants	participant	NOUN
chd-116	86	10	reported	report	VERB
chd-116	86	11	absence	absence	NOUN
chd-116	86	12	of	of	ADP
chd-116	86	13	emotional	emotional	ADJ
chd-116	86	14	stress	stress	NOUN
chd-116	86	15	for	for	ADP
chd-116	86	16	30	30	NUM
chd-116	86	17	days	day	NOUN
chd-116	86	18	within	within	ADP
chd-116	86	19	the	the	DET
chd-116	86	20	last	last	ADJ
chd-116	86	21	month	month	NOUN
chd-116	86	22	,	,	PUNCT
chd-116	86	23	13	13	NUM
chd-116	86	24	%	%	NOUN
chd-116	86	25	reported	report	VERB
chd-116	86	26	presence	presence	NOUN
chd-116	86	27	of	of	ADP
chd-116	86	28	stress	stress	NOUN
chd-116	86	29	for	for	ADP
chd-116	86	30	0	0	NUM
chd-116	86	31	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-116	86	32	e8	e8	PROPN
chd-116	86	33	cancer	cancer	NOUN
chd-116	86	34	health	health	NOUN
chd-116	86	35	disparities	disparity	NOUN
chd-116	86	36	research	research	VERB
chd-116	86	37	to	to	ADP
chd-116	86	38	9	9	NUM
chd-116	86	39	days	day	NOUN
chd-116	86	40	,	,	PUNCT
chd-116	86	41	3	3	NUM
chd-116	86	42	%	%	NOUN
chd-116	86	43	reported	report	VERB
chd-116	86	44	presence	presence	NOUN
chd-116	86	45	of	of	ADP
chd-116	86	46	stress	stress	NOUN
chd-116	86	47	for	for	ADP
chd-116	86	48	10	10	NUM
chd-116	86	49	to	to	PART
chd-116	86	50	19	19	NUM
chd-116	86	51	days	day	NOUN
chd-116	86	52	and	and	CCONJ
chd-116	86	53	3	3	NUM
chd-116	86	54	%	%	NOUN
chd-116	86	55	reported	report	VERB
chd-116	86	56	presence	presence	NOUN
chd-116	86	57	of	of	ADP
chd-116	86	58	stress	stress	NOUN
chd-116	86	59	for	for	ADP
chd-116	86	60	20	20	NUM
chd-116	86	61	to	to	PART
chd-116	86	62	30	30	NUM
chd-116	86	63	days	day	NOUN
chd-116	86	64	(	(	PUNCT
chd-116	86	65	figure	figure	NOUN
chd-116	86	66	1	1	NUM
chd-116	86	67	)	)	PUNCT
chd-116	86	68	.	.	PUNCT
chd-116	87	1	there	there	PRON
chd-116	87	2	were	be	VERB
chd-116	87	3	significant	significant	ADJ
chd-116	87	4	differences	difference	NOUN
chd-116	87	5	(	(	PUNCT
chd-116	87	6	p	p	X
chd-116	87	7	=	=	NOUN
chd-116	87	8	0.0051	0.0051	NUM
chd-116	87	9	)	)	PUNCT
chd-116	87	10	in	in	ADP
chd-116	87	11	participants	participant	NOUN
chd-116	87	12	’	'	PUNCT
chd-116	87	13	report	report	NOUN
chd-116	87	14	on	on	ADP
chd-116	87	15	self	self	NOUN
chd-116	87	16	-	-	PUNCT
chd-116	87	17	care	care	NOUN
chd-116	87	18	within	within	ADP
chd-116	87	19	the	the	DET
chd-116	87	20	last	last	ADJ
chd-116	87	21	month	month	NOUN
chd-116	87	22	.	.	PUNCT
chd-116	88	1	sixty	sixty	NUM
chd-116	88	2	-	-	PUNCT
chd-116	88	3	three	three	NUM
chd-116	88	4	(	(	PUNCT
chd-116	88	5	63	63	NUM
chd-116	88	6	%	%	NOUN
chd-116	88	7	)	)	PUNCT
chd-116	88	8	indicated	indicate	VERB
chd-116	88	9	that	that	SCONJ
chd-116	88	10	they	they	PRON
chd-116	88	11	had	have	AUX
chd-116	88	12	not	not	PART
chd-116	88	13	been	be	AUX
chd-116	88	14	able	able	ADJ
chd-116	88	15	to	to	PART
chd-116	88	16	carry	carry	VERB
chd-116	88	17	out	out	ADP
chd-116	88	18	self	self	NOUN
chd-116	88	19	-	-	PUNCT
chd-116	88	20	care	care	NOUN
chd-116	88	21	for	for	ADP
chd-116	88	22	30	30	NUM
chd-116	88	23	days	day	NOUN
chd-116	88	24	,	,	PUNCT
chd-116	88	25	16	16	NUM
chd-116	88	26	%	%	NOUN
chd-116	88	27	indicated	indicate	VERB
chd-116	88	28	that	that	SCONJ
chd-116	88	29	they	they	PRON
chd-116	88	30	had	have	AUX
chd-116	88	31	not	not	PART
chd-116	88	32	been	be	AUX
chd-116	88	33	able	able	ADJ
chd-116	88	34	to	to	PART
chd-116	88	35	carry	carry	VERB
chd-116	88	36	out	out	ADP
chd-116	88	37	self	self	NOUN
chd-116	88	38	-	-	PUNCT
chd-116	88	39	care	care	NOUN
chd-116	88	40	for	for	ADP
chd-116	88	41	0	0	NUM
chd-116	88	42	to	to	PART
chd-116	88	43	9	9	NUM
chd-116	88	44	days	day	NOUN
chd-116	88	45	,	,	PUNCT
chd-116	88	46	2	2	NUM
chd-116	88	47	%	%	NOUN
chd-116	88	48	had	have	AUX
chd-116	88	49	not	not	PART
chd-116	88	50	been	be	AUX
chd-116	88	51	able	able	ADJ
chd-116	88	52	to	to	PART
chd-116	88	53	carry	carry	VERB
chd-116	88	54	out	out	ADP
chd-116	88	55	self	self	NOUN
chd-116	88	56	-	-	PUNCT
chd-116	88	57	care	care	NOUN
chd-116	88	58	for	for	ADP
chd-116	88	59	10	10	NUM
chd-116	88	60	to	to	PART
chd-116	88	61	19	19	NUM
chd-116	88	62	days	day	NOUN
chd-116	88	63	and	and	CCONJ
chd-116	88	64	3	3	NUM
chd-116	88	65	%	%	NOUN
chd-116	88	66	had	have	AUX
chd-116	88	67	not	not	PART
chd-116	88	68	been	be	AUX
chd-116	88	69	able	able	ADJ
chd-116	88	70	to	to	PART
chd-116	88	71	carry	carry	VERB
chd-116	88	72	out	out	ADP
chd-116	88	73	self	self	NOUN
chd-116	88	74	-	-	PUNCT
chd-116	88	75	care	care	NOUN
chd-116	88	76	20	20	NUM
chd-116	88	77	to	to	PART
chd-116	88	78	30	30	NUM
chd-116	88	79	days	day	NOUN
chd-116	88	80	.	.	PUNCT
chd-116	89	1	in	in	ADP
chd-116	89	2	general	general	ADJ
chd-116	89	3	,	,	PUNCT
chd-116	89	4	most	most	ADJ
chd-116	89	5	of	of	ADP
chd-116	89	6	the	the	DET
chd-116	89	7	participants	participant	NOUN
chd-116	89	8	reported	report	VERB
chd-116	89	9	good	good	ADJ
chd-116	89	10	healthcare	healthcare	PROPN
chd-116	89	11	status	status	NOUN
chd-116	89	12	.	.	PUNCT
chd-116	90	1	eighty	eighty	NUM
chd-116	90	2	-	-	PUNCT
chd-116	90	3	four	four	NUM
chd-116	90	4	per	per	ADP
chd-116	90	5	cent	cent	NOUN
chd-116	90	6	of	of	ADP
chd-116	90	7	the	the	DET
chd-116	90	8	participants	participant	NOUN
chd-116	90	9	indicated	indicate	VERB
chd-116	90	10	that	that	SCONJ
chd-116	90	11	they	they	PRON
chd-116	90	12	were	be	AUX
chd-116	90	13	in	in	ADP
chd-116	90	14	good	good	ADJ
chd-116	90	15	health	health	NOUN
chd-116	90	16	while	while	SCONJ
chd-116	90	17	14	14	NUM
chd-116	90	18	%	%	NOUN
chd-116	90	19	reported	report	VERB
chd-116	90	20	poor	poor	ADJ
chd-116	90	21	or	or	CCONJ
chd-116	90	22	fair	fair	ADJ
chd-116	90	23	health	health	NOUN
chd-116	90	24	within	within	ADP
chd-116	90	25	the	the	DET
chd-116	90	26	last	last	ADJ
chd-116	90	27	month	month	NOUN
chd-116	90	28	.	.	PUNCT
chd-116	91	1	furthermore	furthermore	ADV
chd-116	91	2	,	,	PUNCT
chd-116	91	3	94	94	NUM
chd-116	91	4	%	%	NOUN
chd-116	91	5	of	of	ADP
chd-116	91	6	the	the	DET
chd-116	91	7	participants	participant	NOUN
chd-116	91	8	reported	report	VERB
chd-116	91	9	that	that	SCONJ
chd-116	91	10	they	they	PRON
chd-116	91	11	had	have	VERB
chd-116	91	12	no	no	DET
chd-116	91	13	need	need	NOUN
chd-116	91	14	for	for	ADP
chd-116	91	15	specialized	specialized	ADJ
chd-116	91	16	equipment	equipment	NOUN
chd-116	91	17	to	to	ADP
chd-116	91	18	carryout	carryout	NOUN
chd-116	91	19	daily	daily	ADJ
chd-116	91	20	personal	personal	ADJ
chd-116	91	21	activities	activity	NOUN
chd-116	91	22	while	while	SCONJ
chd-116	91	23	4	4	NUM
chd-116	91	24	%	%	NOUN
chd-116	91	25	reported	report	VERB
chd-116	91	26	that	that	SCONJ
chd-116	91	27	they	they	PRON
chd-116	91	28	needed	need	VERB
chd-116	91	29	special	special	ADJ
chd-116	91	30	equipment	equipment	NOUN
chd-116	91	31	for	for	ADP
chd-116	91	32	daily	daily	ADJ
chd-116	91	33	life	life	NOUN
chd-116	91	34	activities	activity	NOUN
chd-116	91	35	within	within	ADP
chd-116	91	36	the	the	DET
chd-116	91	37	last	last	ADJ
chd-116	91	38	month	month	NOUN
chd-116	91	39	.	.	PUNCT
chd-116	92	1	table	table	NOUN
chd-116	92	2	2	2	NUM
chd-116	92	3	compares	compare	VERB
chd-116	92	4	hrqol	hrqol	ADJ
chd-116	92	5	indicators	indicator	NOUN
chd-116	92	6	between	between	ADP
chd-116	92	7	participants	participant	NOUN
chd-116	92	8	with	with	ADP
chd-116	92	9	history	history	NOUN
chd-116	92	10	of	of	ADP
chd-116	92	11	cap	cap	NOUN
chd-116	92	12	and	and	CCONJ
chd-116	92	13	cap	cap	NOUN
chd-116	92	14	-	-	PUNCT
chd-116	92	15	free	free	ADJ
chd-116	92	16	participants	participant	NOUN
chd-116	92	17	.	.	PUNCT
chd-116	93	1	the	the	DET
chd-116	93	2	hrqol	hrqol	NOUN
chd-116	93	3	indicators	indicator	NOUN
chd-116	93	4	show	show	VERB
chd-116	93	5	no	no	DET
chd-116	93	6	significant	significant	ADJ
chd-116	93	7	difference	difference	NOUN
chd-116	93	8	in	in	ADP
chd-116	93	9	exercise	exercise	NOUN
chd-116	93	10	(	(	PUNCT
chd-116	93	11	p	p	X
chd-116	93	12	=	=	NOUN
chd-116	93	13	0.1441	0.1441	NUM
chd-116	93	14	)	)	PUNCT
chd-116	93	15	,	,	PUNCT
chd-116	93	16	stress	stress	NOUN
chd-116	93	17	(	(	PUNCT
chd-116	93	18	p	p	X
chd-116	93	19	=	=	NOUN
chd-116	93	20	0.1789	0.1789	NUM
chd-116	93	21	)	)	PUNCT
chd-116	93	22	,	,	PUNCT
chd-116	93	23	ability	ability	NOUN
chd-116	93	24	to	to	PART
chd-116	93	25	self	self	NOUN
chd-116	93	26	-	-	PUNCT
chd-116	93	27	care	care	NOUN
chd-116	93	28	(	(	PUNCT
chd-116	93	29	p	p	X
chd-116	93	30	=	=	NOUN
chd-116	93	31	0.1434	0.1434	NUM
chd-116	93	32	)	)	PUNCT
chd-116	93	33	,	,	PUNCT
chd-116	93	34	health	health	NOUN
chd-116	93	35	status	status	NOUN
chd-116	93	36	perception	perception	NOUN
chd-116	93	37	(	(	PUNCT
chd-116	93	38	p	p	X
chd-116	93	39	=	=	NOUN
chd-116	93	40	0.3066	0.3066	NUM
chd-116	93	41	)	)	PUNCT
chd-116	93	42	,	,	PUNCT
chd-116	93	43	and	and	CCONJ
chd-116	93	44	need	need	VERB
chd-116	93	45	for	for	ADP
chd-116	93	46	specialized	specialized	ADJ
chd-116	93	47	equipment	equipment	NOUN
chd-116	93	48	(	(	PUNCT
chd-116	93	49	p	p	X
chd-116	93	50	=	=	NOUN
chd-116	93	51	0.3784	0.3784	NUM
chd-116	93	52	)	)	PUNCT
chd-116	93	53	between	between	ADP
chd-116	93	54	patients	patient	NOUN
chd-116	93	55	with	with	ADP
chd-116	93	56	history	history	NOUN
chd-116	93	57	of	of	ADP
chd-116	93	58	cap	cap	NOUN
chd-116	93	59	and	and	CCONJ
chd-116	93	60	cap	cap	NOUN
chd-116	93	61	-	-	PUNCT
chd-116	93	62	free	free	ADJ
chd-116	93	63	participants	participant	NOUN
chd-116	93	64	.	.	PUNCT
chd-116	94	1	figure	figure	VERB
chd-116	94	2	1	1	NUM
chd-116	94	3	.	.	PUNCT
chd-116	95	1	summary	summary	NOUN
chd-116	95	2	of	of	ADP
chd-116	95	3	health	health	NOUN
chd-116	95	4	related	relate	VERB
chd-116	95	5	quality	quality	NOUN
chd-116	95	6	of	of	ADP
chd-116	95	7	life	life	NOUN
chd-116	95	8	of	of	ADP
chd-116	95	9	participants	participant	NOUN
chd-116	95	10	recruited	recruit	VERB
chd-116	95	11	.	.	PUNCT
chd-116	96	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-116	96	2	e9	e9	PROPN
chd-116	96	3	cancer	cancer	NOUN
chd-116	96	4	health	health	NOUN
chd-116	96	5	disparities	disparity	NOUN
chd-116	96	6	research	research	NOUN
chd-116	96	7	figure	figure	NOUN
chd-116	96	8	2	2	NUM
chd-116	96	9	.	.	PUNCT
chd-116	97	1	response	response	NOUN
chd-116	97	2	of	of	ADP
chd-116	97	3	perceived	perceive	VERB
chd-116	97	4	health	health	NOUN
chd-116	97	5	status	status	NOUN
chd-116	97	6	of	of	ADP
chd-116	97	7	the	the	DET
chd-116	97	8	participants	participant	NOUN
chd-116	97	9	.	.	PUNCT
chd-116	98	1	table	table	NOUN
chd-116	98	2	2	2	NUM
chd-116	98	3	.	.	PUNCT
chd-116	98	4	comparison	comparison	NOUN
chd-116	98	5	of	of	ADP
chd-116	98	6	health	health	NOUN
chd-116	98	7	-	-	PUNCT
chd-116	98	8	related	relate	VERB
chd-116	98	9	quality	quality	NOUN
chd-116	98	10	of	of	ADP
chd-116	98	11	life	life	NOUN
chd-116	98	12	for	for	ADP
chd-116	98	13	participants	participant	NOUN
chd-116	98	14	with	with	ADP
chd-116	98	15	history	history	NOUN
chd-116	98	16	of	of	ADP
chd-116	98	17	prostate	prostate	NOUN
chd-116	98	18	cancer	cancer	NOUN
chd-116	98	19	and	and	CCONJ
chd-116	98	20	prostate	prostate	NOUN
chd-116	98	21	cancer	cancer	NOUN
chd-116	98	22	-	-	PUNCT
chd-116	98	23	free	free	ADJ
chd-116	98	24	participants	participant	NOUN
chd-116	98	25	.	.	PUNCT
chd-116	99	1	variable	variable	NOUN
chd-116	99	2	s	s	PART
chd-116	99	3	participants	participant	NOUN
chd-116	99	4	with	with	ADP
chd-116	99	5	cap	cap	NOUN
chd-116	99	6	history	history	NOUN
chd-116	99	7	n=40	n=40	PROPN
chd-116	99	8	(	(	PUNCT
chd-116	99	9	%	%	INTJ
chd-116	99	10	)	)	PUNCT
chd-116	99	11	participant	participant	NOUN
chd-116	99	12	without	without	ADP
chd-116	99	13	cap	cap	NOUN
chd-116	99	14	history	history	NOUN
chd-116	99	15	n=460	n=460	NUM
chd-116	99	16	(	(	PUNCT
chd-116	99	17	%	%	NOUN
chd-116	99	18	)	)	PUNCT
chd-116	99	19	p	p	X
chd-116	99	20	-	-	PUNCT
chd-116	99	21	value	value	NOUN
chd-116	99	22	exercise	exercise	NOUN
chd-116	99	23	30	30	NUM
chd-116	99	24	days	day	NOUN
chd-116	99	25	active	active	ADJ
chd-116	99	26	exercise	exercise	NOUN
chd-116	99	27	19	19	NUM
chd-116	99	28	(	(	PUNCT
chd-116	99	29	47.5	47.5	NUM
chd-116	99	30	)	)	PUNCT
chd-116	99	31	289	289	NUM
chd-116	99	32	(	(	PUNCT
chd-116	99	33	64.3	64.3	NUM
chd-116	99	34	)	)	PUNCT
chd-116	99	35	0.1441	0.1441	NUM
chd-116	99	36	no	no	DET
chd-116	99	37	exercise	exercise	NOUN
chd-116	99	38	0	0	NUM
chd-116	99	39	-	-	SYM
chd-116	99	40	9	9	NUM
chd-116	99	41	days	day	NOUN
chd-116	99	42	13	13	NUM
chd-116	99	43	(	(	PUNCT
chd-116	99	44	32.5	32.5	NUM
chd-116	99	45	)	)	PUNCT
chd-116	99	46	101	101	NUM
chd-116	99	47	(	(	PUNCT
chd-116	99	48	21.9	21.9	NUM
chd-116	99	49	)	)	PUNCT
chd-116	99	50	no	no	DET
chd-116	99	51	exercise	exercise	NOUN
chd-116	99	52	10	10	NUM
chd-116	99	53	-	-	SYM
chd-116	99	54	19	19	NUM
chd-116	99	55	2	2	NUM
chd-116	99	56	(	(	PUNCT
chd-116	99	57	5.0	5.0	NUM
chd-116	99	58	)	)	PUNCT
chd-116	99	59	14	14	NUM
chd-116	99	60	(	(	PUNCT
chd-116	99	61	3.0	3.0	NUM
chd-116	99	62	)	)	PUNCT
chd-116	99	63	no	no	DET
chd-116	99	64	exercise	exercise	NOUN
chd-116	99	65	20	20	NUM
chd-116	99	66	-	-	SYM
chd-116	99	67	30	30	NUM
chd-116	99	68	days	day	NOUN
chd-116	99	69	3	3	NUM
chd-116	99	70	(	(	PUNCT
chd-116	99	71	7.5	7.5	NUM
chd-116	99	72	)	)	PUNCT
chd-116	99	73	13	13	NUM
chd-116	99	74	(	(	PUNCT
chd-116	99	75	2.8	2.8	NUM
chd-116	99	76	)	)	PUNCT
chd-116	99	77	no	no	DET
chd-116	99	78	response	response	NOUN
chd-116	99	79	3	3	NUM
chd-116	99	80	(	(	PUNCT
chd-116	99	81	7.5	7.5	NUM
chd-116	99	82	)	)	PUNCT
chd-116	99	83	43	43	NUM
chd-116	99	84	(	(	PUNCT
chd-116	99	85	7.9	7.9	NUM
chd-116	99	86	)	)	PUNCT
chd-116	99	87	stress	stress	VERB
chd-116	99	88	no	no	DET
chd-116	99	89	stress	stress	NOUN
chd-116	99	90	30	30	NUM
chd-116	99	91	days	day	NOUN
chd-116	99	92	22	22	NUM
chd-116	99	93	(	(	PUNCT
chd-116	99	94	55.0	55.0	NUM
chd-116	99	95	)	)	PUNCT
chd-116	99	96	316	316	NUM
chd-116	99	97	(	(	PUNCT
chd-116	99	98	70.1	70.1	NUM
chd-116	99	99	)	)	PUNCT
chd-116	99	100	0.1789	0.1789	NUM
chd-116	99	101	stress	stress	NOUN
chd-116	99	102	0	0	NUM
chd-116	99	103	-	-	SYM
chd-116	99	104	9	9	NUM
chd-116	99	105	days	day	NOUN
chd-116	99	106	8	8	NUM
chd-116	99	107	(	(	PUNCT
chd-116	99	108	20.0	20.0	NUM
chd-116	99	109	)	)	PUNCT
chd-116	99	110	61	61	NUM
chd-116	99	111	(	(	PUNCT
chd-116	99	112	13.3	13.3	NUM
chd-116	99	113	)	)	PUNCT
chd-116	99	114	stress	stress	NOUN
chd-116	99	115	10	10	NUM
chd-116	99	116	-	-	SYM
chd-116	99	117	19	19	NUM
chd-116	99	118	days	day	NOUN
chd-116	99	119	2	2	NUM
chd-116	99	120	(	(	PUNCT
chd-116	99	121	5.0	5.0	NUM
chd-116	99	122	)	)	PUNCT
chd-116	99	123	14	14	NUM
chd-116	99	124	(	(	PUNCT
chd-116	99	125	3.1	3.1	NUM
chd-116	99	126	)	)	PUNCT
chd-116	99	127	stress	stress	NOUN
chd-116	99	128	20	20	NUM
chd-116	99	129	-	-	SYM
chd-116	99	130	30	30	NUM
chd-116	99	131	days	day	NOUN
chd-116	99	132	3	3	NUM
chd-116	99	133	(	(	PUNCT
chd-116	99	134	7.5	7.5	NUM
chd-116	99	135	)	)	PUNCT
chd-116	99	136	13	13	NUM
chd-116	99	137	(	(	PUNCT
chd-116	99	138	2.8	2.8	NUM
chd-116	99	139	)	)	PUNCT
chd-116	99	140	no	no	DET
chd-116	99	141	response	response	NOUN
chd-116	99	142	5	5	NUM
chd-116	99	143	(	(	PUNCT
chd-116	99	144	12.5	12.5	NUM
chd-116	99	145	)	)	PUNCT
chd-116	99	146	56	56	NUM
chd-116	99	147	(	(	PUNCT
chd-116	99	148	10.7	10.7	NUM
chd-116	99	149	)	)	PUNCT
chd-116	99	150	ability	ability	NOUN
chd-116	99	151	to	to	PART
chd-116	99	152	self	self	NOUN
chd-116	99	153	-	-	PUNCT
chd-116	99	154	care	care	NOUN
chd-116	99	155	self	self	NOUN
chd-116	99	156	-	-	PUNCT
chd-116	99	157	care	care	NOUN
chd-116	99	158	30	30	NUM
chd-116	99	159	days	day	NOUN
chd-116	99	160	25	25	NUM
chd-116	99	161	(	(	PUNCT
chd-116	99	162	62.5	62.5	NUM
chd-116	99	163	)	)	PUNCT
chd-116	99	164	290	290	NUM
chd-116	99	165	(	(	PUNCT
chd-116	99	166	63.0	63.0	NUM
chd-116	99	167	)	)	PUNCT
chd-116	99	168	0.1434	0.1434	NUM
chd-116	99	169	no	no	DET
chd-116	99	170	self	self	NOUN
chd-116	99	171	-	-	PUNCT
chd-116	99	172	care	care	NOUN
chd-116	99	173	0	0	NUM
chd-116	99	174	-	-	SYM
chd-116	99	175	9	9	NUM
chd-116	99	176	6	6	NUM
chd-116	99	177	(	(	PUNCT
chd-116	99	178	15.0	15.0	NUM
chd-116	99	179	)	)	PUNCT
chd-116	99	180	74	74	NUM
chd-116	99	181	(	(	PUNCT
chd-116	99	182	16.1	16.1	NUM
chd-116	99	183	)	)	PUNCT
chd-116	99	184	no	no	DET
chd-116	99	185	self	self	NOUN
chd-116	99	186	-	-	PUNCT
chd-116	99	187	care	care	NOUN
chd-116	99	188	10	10	NUM
chd-116	99	189	-	-	SYM
chd-116	99	190	19	19	NUM
chd-116	99	191	3	3	NUM
chd-116	99	192	(	(	PUNCT
chd-116	99	193	7.5	7.5	NUM
chd-116	99	194	)	)	PUNCT
chd-116	99	195	7	7	NUM
chd-116	99	196	(	(	PUNCT
chd-116	99	197	1.5	1.5	NUM
chd-116	99	198	)	)	PUNCT
chd-116	99	199	no	no	DET
chd-116	99	200	self	self	NOUN
chd-116	99	201	-	-	PUNCT
chd-116	99	202	care	care	NOUN
chd-116	99	203	20	20	NUM
chd-116	99	204	-	-	SYM
chd-116	99	205	30	30	NUM
chd-116	99	206	2	2	NUM
chd-116	99	207	(	(	PUNCT
chd-116	99	208	5.0	5.0	NUM
chd-116	99	209	)	)	PUNCT
chd-116	99	210	13	13	NUM
chd-116	99	211	(	(	PUNCT
chd-116	99	212	2.8	2.8	NUM
chd-116	99	213	)	)	PUNCT
chd-116	99	214	no	no	DET
chd-116	99	215	response	response	NOUN
chd-116	99	216	4	4	NUM
chd-116	99	217	(	(	PUNCT
chd-116	99	218	10.0	10.0	NUM
chd-116	99	219	)	)	PUNCT
chd-116	99	220	76	76	NUM
chd-116	99	221	(	(	PUNCT
chd-116	99	222	16.5	16.5	NUM
chd-116	99	223	)	)	PUNCT
chd-116	99	224	0	0	NUM
chd-116	100	1	10	10	NUM
chd-116	100	2	20	20	NUM
chd-116	100	3	30	30	NUM
chd-116	100	4	40	40	NUM
chd-116	100	5	50	50	NUM
chd-116	100	6	60	60	NUM
chd-116	100	7	70	70	NUM
chd-116	100	8	80	80	NUM
chd-116	100	9	90	90	NUM
chd-116	100	10	100	100	NUM
chd-116	100	11	good	good	ADJ
chd-116	100	12	–	–	PUNCT
chd-116	100	13	excellent	excellent	ADJ
chd-116	100	14	health	health	NOUN
chd-116	100	15	poor	poor	ADJ
chd-116	100	16	–	–	PUNCT
chd-116	100	17	fair	fair	ADJ
chd-116	100	18	health	health	NOUN
chd-116	100	19	unclassified	unclassifie	VERB
chd-116	100	20	do	do	AUX
chd-116	100	21	not	not	PART
chd-116	100	22	need	need	VERB
chd-116	100	23	special	special	ADJ
chd-116	100	24	equipment	equipment	NOUN
chd-116	100	25	need	need	VERB
chd-116	100	26	special	special	ADJ
chd-116	100	27	equipment	equipment	NOUN
chd-116	100	28	unclassified	unclassifie	VERB
chd-116	100	29	re	re	ADP
chd-116	100	30	sp	sp	NOUN
chd-116	100	31	on	on	ADV
chd-116	100	32	se	se	PROPN
chd-116	100	33	o	o	PROPN
chd-116	101	1	f	f	PROPN
chd-116	101	2	t	t	X
chd-116	101	3	he	he	PRON
chd-116	101	4	s	s	VERB
chd-116	101	5	ub	ub	INTJ
chd-116	101	6	je	je	PROPN
chd-116	101	7	ct	ct	PROPN
chd-116	101	8	s	s	PROPN
chd-116	101	9	(	(	PUNCT
chd-116	101	10	%	%	NOUN
chd-116	101	11	)	)	PUNCT
chd-116	101	12	perceived	perceive	VERB
chd-116	101	13	health	health	NOUN
chd-116	101	14	status	status	NOUN
chd-116	101	15	scale	scale	NOUN
chd-116	101	16	of	of	ADP
chd-116	101	17	the	the	DET
chd-116	101	18	subjects	subject	NOUN
chd-116	101	19	recruited	recruit	VERB
chd-116	101	20	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	ADP
chd-116	101	21	e10	e10	NUM
chd-116	101	22	cancer	cancer	NOUN
chd-116	101	23	health	health	NOUN
chd-116	101	24	disparities	disparity	NOUN
chd-116	101	25	research	research	NOUN
chd-116	101	26	health	health	NOUN
chd-116	101	27	status	status	NOUN
chd-116	101	28	perception	perception	NOUN
chd-116	101	29	good	good	ADJ
chd-116	101	30	to	to	ADP
chd-116	101	31	excellent	excellent	ADJ
chd-116	101	32	20	20	NUM
chd-116	101	33	(	(	PUNCT
chd-116	101	34	50	50	NUM
chd-116	101	35	)	)	PUNCT
chd-116	101	36	390	390	NUM
chd-116	101	37	(	(	PUNCT
chd-116	101	38	84.8	84.8	NUM
chd-116	101	39	)	)	PUNCT
chd-116	101	40	0.3066	0.3066	NUM
chd-116	101	41	poor	poor	ADJ
chd-116	101	42	to	to	PART
chd-116	101	43	fair	fair	VERB
chd-116	101	44	17	17	NUM
chd-116	101	45	(	(	PUNCT
chd-116	101	46	42.5	42.5	NUM
chd-116	101	47	)	)	PUNCT
chd-116	101	48	63	63	NUM
chd-116	101	49	(	(	PUNCT
chd-116	101	50	13.7	13.7	NUM
chd-116	101	51	)	)	PUNCT
chd-116	101	52	no	no	DET
chd-116	101	53	response	response	NOUN
chd-116	101	54	3	3	NUM
chd-116	101	55	(	(	PUNCT
chd-116	101	56	7.5	7.5	NUM
chd-116	101	57	)	)	PUNCT
chd-116	101	58	7	7	NUM
chd-116	101	59	(	(	PUNCT
chd-116	101	60	1.5)10	1.5)10	NUM
chd-116	101	61	need	need	NOUN
chd-116	101	62	for	for	ADP
chd-116	101	63	specialized	specialized	ADJ
chd-116	101	64	equipment	equipment	NOUN
chd-116	101	65	do	do	AUX
chd-116	101	66	not	not	PART
chd-116	101	67	need	need	VERB
chd-116	101	68	24	24	NUM
chd-116	101	69	(	(	PUNCT
chd-116	101	70	60	60	NUM
chd-116	101	71	)	)	PUNCT
chd-116	101	72	436	436	NUM
chd-116	101	73	(	(	PUNCT
chd-116	101	74	94.8	94.8	NUM
chd-116	101	75	)	)	PUNCT
chd-116	101	76	0.3784	0.3784	NUM
chd-116	101	77	need	need	VERB
chd-116	101	78	13	13	NUM
chd-116	101	79	(	(	PUNCT
chd-116	101	80	32.5	32.5	NUM
chd-116	101	81	)	)	PUNCT
chd-116	101	82	11	11	NUM
chd-116	101	83	(	(	PUNCT
chd-116	101	84	2.4	2.4	NUM
chd-116	101	85	)	)	PUNCT
chd-116	101	86	no	no	DET
chd-116	101	87	response	response	NOUN
chd-116	101	88	3	3	NUM
chd-116	101	89	(	(	PUNCT
chd-116	101	90	7.5	7.5	NUM
chd-116	101	91	)	)	PUNCT
chd-116	101	92	13	13	NUM
chd-116	101	93	(	(	PUNCT
chd-116	101	94	2.8	2.8	NUM
chd-116	101	95	)	)	PUNCT
chd-116	101	96	salivary	salivary	ADJ
chd-116	101	97	cortisol	cortisol	ADJ
chd-116	101	98	levels	level	NOUN
chd-116	101	99	of	of	ADP
chd-116	101	100	cap	cap	NOUN
chd-116	101	101	patients	patient	NOUN
chd-116	101	102	and	and	CCONJ
chd-116	101	103	capfree	capfree	NOUN
chd-116	101	104	participants	participant	NOUN
chd-116	101	105	results	result	VERB
chd-116	101	106	from	from	ADP
chd-116	101	107	the	the	DET
chd-116	101	108	salivary	salivary	ADJ
chd-116	101	109	cortisol	cortisol	ADJ
chd-116	101	110	analysis	analysis	NOUN
chd-116	101	111	by	by	ADP
chd-116	101	112	elisa	elisa	NOUN
chd-116	101	113	show	show	VERB
chd-116	101	114	significant	significant	ADJ
chd-116	101	115	increase	increase	NOUN
chd-116	101	116	in	in	ADP
chd-116	101	117	expression	expression	NOUN
chd-116	101	118	(	(	PUNCT
chd-116	101	119	p	p	NOUN
chd-116	101	120	=	=	NOUN
chd-116	101	121	0.003	0.003	NUM
chd-116	101	122	)	)	PUNCT
chd-116	101	123	of	of	ADP
chd-116	101	124	salivary	salivary	ADJ
chd-116	101	125	cortisol	cortisol	NOUN
chd-116	101	126	levels	level	NOUN
chd-116	101	127	(	(	PUNCT
chd-116	101	128	0.18±0.03	0.18±0.03	NOUN
chd-116	101	129	)	)	PUNCT
chd-116	101	130	in	in	ADP
chd-116	101	131	the	the	DET
chd-116	101	132	prostate	prostate	NOUN
chd-116	101	133	cancer	cancer	NOUN
chd-116	101	134	patients	patient	NOUN
chd-116	101	135	(	(	PUNCT
chd-116	101	136	n=10	n=10	NOUN
chd-116	101	137	)	)	PUNCT
chd-116	101	138	compared	compare	VERB
chd-116	101	139	to	to	ADP
chd-116	101	140	the	the	DET
chd-116	101	141	values	value	NOUN
chd-116	101	142	(	(	PUNCT
chd-116	101	143	0.08±0.01	0.08±0.01	NOUN
chd-116	101	144	)	)	PUNCT
chd-116	101	145	from	from	ADP
chd-116	101	146	the	the	DET
chd-116	101	147	cap	cap	NOUN
chd-116	101	148	-	-	PUNCT
chd-116	101	149	free	free	ADJ
chd-116	101	150	participant	participant	NOUN
chd-116	101	151	(	(	PUNCT
chd-116	101	152	n=40	n=40	ADJ
chd-116	101	153	)	)	PUNCT
chd-116	101	154	(	(	PUNCT
chd-116	101	155	figure	figure	NOUN
chd-116	101	156	3a	3a	NUM
chd-116	101	157	)	)	PUNCT
chd-116	101	158	.	.	PUNCT
chd-116	102	1	the	the	DET
chd-116	102	2	maximum	maximum	ADJ
chd-116	102	3	value	value	NOUN
chd-116	102	4	of	of	ADP
chd-116	102	5	the	the	DET
chd-116	102	6	salivary	salivary	ADJ
chd-116	102	7	cortisol	cortisol	ADJ
chd-116	102	8	level	level	NOUN
chd-116	102	9	among	among	ADP
chd-116	102	10	the	the	DET
chd-116	102	11	cap	cap	NOUN
chd-116	102	12	patients	patient	NOUN
chd-116	102	13	was	be	AUX
chd-116	102	14	1.029	1.029	NUM
chd-116	102	15	and	and	CCONJ
chd-116	102	16	the	the	DET
chd-116	102	17	minimum	minimum	ADJ
chd-116	102	18	value	value	NOUN
chd-116	102	19	was	be	AUX
chd-116	102	20	0.037	0.037	NUM
chd-116	102	21	.	.	PUNCT
chd-116	103	1	the	the	DET
chd-116	103	2	maximum	maximum	ADJ
chd-116	103	3	and	and	CCONJ
chd-116	103	4	minimum	minimum	ADJ
chd-116	103	5	values	value	NOUN
chd-116	103	6	of	of	ADP
chd-116	103	7	the	the	DET
chd-116	103	8	salivary	salivary	ADJ
chd-116	103	9	cortisol	cortisol	NOUN
chd-116	103	10	in	in	ADP
chd-116	103	11	cap	cap	NOUN
chd-116	103	12	-	-	PUNCT
chd-116	103	13	free	free	ADJ
chd-116	103	14	participants	participant	NOUN
chd-116	103	15	were	be	AUX
chd-116	103	16	0.139	0.139	NUM
chd-116	103	17	and	and	CCONJ
chd-116	103	18	0.026	0.026	NUM
chd-116	103	19	respectively	respectively	ADV
chd-116	103	20	(	(	PUNCT
chd-116	103	21	figure	figure	NOUN
chd-116	103	22	3b	3b	NUM
chd-116	103	23	)	)	PUNCT
chd-116	103	24	.	.	PUNCT
chd-116	104	1	figure	figure	NOUN
chd-116	104	2	3a	3a	NUM
chd-116	104	3	.	.	PUNCT
chd-116	105	1	salivary	salivary	ADJ
chd-116	105	2	cortisol	cortisol	ADJ
chd-116	105	3	levels	level	NOUN
chd-116	105	4	of	of	ADP
chd-116	105	5	few	few	ADJ
chd-116	105	6	of	of	ADP
chd-116	105	7	the	the	DET
chd-116	105	8	participants	participant	NOUN
chd-116	105	9	recruited	recruit	VERB
chd-116	105	10	.	.	PUNCT
chd-116	106	1	figure	figure	NOUN
chd-116	106	2	3b	3b	NUM
chd-116	106	3	.	.	PUNCT
chd-116	107	1	salivary	salivary	ADJ
chd-116	107	2	cortisol	cortisol	ADJ
chd-116	107	3	levels	level	NOUN
chd-116	107	4	from	from	ADP
chd-116	107	5	a	a	DET
chd-116	107	6	portion	portion	NOUN
chd-116	107	7	of	of	ADP
chd-116	107	8	cap	cap	NOUN
chd-116	107	9	patients	patient	NOUN
chd-116	107	10	and	and	CCONJ
chd-116	107	11	cap	cap	NOUN
chd-116	107	12	-	-	PUNCT
chd-116	107	13	free	free	ADJ
chd-116	107	14	participant	participant	NOUN
chd-116	107	15	recruited	recruit	VERB
chd-116	107	16	.	.	PUNCT
chd-116	108	1	one	one	NUM
chd-116	108	2	of	of	ADP
chd-116	108	3	the	the	DET
chd-116	108	4	cap	cap	NOUN
chd-116	108	5	participants	participant	NOUN
chd-116	108	6	in	in	ADP
chd-116	108	7	position	position	NOUN
chd-116	108	8	8	8	NUM
chd-116	108	9	above	above	ADV
chd-116	108	10	showed	show	VERB
chd-116	108	11	abnormal	abnormal	ADJ
chd-116	108	12	increase	increase	NOUN
chd-116	108	13	in	in	ADP
chd-116	108	14	cortisol	cortisol	NOUN
chd-116	108	15	even	even	ADV
chd-116	108	16	after	after	ADP
chd-116	108	17	repeating	repeat	VERB
chd-116	108	18	the	the	DET
chd-116	108	19	analysis	analysis	NOUN
chd-116	108	20	for	for	ADP
chd-116	108	21	accuracy	accuracy	NOUN
chd-116	108	22	.	.	PUNCT
chd-116	109	1	0	0	NUM
chd-116	109	2	0.2	0.2	NUM
chd-116	109	3	0.4	0.4	NUM
chd-116	109	4	0.6	0.6	NUM
chd-116	109	5	0.8	0.8	NUM
chd-116	109	6	1	1	NUM
chd-116	109	7	1.2	1.2	NUM
chd-116	109	8	1	1	NUM
chd-116	109	9	2	2	NUM
chd-116	109	10	3	3	NUM
chd-116	109	11	4	4	NUM
chd-116	109	12	5	5	NUM
chd-116	109	13	6	6	NUM
chd-116	109	14	7	7	NUM
chd-116	109	15	8	8	NUM
chd-116	109	16	9	9	NUM
chd-116	109	17	10	10	NUM
chd-116	109	18	prostate	prostate	NOUN
chd-116	109	19	cancer	cancer	NOUN
chd-116	109	20	patients	patient	NOUN
chd-116	109	21	control	control	VERB
chd-116	109	22	subjects	subject	NOUN
chd-116	109	23	sa	sa	PROPN
chd-116	109	24	liv	liv	PROPN
chd-116	109	25	ar	ar	PROPN
chd-116	109	26	y	y	PROPN
chd-116	109	27	co	co	PROPN
chd-116	109	28	rt	rt	PROPN
chd-116	109	29	iso	iso	PROPN
chd-116	109	30	l	l	PROPN
chd-116	109	31	l	l	PROPN
chd-116	110	1	ev	ev	X
chd-116	110	2	el	el	PROPN
chd-116	110	3	s	s	PROPN
chd-116	110	4	(	(	PUNCT
chd-116	110	5	µg	µg	ADV
chd-116	110	6	/d	/d	ADJ
chd-116	110	7	l	l	NOUN
chd-116	110	8	)	)	PUNCT
chd-116	110	9	cap	cap	NOUN
chd-116	110	10	patients	patient	NOUN
chd-116	110	11	and	and	CCONJ
chd-116	110	12	cap	cap	NOUN
chd-116	110	13	-	-	PUNCT
chd-116	110	14	free	free	ADJ
chd-116	110	15	participants	participant	NOUN
chd-116	110	16	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-116	110	17	e11	e11	ADJ
chd-116	110	18	cancer	cancer	NOUN
chd-116	110	19	health	health	NOUN
chd-116	110	20	disparities	disparity	NOUN
chd-116	110	21	research	research	NOUN
chd-116	110	22	tissue	tissue	NOUN
chd-116	110	23	cortisol	cortisol	NOUN
chd-116	110	24	and	and	CCONJ
chd-116	110	25	annexin	annexin	NOUN
chd-116	110	26	v	v	ADP
chd-116	110	27	expression	expression	NOUN
chd-116	110	28	in	in	ADP
chd-116	110	29	cap	cap	NOUN
chd-116	110	30	patients	patient	NOUN
chd-116	110	31	and	and	CCONJ
chd-116	110	32	cap	cap	NOUN
chd-116	110	33	-	-	PUNCT
chd-116	110	34	free	free	ADJ
chd-116	110	35	participants	participant	NOUN
chd-116	110	36	result	result	VERB
chd-116	110	37	show	show	NOUN
chd-116	110	38	overexpression	overexpression	NOUN
chd-116	110	39	of	of	ADP
chd-116	110	40	cortisol	cortisol	ADJ
chd-116	110	41	protein	protein	NOUN
chd-116	110	42	in	in	ADP
chd-116	110	43	the	the	DET
chd-116	110	44	cap	cap	NOUN
chd-116	110	45	cases	case	NOUN
chd-116	110	46	with	with	ADP
chd-116	110	47	gleason	gleason	PROPN
chd-116	110	48	score	score	NOUN
chd-116	110	49	of	of	ADP
chd-116	110	50	8	8	NUM
chd-116	110	51	compared	compare	VERB
chd-116	110	52	to	to	ADP
chd-116	110	53	those	those	PRON
chd-116	110	54	with	with	ADP
chd-116	110	55	lower	low	ADJ
chd-116	110	56	gleason	gleason	PROPN
chd-116	110	57	scores	score	NOUN
chd-116	110	58	.	.	PUNCT
chd-116	111	1	the	the	DET
chd-116	111	2	cap	cap	NOUN
chd-116	111	3	-	-	PUNCT
chd-116	111	4	free	free	ADJ
chd-116	111	5	tissues	tissue	NOUN
chd-116	111	6	show	show	VERB
chd-116	111	7	negative	negative	ADJ
chd-116	111	8	expression	expression	NOUN
chd-116	111	9	of	of	ADP
chd-116	111	10	the	the	DET
chd-116	111	11	cortisol	cortisol	ADJ
chd-116	111	12	protein	protein	NOUN
chd-116	111	13	(	(	PUNCT
chd-116	111	14	figure	figure	VERB
chd-116	111	15	a	a	PRON
chd-116	111	16	)	)	PUNCT
chd-116	111	17	.	.	PUNCT
chd-116	112	1	figure	figure	VERB
chd-116	112	2	4b	4b	PROPN
chd-116	112	3	contains	contain	VERB
chd-116	112	4	h&e	h&e	PROPN
chd-116	112	5	stained	stain	VERB
chd-116	112	6	sections	section	NOUN
chd-116	112	7	of	of	ADP
chd-116	112	8	cap	cap	NOUN
chd-116	112	9	showing	show	VERB
chd-116	112	10	cap	cap	NOUN
chd-116	112	11	cells	cell	NOUN
chd-116	112	12	and	and	CCONJ
chd-116	112	13	3	3	NUM
chd-116	112	14	different	different	ADJ
chd-116	112	15	sections	section	NOUN
chd-116	112	16	stained	stain	VERB
chd-116	112	17	for	for	ADP
chd-116	112	18	ihc	ihc	PROPN
chd-116	112	19	with	with	ADP
chd-116	112	20	the	the	DET
chd-116	112	21	anti	anti	ADJ
chd-116	112	22	-	-	ADJ
chd-116	112	23	cortisol	cortisol	ADJ
chd-116	112	24	antibody	antibody	NOUN
chd-116	112	25	signifying	signify	VERB
chd-116	112	26	strong	strong	ADJ
chd-116	112	27	expression	expression	NOUN
chd-116	112	28	of	of	ADP
chd-116	112	29	the	the	DET
chd-116	112	30	cortisol	cortisol	ADJ
chd-116	112	31	protein	protein	NOUN
chd-116	112	32	.	.	PUNCT
chd-116	113	1	the	the	DET
chd-116	113	2	sections	section	NOUN
chd-116	113	3	are	be	AUX
chd-116	113	4	cap	cap	NOUN
chd-116	113	5	cases	case	NOUN
chd-116	113	6	with	with	ADP
chd-116	113	7	gleason	gleason	PROPN
chd-116	113	8	score	score	NOUN
chd-116	113	9	of	of	ADP
chd-116	113	10	8	8	NUM
chd-116	113	11	.	.	PUNCT
chd-116	114	1	also	also	ADV
chd-116	114	2	shown	show	VERB
chd-116	114	3	in	in	ADP
chd-116	114	4	the	the	DET
chd-116	114	5	ihc	ihc	PROPN
chd-116	114	6	result	result	NOUN
chd-116	114	7	is	be	AUX
chd-116	114	8	moderate	moderate	ADJ
chd-116	114	9	expression	expression	NOUN
chd-116	114	10	of	of	ADP
chd-116	114	11	cortisol	cortisol	ADJ
chd-116	114	12	protein	protein	NOUN
chd-116	114	13	in	in	ADP
chd-116	114	14	the	the	DET
chd-116	114	15	cap	cap	NOUN
chd-116	114	16	cells	cell	NOUN
chd-116	114	17	with	with	ADP
chd-116	114	18	lower	low	ADJ
chd-116	114	19	gleason	gleason	PROPN
chd-116	114	20	score	score	NOUN
chd-116	114	21	of	of	ADP
chd-116	114	22	6	6	NUM
chd-116	114	23	and	and	CCONJ
chd-116	114	24	below	below	ADV
chd-116	114	25	(	(	PUNCT
chd-116	114	26	figure	figure	NOUN
chd-116	114	27	4c	4c	NOUN
chd-116	114	28	)	)	PUNCT
chd-116	114	29	.	.	PUNCT
chd-116	115	1	all	all	PRON
chd-116	115	2	but	but	SCONJ
chd-116	115	3	one	one	NUM
chd-116	115	4	of	of	ADP
chd-116	115	5	the	the	DET
chd-116	115	6	cap	cap	NOUN
chd-116	115	7	cases	case	NOUN
chd-116	115	8	stained	stain	VERB
chd-116	115	9	with	with	ADP
chd-116	115	10	anti	anti	ADJ
chd-116	115	11	-	-	ADJ
chd-116	115	12	annexin	annexin	ADJ
chd-116	115	13	v	v	NOUN
chd-116	115	14	antibody	antibody	NOUN
chd-116	115	15	show	show	VERB
chd-116	115	16	increased	increase	VERB
chd-116	115	17	expression	expression	NOUN
chd-116	115	18	of	of	ADP
chd-116	115	19	annexin	annexin	NOUN
chd-116	115	20	v	v	ADP
chd-116	115	21	protein	protein	NOUN
chd-116	115	22	(	(	PUNCT
chd-116	115	23	figure	figure	NOUN
chd-116	115	24	4d	4d	NUM
chd-116	115	25	)	)	PUNCT
chd-116	115	26	.	.	PUNCT
chd-116	116	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	116	2	e12	e12	NOUN
chd-116	116	3	cancer	cancer	NOUN
chd-116	116	4	health	health	NOUN
chd-116	116	5	disparities	disparity	NOUN
chd-116	116	6	research	research	NOUN
chd-116	116	7	figure	figure	NOUN
chd-116	116	8	4a	4a	NOUN
chd-116	116	9	.	.	PUNCT
chd-116	117	1	left	leave	VERB
chd-116	117	2	:	:	PUNCT
chd-116	117	3	benign	benign	ADJ
chd-116	117	4	or	or	CCONJ
chd-116	117	5	non	non	ADJ
chd-116	117	6	-	-	ADJ
chd-116	117	7	malignant	malignant	ADJ
chd-116	117	8	prostate	prostate	NOUN
chd-116	117	9	tissue	tissue	NOUN
chd-116	117	10	stained	stain	VERB
chd-116	117	11	with	with	ADP
chd-116	117	12	haematoxylin	haematoxylin	NOUN
chd-116	117	13	and	and	CCONJ
chd-116	117	14	eosin	eosin	NOUN
chd-116	117	15	(	(	PUNCT
chd-116	117	16	h&e	h&e	PROPN
chd-116	117	17	)	)	PUNCT
chd-116	117	18	,	,	PUNCT
chd-116	117	19	and	and	CCONJ
chd-116	117	20	right	right	ADV
chd-116	117	21	:	:	PUNCT
chd-116	117	22	anti	anti	ADJ
chd-116	117	23	-	-	ADJ
chd-116	117	24	cortisol	cortisol	ADJ
chd-116	117	25	antibody	antibody	NOUN
chd-116	117	26	stain	stain	NOUN
chd-116	117	27	for	for	ADP
chd-116	117	28	showing	show	VERB
chd-116	117	29	no	no	DET
chd-116	117	30	cortisol	cortisol	ADJ
chd-116	117	31	expression	expression	NOUN
chd-116	117	32	in	in	ADP
chd-116	117	33	the	the	DET
chd-116	117	34	prostate	prostate	NOUN
chd-116	117	35	.	.	PUNCT
chd-116	118	1	figure	figure	NOUN
chd-116	118	2	4b	4b	PROPN
chd-116	118	3	:	:	PUNCT
chd-116	118	4	cortisol	cortisol	ADJ
chd-116	118	5	expression	expression	NOUN
chd-116	118	6	pattern	pattern	NOUN
chd-116	118	7	in	in	ADP
chd-116	118	8	cap	cap	NOUN
chd-116	118	9	cells	cell	NOUN
chd-116	118	10	with	with	ADP
chd-116	118	11	gleason	gleason	PROPN
chd-116	118	12	score	score	PROPN
chd-116	118	13	8	8	NUM
chd-116	118	14	.	.	PUNCT
chd-116	119	1	the	the	DET
chd-116	119	2	top	top	ADJ
chd-116	119	3	left	left	ADJ
chd-116	119	4	photograph	photograph	NOUN
chd-116	119	5	is	be	AUX
chd-116	119	6	an	an	DET
chd-116	119	7	h&e	h&e	PROPN
chd-116	119	8	stained	stain	VERB
chd-116	119	9	section	section	NOUN
chd-116	119	10	of	of	ADP
chd-116	119	11	cap	cap	NOUN
chd-116	119	12	tissue	tissue	NOUN
chd-116	119	13	showing	show	VERB
chd-116	119	14	malignant	malignant	ADJ
chd-116	119	15	cells	cell	NOUN
chd-116	119	16	.	.	PUNCT
chd-116	120	1	the	the	DET
chd-116	120	2	other	other	ADJ
chd-116	120	3	photographs	photograph	NOUN
chd-116	120	4	show	show	VERB
chd-116	120	5	sections	section	NOUN
chd-116	120	6	of	of	ADP
chd-116	120	7	cap	cap	NOUN
chd-116	120	8	cells	cell	NOUN
chd-116	120	9	with	with	ADP
chd-116	120	10	gleason	gleason	PROPN
chd-116	120	11	score	score	PROPN
chd-116	120	12	8	8	NUM
chd-116	120	13	stained	stain	VERB
chd-116	120	14	by	by	ADP
chd-116	120	15	immunocytochemistry	immunocytochemistry	NOUN
chd-116	120	16	with	with	ADP
chd-116	120	17	anti	anti	ADJ
chd-116	120	18	-	-	ADJ
chd-116	120	19	cortisol	cortisol	ADJ
chd-116	120	20	antibody	antibody	NOUN
chd-116	120	21	;	;	PUNCT
chd-116	120	22	there	there	PRON
chd-116	120	23	is	be	VERB
chd-116	120	24	strong	strong	ADJ
chd-116	120	25	expression	expression	NOUN
chd-116	120	26	of	of	ADP
chd-116	120	27	cortisol	cortisol	NOUN
chd-116	120	28	.	.	PUNCT
chd-116	121	1	fig	fig	NOUN
chd-116	121	2	4c	4c	NOUN
chd-116	121	3	:	:	PUNCT
chd-116	121	4	expression	expression	NOUN
chd-116	121	5	pattern	pattern	NOUN
chd-116	121	6	of	of	ADP
chd-116	121	7	cortisol	cortisol	NOUN
chd-116	121	8	in	in	ADP
chd-116	121	9	cap	cap	NOUN
chd-116	121	10	cells	cell	NOUN
chd-116	121	11	with	with	ADP
chd-116	121	12	gleason	gleason	PROPN
chd-116	121	13	score	score	NOUN
chd-116	121	14	6	6	NUM
chd-116	121	15	and	and	CCONJ
chd-116	121	16	below	below	ADV
chd-116	121	17	.	.	PUNCT
chd-116	122	1	the	the	DET
chd-116	122	2	ihc	ihc	PROPN
chd-116	122	3	result	result	NOUN
chd-116	122	4	show	show	VERB
chd-116	122	5	moderate	moderate	ADJ
chd-116	122	6	expression	expression	NOUN
chd-116	122	7	of	of	ADP
chd-116	122	8	the	the	DET
chd-116	122	9	cortisol	cortisol	NOUN
chd-116	122	10	in	in	ADP
chd-116	122	11	the	the	DET
chd-116	122	12	cells	cell	NOUN
chd-116	122	13	.	.	PUNCT
chd-116	123	1	figure	figure	NOUN
chd-116	123	2	4d	4d	NUM
chd-116	123	3	.	.	PUNCT
chd-116	124	1	expression	expression	NOUN
chd-116	124	2	pattern	pattern	NOUN
chd-116	124	3	of	of	ADP
chd-116	124	4	annexin	annexin	NOUN
chd-116	124	5	v	v	ADP
chd-116	124	6	protein	protein	NOUN
chd-116	124	7	in	in	ADP
chd-116	124	8	cap	cap	NOUN
chd-116	124	9	cells	cell	NOUN
chd-116	124	10	.	.	PUNCT
chd-116	125	1	the	the	DET
chd-116	125	2	stain	stain	NOUN
chd-116	125	3	shows	show	VERB
chd-116	125	4	all	all	PRON
chd-116	125	5	but	but	SCONJ
chd-116	125	6	one	one	NUM
chd-116	125	7	of	of	ADP
chd-116	125	8	the	the	DET
chd-116	125	9	cap	cap	NOUN
chd-116	125	10	sections	section	NOUN
chd-116	125	11	stained	stain	VERB
chd-116	125	12	with	with	ADP
chd-116	125	13	anti	anti	ADJ
chd-116	125	14	-	-	ADJ
chd-116	125	15	annexin	annexin	ADJ
chd-116	125	16	v	v	NOUN
chd-116	125	17	antibody	antibody	NOUN
chd-116	125	18	to	to	PART
chd-116	125	19	have	have	AUX
chd-116	125	20	increase	increase	VERB
chd-116	125	21	expression	expression	NOUN
chd-116	125	22	of	of	ADP
chd-116	125	23	the	the	DET
chd-116	125	24	protein	protein	NOUN
chd-116	125	25	.	.	PUNCT
chd-116	126	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	126	2	e13	e13	PROPN
chd-116	126	3	cancer	cancer	NOUN
chd-116	126	4	health	health	NOUN
chd-116	126	5	disparities	disparity	NOUN
chd-116	126	6	research	research	NOUN
chd-116	126	7	figure	figure	NOUN
chd-116	126	8	4e	4e	NOUN
chd-116	126	9	.	.	PUNCT
chd-116	127	1	show	show	VERB
chd-116	127	2	h	h	NOUN
chd-116	127	3	score	score	NOUN
chd-116	127	4	depicting	depict	VERB
chd-116	127	5	pattern	pattern	NOUN
chd-116	127	6	of	of	ADP
chd-116	127	7	cortisol	cortisol	ADJ
chd-116	127	8	expression	expression	NOUN
chd-116	127	9	in	in	ADP
chd-116	127	10	normal	normal	ADJ
chd-116	127	11	prostatic	prostatic	ADJ
chd-116	127	12	lesion	lesion	NOUN
chd-116	127	13	and	and	CCONJ
chd-116	127	14	cap	cap	NOUN
chd-116	127	15	cells	cell	NOUN
chd-116	127	16	.	.	PUNCT
chd-116	128	1	the	the	DET
chd-116	128	2	score	score	NOUN
chd-116	128	3	show	show	VERB
chd-116	128	4	2	2	NUM
chd-116	128	5	-	-	ADJ
chd-116	128	6	fold	fold	ADJ
chd-116	128	7	increase	increase	NOUN
chd-116	128	8	in	in	ADP
chd-116	128	9	cortisol	cortisol	ADJ
chd-116	128	10	expression	expression	NOUN
chd-116	128	11	in	in	ADP
chd-116	128	12	the	the	DET
chd-116	128	13	cap	cap	NOUN
chd-116	128	14	sections	section	NOUN
chd-116	128	15	.	.	PUNCT
chd-116	129	1	discussion	discussion	NOUN
chd-116	129	2	the	the	DET
chd-116	129	3	results	result	NOUN
chd-116	129	4	from	from	ADP
chd-116	129	5	this	this	DET
chd-116	129	6	captc	captc	NOUN
chd-116	129	7	pilot	pilot	NOUN
chd-116	129	8	study	study	NOUN
chd-116	129	9	of	of	ADP
chd-116	129	10	500	500	NUM
chd-116	129	11	west	west	ADJ
chd-116	129	12	african	african	ADJ
chd-116	129	13	balck	balck	ADJ
chd-116	129	14	men	man	NOUN
chd-116	129	15	within	within	ADP
chd-116	129	16	the	the	DET
chd-116	129	17	age	age	NOUN
chd-116	129	18	bracket	bracket	NOUN
chd-116	129	19	of	of	ADP
chd-116	129	20	35	35	NUM
chd-116	129	21	and	and	CCONJ
chd-116	129	22	70	70	NUM
chd-116	129	23	years	year	NOUN
chd-116	129	24	show	show	VERB
chd-116	129	25	variation	variation	NOUN
chd-116	129	26	in	in	ADP
chd-116	129	27	hrqol	hrqol	ADJ
chd-116	129	28	indicators	indicator	NOUN
chd-116	129	29	such	such	ADJ
chd-116	129	30	as	as	ADP
chd-116	129	31	exercise	exercise	NOUN
chd-116	129	32	,	,	PUNCT
chd-116	129	33	stress	stress	NOUN
chd-116	129	34	,	,	PUNCT
chd-116	129	35	and	and	CCONJ
chd-116	129	36	ability	ability	NOUN
chd-116	129	37	to	to	PART
chd-116	129	38	self	self	NOUN
chd-116	129	39	-	-	PUNCT
chd-116	129	40	care	care	NOUN
chd-116	129	41	,	,	PUNCT
chd-116	129	42	health	health	NOUN
chd-116	129	43	status	status	NOUN
chd-116	129	44	perception	perception	NOUN
chd-116	129	45	and	and	CCONJ
chd-116	129	46	the	the	DET
chd-116	129	47	need	need	NOUN
chd-116	129	48	for	for	ADP
chd-116	129	49	specialized	specialized	ADJ
chd-116	129	50	equipment	equipment	NOUN
chd-116	129	51	in	in	ADP
chd-116	129	52	carrying	carry	VERB
chd-116	129	53	out	out	ADP
chd-116	129	54	daily	daily	ADJ
chd-116	129	55	life	life	NOUN
chd-116	129	56	activities	activity	NOUN
chd-116	129	57	.	.	PUNCT
chd-116	130	1	the	the	DET
chd-116	130	2	most	most	ADV
chd-116	130	3	interesting	interesting	ADJ
chd-116	130	4	finding	finding	NOUN
chd-116	130	5	was	be	AUX
chd-116	130	6	,	,	PUNCT
chd-116	130	7	indicators	indicator	NOUN
chd-116	130	8	associated	associate	VERB
chd-116	130	9	to	to	ADP
chd-116	130	10	hrqol	hrqol	NOUN
chd-116	130	11	themes	theme	NOUN
chd-116	130	12	appeared	appear	VERB
chd-116	130	13	to	to	PART
chd-116	130	14	have	have	VERB
chd-116	130	15	the	the	DET
chd-116	130	16	existence	existence	NOUN
chd-116	130	17	of	of	ADP
chd-116	130	18	about	about	ADV
chd-116	130	19	3	3	NUM
chd-116	130	20	%	%	NOUN
chd-116	130	21	of	of	ADP
chd-116	130	22	the	the	DET
chd-116	130	23	respondents	respondent	NOUN
chd-116	130	24	reporting	report	VERB
chd-116	130	25	their	their	PRON
chd-116	130	26	inability	inability	NOUN
chd-116	130	27	to	to	PART
chd-116	130	28	carry	carry	VERB
chd-116	130	29	out	out	ADP
chd-116	130	30	daily	daily	ADJ
chd-116	130	31	exercise	exercise	NOUN
chd-116	130	32	,	,	PUNCT
chd-116	130	33	self	self	NOUN
chd-116	130	34	-	-	PUNCT
chd-116	130	35	care	care	NOUN
chd-116	130	36	and	and	CCONJ
chd-116	130	37	hence	hence	ADV
chd-116	130	38	consistent	consistent	ADJ
chd-116	130	39	stress	stress	NOUN
chd-116	130	40	for	for	ADP
chd-116	130	41	20	20	NUM
chd-116	130	42	to	to	PART
chd-116	130	43	30	30	NUM
chd-116	130	44	days	day	NOUN
chd-116	130	45	within	within	ADP
chd-116	130	46	period	period	NOUN
chd-116	130	47	of	of	ADP
chd-116	130	48	one	one	NUM
chd-116	130	49	month	month	NOUN
chd-116	130	50	.	.	PUNCT
chd-116	131	1	the	the	DET
chd-116	131	2	percentage	percentage	NOUN
chd-116	131	3	of	of	ADP
chd-116	131	4	the	the	DET
chd-116	131	5	hrqol	hrqol	NOUN
chd-116	131	6	indicators	indicator	NOUN
chd-116	131	7	increased	increase	VERB
chd-116	131	8	slightly	slightly	ADV
chd-116	131	9	to	to	ADP
chd-116	131	10	about	about	ADP
chd-116	131	11	19	19	NUM
chd-116	131	12	%	%	NOUN
chd-116	131	13	for	for	ADP
chd-116	131	14	the	the	DET
chd-116	131	15	participants	participant	NOUN
chd-116	131	16	when	when	SCONJ
chd-116	131	17	increasing	increase	VERB
chd-116	131	18	the	the	DET
chd-116	131	19	number	number	NOUN
chd-116	131	20	of	of	ADP
chd-116	131	21	days	day	NOUN
chd-116	131	22	for	for	ADP
chd-116	131	23	physical	physical	ADJ
chd-116	131	24	activity	activity	NOUN
chd-116	131	25	by	by	ADP
chd-116	131	26	10	10	NUM
chd-116	131	27	days	day	NOUN
chd-116	131	28	.	.	PUNCT
chd-116	132	1	poor	poor	ADJ
chd-116	132	2	health	health	NOUN
chd-116	132	3	-	-	PUNCT
chd-116	132	4	related	relate	VERB
chd-116	132	5	quality	quality	NOUN
chd-116	132	6	of	of	ADP
chd-116	132	7	life	life	NOUN
chd-116	132	8	parameters	parameter	NOUN
chd-116	132	9	which	which	PRON
chd-116	132	10	interfere	interfere	VERB
chd-116	132	11	with	with	ADP
chd-116	132	12	physical	physical	ADJ
chd-116	132	13	,	,	PUNCT
chd-116	132	14	functional	functional	ADJ
chd-116	132	15	,	,	PUNCT
chd-116	132	16	social	social	ADJ
chd-116	132	17	and	and	CCONJ
chd-116	132	18	emotional	emotional	ADJ
chd-116	132	19	states	state	NOUN
chd-116	132	20	of	of	ADP
chd-116	132	21	an	an	DET
chd-116	132	22	individual	individual	NOUN
chd-116	132	23	have	have	AUX
chd-116	132	24	been	be	AUX
chd-116	132	25	associated	associate	VERB
chd-116	132	26	to	to	PART
chd-116	132	27	worsen	worsen	VERB
chd-116	132	28	disease	disease	NOUN
chd-116	132	29	prognosis	prognosis	NOUN
chd-116	132	30	especially	especially	ADV
chd-116	132	31	in	in	ADP
chd-116	132	32	african	african	ADJ
chd-116	132	33	american	american	ADJ
chd-116	132	34	men	man	NOUN
chd-116	132	35	with	with	ADP
chd-116	132	36	cap	cap	NOUN
chd-116	132	37	(	(	PUNCT
chd-116	132	38	blankenberg	blankenberg	PROPN
chd-116	132	39	2009	2009	NUM
chd-116	132	40	;	;	PUNCT
chd-116	132	41	desantis	desantis	PROPN
chd-116	132	42	et	et	PROPN
chd-116	132	43	al	al	PROPN
chd-116	132	44	.	.	PROPN
chd-116	132	45	,	,	PUNCT
chd-116	132	46	2012	2012	NUM
chd-116	132	47	)	)	PUNCT
chd-116	132	48	.	.	PUNCT
chd-116	133	1	previous	previous	ADJ
chd-116	133	2	studies	study	NOUN
chd-116	133	3	have	have	AUX
chd-116	133	4	showed	show	VERB
chd-116	133	5	that	that	SCONJ
chd-116	133	6	western	western	ADJ
chd-116	133	7	lifestyle	lifestyle	NOUN
chd-116	133	8	,	,	PUNCT
chd-116	133	9	reduced	reduce	VERB
chd-116	133	10	physical	physical	ADJ
chd-116	133	11	activity	activity	NOUN
chd-116	133	12	and	and	CCONJ
chd-116	133	13	high	high	ADJ
chd-116	133	14	fat	fat	ADJ
chd-116	133	15	diet	diet	PROPN
chd-116	133	16	intake	intake	NOUN
chd-116	133	17	are	be	AUX
chd-116	133	18	related	relate	VERB
chd-116	133	19	to	to	PART
chd-116	133	20	cap	cap	VERB
chd-116	133	21	risk	risk	NOUN
chd-116	133	22	(	(	PUNCT
chd-116	133	23	freedland	freedland	NOUN
chd-116	133	24	and	and	CCONJ
chd-116	133	25	aronson	aronson	PROPN
chd-116	133	26	,	,	PUNCT
chd-116	133	27	2009	2009	NUM
chd-116	133	28	;	;	PUNCT
chd-116	133	29	fradet	fradet	NOUN
chd-116	133	30	et	et	PROPN
chd-116	133	31	al	al	PROPN
chd-116	133	32	.	.	PROPN
chd-116	133	33	,	,	PUNCT
chd-116	133	34	2009	2009	NUM
chd-116	133	35	)	)	PUNCT
chd-116	133	36	.	.	PUNCT
chd-116	134	1	stress	stress	NOUN
chd-116	134	2	and	and	CCONJ
chd-116	134	3	psychosocial	psychosocial	ADJ
chd-116	134	4	factors	factor	NOUN
chd-116	134	5	are	be	AUX
chd-116	134	6	also	also	ADV
chd-116	134	7	associated	associate	VERB
chd-116	134	8	with	with	ADP
chd-116	134	9	the	the	DET
chd-116	134	10	onset	onset	NOUN
chd-116	134	11	and	and	CCONJ
chd-116	134	12	prognosis	prognosis	NOUN
chd-116	134	13	of	of	ADP
chd-116	134	14	malignant	malignant	ADJ
chd-116	134	15	tumours	tumour	NOUN
chd-116	134	16	.	.	PUNCT
chd-116	135	1	a	a	DET
chd-116	135	2	recent	recent	ADJ
chd-116	135	3	meta	meta	ADJ
chd-116	135	4	-	-	PUNCT
chd-116	135	5	analysis	analysis	NOUN
chd-116	135	6	of	of	ADP
chd-116	135	7	165	165	NUM
chd-116	135	8	studies	study	NOUN
chd-116	135	9	reports	report	VERB
chd-116	135	10	that	that	SCONJ
chd-116	135	11	psychosocial	psychosocial	ADJ
chd-116	135	12	factors	factor	NOUN
chd-116	135	13	are	be	AUX
chd-116	135	14	predictive	predictive	ADJ
chd-116	135	15	of	of	ADP
chd-116	135	16	cancer	cancer	NOUN
chd-116	135	17	prognosis	prognosis	NOUN
chd-116	135	18	,	,	PUNCT
chd-116	135	19	independent	independent	ADJ
chd-116	135	20	of	of	ADP
chd-116	135	21	initial	initial	ADJ
chd-116	135	22	tumor	tumor	NOUN
chd-116	135	23	stage	stage	NOUN
chd-116	135	24	and	and	CCONJ
chd-116	135	25	other	other	ADJ
chd-116	135	26	confounders	confounder	NOUN
chd-116	135	27	(	(	PUNCT
chd-116	135	28	chida	chida	PROPN
chd-116	135	29	et	et	PROPN
chd-116	135	30	al	al	PROPN
chd-116	135	31	.	.	PROPN
chd-116	135	32	,	,	PUNCT
chd-116	135	33	2008	2008	NUM
chd-116	135	34	)	)	PUNCT
chd-116	135	35	.	.	PUNCT
chd-116	136	1	of	of	ADP
chd-116	136	2	the	the	DET
chd-116	136	3	500	500	NUM
chd-116	136	4	study	study	NOUN
chd-116	136	5	participants	participant	NOUN
chd-116	136	6	,	,	PUNCT
chd-116	136	7	40	40	NUM
chd-116	136	8	were	be	AUX
chd-116	136	9	patients	patient	NOUN
chd-116	136	10	diagnosed	diagnose	VERB
chd-116	136	11	with	with	ADP
chd-116	136	12	cap	cap	NOUN
chd-116	136	13	,	,	PUNCT
chd-116	136	14	thus	thus	ADV
chd-116	136	15	contributing	contribute	VERB
chd-116	136	16	to	to	ADP
chd-116	136	17	the	the	DET
chd-116	136	18	percentage	percentage	NOUN
chd-116	136	19	of	of	ADP
chd-116	136	20	the	the	DET
chd-116	136	21	participants	participant	NOUN
chd-116	136	22	with	with	ADP
chd-116	136	23	poor	poor	ADJ
chd-116	136	24	health	health	NOUN
chd-116	136	25	-	-	PUNCT
chd-116	136	26	related	relate	VERB
chd-116	136	27	quality	quality	NOUN
chd-116	136	28	of	of	ADP
chd-116	136	29	life	life	NOUN
chd-116	136	30	in	in	ADP
chd-116	136	31	this	this	DET
chd-116	136	32	research	research	NOUN
chd-116	136	33	.	.	PUNCT
chd-116	137	1	results	result	NOUN
chd-116	137	2	that	that	PRON
chd-116	137	3	compare	compare	VERB
chd-116	137	4	hrqol	hrqol	ADJ
chd-116	137	5	indicators	indicator	NOUN
chd-116	137	6	between	between	ADP
chd-116	137	7	participants	participant	NOUN
chd-116	137	8	with	with	ADP
chd-116	137	9	history	history	NOUN
chd-116	137	10	of	of	ADP
chd-116	137	11	cap	cap	NOUN
chd-116	137	12	and	and	CCONJ
chd-116	137	13	cap	cap	NOUN
chd-116	137	14	-	-	PUNCT
chd-116	137	15	free	free	ADJ
chd-116	137	16	participants	participant	NOUN
chd-116	137	17	show	show	VERB
chd-116	137	18	no	no	DET
chd-116	137	19	significant	significant	ADJ
chd-116	137	20	differences	difference	NOUN
chd-116	137	21	between	between	ADP
chd-116	137	22	the	the	DET
chd-116	137	23	two	two	NUM
chd-116	137	24	groups	group	NOUN
chd-116	137	25	.	.	PUNCT
chd-116	138	1	the	the	DET
chd-116	138	2	lack	lack	NOUN
chd-116	138	3	of	of	ADP
chd-116	138	4	differences	difference	NOUN
chd-116	138	5	in	in	ADP
chd-116	138	6	the	the	DET
chd-116	138	7	hrqol	hrqol	NOUN
chd-116	138	8	indicators	indicator	NOUN
chd-116	138	9	between	between	ADP
chd-116	138	10	the	the	DET
chd-116	138	11	groups	group	NOUN
chd-116	138	12	may	may	AUX
chd-116	138	13	be	be	AUX
chd-116	138	14	associated	associate	VERB
chd-116	138	15	to	to	ADP
chd-116	138	16	the	the	DET
chd-116	138	17	small	small	ADJ
chd-116	138	18	number	number	NOUN
chd-116	138	19	of	of	ADP
chd-116	138	20	cap	cap	NOUN
chd-116	138	21	participants	participant	NOUN
chd-116	138	22	(	(	PUNCT
chd-116	138	23	n=40	n=40	ADJ
chd-116	138	24	)	)	PUNCT
chd-116	138	25	as	as	SCONJ
chd-116	138	26	compared	compare	VERB
chd-116	138	27	to	to	ADP
chd-116	138	28	cap	cap	NOUN
chd-116	138	29	-	-	PUNCT
chd-116	138	30	free	free	ADJ
chd-116	138	31	participants	participant	NOUN
chd-116	138	32	(	(	PUNCT
chd-116	138	33	n=460	n=460	NUM
chd-116	138	34	)	)	PUNCT
chd-116	138	35	recruited	recruit	VERB
chd-116	138	36	in	in	ADP
chd-116	138	37	this	this	DET
chd-116	138	38	study	study	NOUN
chd-116	138	39	.	.	PUNCT
chd-116	139	1	however	however	ADV
chd-116	139	2	,	,	PUNCT
chd-116	139	3	since	since	SCONJ
chd-116	139	4	the	the	DET
chd-116	139	5	study	study	NOUN
chd-116	139	6	recruitment	recruitment	NOUN
chd-116	139	7	is	be	AUX
chd-116	139	8	on	on	ADP
chd-116	139	9	-	-	PUNCT
chd-116	139	10	going	go	VERB
chd-116	139	11	,	,	PUNCT
chd-116	139	12	further	further	ADJ
chd-116	139	13	effort	effort	NOUN
chd-116	139	14	will	will	AUX
chd-116	139	15	lay	lay	VERB
chd-116	139	16	emphasis	emphasis	NOUN
chd-116	139	17	on	on	ADP
chd-116	139	18	recruiting	recruit	VERB
chd-116	139	19	sufficient	sufficient	ADJ
chd-116	139	20	cap	cap	NOUN
chd-116	139	21	patients	patient	NOUN
chd-116	139	22	.	.	PUNCT
chd-116	140	1	the	the	DET
chd-116	140	2	salivary	salivary	ADJ
chd-116	140	3	cortisol	cortisol	NOUN
chd-116	140	4	level	level	NOUN
chd-116	140	5	analysis	analysis	NOUN
chd-116	140	6	of	of	ADP
chd-116	140	7	40	40	NUM
chd-116	140	8	participants	participant	NOUN
chd-116	140	9	without	without	ADP
chd-116	140	10	cap	cap	NOUN
chd-116	140	11	and	and	CCONJ
chd-116	140	12	10	10	NUM
chd-116	140	13	patients	patient	NOUN
chd-116	140	14	with	with	ADP
chd-116	140	15	cap	cap	NOUN
chd-116	140	16	e	e	ADP
chd-116	140	17	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-116	140	18	e14	e14	PROPN
chd-116	140	19	cancer	cancer	NOUN
chd-116	140	20	health	health	NOUN
chd-116	140	21	disparities	disparity	NOUN
chd-116	140	22	research	research	NOUN
chd-116	140	23	showed	show	VERB
chd-116	140	24	a	a	DET
chd-116	140	25	significant	significant	ADJ
chd-116	140	26	increase	increase	NOUN
chd-116	140	27	in	in	ADP
chd-116	140	28	the	the	DET
chd-116	140	29	mean	mean	ADJ
chd-116	140	30	average	average	ADJ
chd-116	140	31	cortisol	cortisol	ADJ
chd-116	140	32	level	level	NOUN
chd-116	140	33	from	from	ADP
chd-116	140	34	0.08±0.01	0.08±0.01	NOUN
chd-116	140	35	to	to	ADP
chd-116	140	36	0.18±0.03	0.18±0.03	NOUN
chd-116	140	37	respectively	respectively	ADV
chd-116	140	38	.	.	PUNCT
chd-116	141	1	however	however	ADV
chd-116	141	2	,	,	PUNCT
chd-116	141	3	one	one	NUM
chd-116	141	4	of	of	ADP
chd-116	141	5	the	the	DET
chd-116	141	6	patients	patient	NOUN
chd-116	141	7	with	with	ADP
chd-116	141	8	cap	cap	NOUN
chd-116	141	9	showed	show	VERB
chd-116	141	10	a	a	DET
chd-116	141	11	four	four	NUM
chd-116	141	12	-	-	ADJ
chd-116	141	13	fold	fold	ADJ
chd-116	141	14	increase	increase	NOUN
chd-116	141	15	in	in	ADP
chd-116	141	16	salivary	salivary	ADJ
chd-116	141	17	cortisol	cortisol	ADJ
chd-116	141	18	level	level	NOUN
chd-116	141	19	compared	compare	VERB
chd-116	141	20	to	to	ADP
chd-116	141	21	the	the	DET
chd-116	141	22	highest	high	ADJ
chd-116	141	23	level	level	NOUN
chd-116	141	24	in	in	ADP
chd-116	141	25	the	the	DET
chd-116	141	26	non	non	ADJ
chd-116	141	27	-	-	ADJ
chd-116	141	28	cap	cap	ADJ
chd-116	141	29	participants	participant	NOUN
chd-116	141	30	even	even	ADV
chd-116	141	31	after	after	ADP
chd-116	141	32	repeating	repeat	VERB
chd-116	141	33	the	the	DET
chd-116	141	34	analysis	analysis	NOUN
chd-116	141	35	to	to	PART
chd-116	141	36	rule	rule	VERB
chd-116	141	37	out	out	ADP
chd-116	141	38	possible	possible	ADJ
chd-116	141	39	errors	error	NOUN
chd-116	141	40	.	.	PUNCT
chd-116	142	1	previous	previous	ADJ
chd-116	142	2	studies	study	NOUN
chd-116	142	3	have	have	AUX
chd-116	142	4	shown	show	VERB
chd-116	142	5	that	that	SCONJ
chd-116	142	6	cortisol	cortisol	ADJ
chd-116	142	7	levels	level	NOUN
chd-116	142	8	are	be	AUX
chd-116	142	9	associated	associate	VERB
chd-116	142	10	with	with	ADP
chd-116	142	11	circadian	circadian	ADJ
chd-116	142	12	disruption	disruption	NOUN
chd-116	142	13	and	and	CCONJ
chd-116	142	14	poor	poor	ADJ
chd-116	142	15	health	health	NOUN
chd-116	142	16	status	status	NOUN
chd-116	142	17	which	which	PRON
chd-116	142	18	in	in	ADP
chd-116	142	19	turn	turn	NOUN
chd-116	142	20	contribute	contribute	VERB
chd-116	142	21	to	to	ADP
chd-116	142	22	immune	immune	ADJ
chd-116	142	23	dysfunction	dysfunction	NOUN
chd-116	142	24	and	and	CCONJ
chd-116	142	25	cap	cap	NOUN
chd-116	142	26	risk	risk	NOUN
chd-116	142	27	(	(	PUNCT
chd-116	142	28	touitou	touitou	PROPN
chd-116	142	29	1983	1983	NUM
chd-116	142	30	;	;	PUNCT
chd-116	142	31	coussens	coussen	NOUN
chd-116	142	32	and	and	CCONJ
chd-116	142	33	werb	werb	ADJ
chd-116	142	34	,	,	PUNCT
chd-116	142	35	2002	2002	NUM
chd-116	142	36	;	;	PUNCT
chd-116	142	37	desantis	desantis	PROPN
chd-116	142	38	et	et	PROPN
chd-116	142	39	al	al	PROPN
chd-116	142	40	.	.	PROPN
chd-116	142	41	,	,	PUNCT
chd-116	142	42	2012	2012	NUM
chd-116	142	43	;	;	PUNCT
chd-116	142	44	tai	tai	PROPN
chd-116	142	45	et	et	PROPN
chd-116	142	46	al	al	PROPN
chd-116	142	47	.	.	PROPN
chd-116	142	48	,	,	PUNCT
chd-116	142	49	2016	2016	NUM
chd-116	142	50	)	)	PUNCT
chd-116	142	51	.	.	PUNCT
chd-116	143	1	findings	finding	NOUN
chd-116	143	2	from	from	ADP
chd-116	143	3	this	this	DET
chd-116	143	4	study	study	NOUN
chd-116	143	5	further	far	ADV
chd-116	143	6	showed	show	VERB
chd-116	143	7	about	about	ADP
chd-116	143	8	14	14	NUM
chd-116	143	9	%	%	NOUN
chd-116	143	10	of	of	ADP
chd-116	143	11	the	the	DET
chd-116	143	12	respondents	respondent	NOUN
chd-116	143	13	to	to	PART
chd-116	143	14	have	have	VERB
chd-116	143	15	poor	poor	ADJ
chd-116	143	16	health	health	NOUN
chd-116	143	17	status	status	NOUN
chd-116	143	18	,	,	PUNCT
chd-116	143	19	while	while	SCONJ
chd-116	143	20	4	4	NUM
chd-116	143	21	%	%	NOUN
chd-116	143	22	needed	need	VERB
chd-116	143	23	specialized	specialized	ADJ
chd-116	143	24	equipment	equipment	NOUN
chd-116	143	25	to	to	PART
chd-116	143	26	be	be	AUX
chd-116	143	27	able	able	ADJ
chd-116	143	28	to	to	PART
chd-116	143	29	perform	perform	VERB
chd-116	143	30	regular	regular	ADJ
chd-116	143	31	daily	daily	ADJ
chd-116	143	32	activities	activity	NOUN
chd-116	143	33	,	,	PUNCT
chd-116	143	34	probably	probably	ADV
chd-116	143	35	for	for	ADP
chd-116	143	36	reasons	reason	NOUN
chd-116	143	37	,	,	PUNCT
chd-116	143	38	not	not	PART
chd-116	143	39	unrelated	unrelated	ADJ
chd-116	143	40	to	to	ADP
chd-116	143	41	stress	stress	NOUN
chd-116	143	42	.	.	PUNCT
chd-116	144	1	additionally	additionally	ADV
chd-116	144	2	,	,	PUNCT
chd-116	144	3	the	the	DET
chd-116	144	4	expression	expression	NOUN
chd-116	144	5	patterns	pattern	NOUN
chd-116	144	6	of	of	ADP
chd-116	144	7	cortisol	cortisol	ADJ
chd-116	144	8	protein	protein	NOUN
chd-116	144	9	at	at	ADP
chd-116	144	10	tissue	tissue	NOUN
chd-116	144	11	level	level	NOUN
chd-116	144	12	were	be	AUX
chd-116	144	13	assessed	assess	VERB
chd-116	144	14	by	by	ADP
chd-116	144	15	immunohistochemistry	immunohistochemistry	NOUN
chd-116	144	16	to	to	PART
chd-116	144	17	further	far	ADV
chd-116	144	18	explore	explore	VERB
chd-116	144	19	the	the	DET
chd-116	144	20	role	role	NOUN
chd-116	144	21	of	of	ADP
chd-116	144	22	the	the	DET
chd-116	144	23	protien	protien	NOUN
chd-116	144	24	in	in	ADP
chd-116	144	25	cap	cap	NOUN
chd-116	144	26	pathogenesis	pathogenesis	NOUN
chd-116	144	27	.	.	PUNCT
chd-116	145	1	the	the	DET
chd-116	145	2	results	result	NOUN
chd-116	145	3	obtained	obtain	VERB
chd-116	145	4	show	show	VERB
chd-116	145	5	an	an	DET
chd-116	145	6	increase	increase	NOUN
chd-116	145	7	in	in	ADP
chd-116	145	8	the	the	DET
chd-116	145	9	expression	expression	NOUN
chd-116	145	10	of	of	ADP
chd-116	145	11	the	the	DET
chd-116	145	12	cortisol	cortisol	NOUN
chd-116	145	13	in	in	ADP
chd-116	145	14	cap	cap	NOUN
chd-116	145	15	cells	cell	NOUN
chd-116	145	16	,	,	PUNCT
chd-116	145	17	which	which	PRON
chd-116	145	18	was	be	AUX
chd-116	145	19	directly	directly	ADV
chd-116	145	20	associated	associate	VERB
chd-116	145	21	with	with	ADP
chd-116	145	22	increase	increase	NOUN
chd-116	145	23	in	in	ADP
chd-116	145	24	gleason	gleason	PROPN
chd-116	145	25	score	score	NOUN
chd-116	145	26	and	and	CCONJ
chd-116	145	27	hence	hence	ADV
chd-116	145	28	the	the	DET
chd-116	145	29	disease	disease	NOUN
chd-116	145	30	aggressiveness	aggressiveness	NOUN
chd-116	145	31	.	.	PUNCT
chd-116	146	1	the	the	DET
chd-116	146	2	luminal	luminal	ADJ
chd-116	146	3	cells	cell	NOUN
chd-116	146	4	of	of	ADP
chd-116	146	5	the	the	DET
chd-116	146	6	glandular	glandular	ADJ
chd-116	146	7	epithelium	epithelium	NOUN
chd-116	146	8	in	in	ADP
chd-116	146	9	cap	cap	NOUN
chd-116	146	10	secrete	secrete	VERB
chd-116	146	11	various	various	ADJ
chd-116	146	12	hormones	hormone	NOUN
chd-116	146	13	including	include	VERB
chd-116	146	14	androgens	androgen	NOUN
chd-116	146	15	(	(	PUNCT
chd-116	146	16	feldman	feldman	NOUN
chd-116	146	17	and	and	CCONJ
chd-116	146	18	feldman	feldman	PROPN
chd-116	146	19	,	,	PUNCT
chd-116	146	20	2001	2001	NUM
chd-116	146	21	)	)	PUNCT
chd-116	146	22	and	and	CCONJ
chd-116	146	23	perhaps	perhaps	ADV
chd-116	146	24	cortisol	cortisol	ADJ
chd-116	146	25	for	for	ADP
chd-116	146	26	a	a	DET
chd-116	146	27	role	role	NOUN
chd-116	146	28	in	in	ADP
chd-116	146	29	cellular	cellular	ADJ
chd-116	146	30	proliferation	proliferation	NOUN
chd-116	146	31	and	and	CCONJ
chd-116	146	32	apoptosis	apoptosis	NOUN
chd-116	146	33	.	.	PUNCT
chd-116	147	1	previous	previous	ADJ
chd-116	147	2	report	report	NOUN
chd-116	147	3	shows	show	VERB
chd-116	147	4	that	that	SCONJ
chd-116	147	5	stress	stress	NOUN
chd-116	147	6	increases	increase	VERB
chd-116	147	7	cytokines	cytokine	NOUN
chd-116	147	8	level	level	VERB
chd-116	147	9	especially	especially	ADV
chd-116	147	10	interleukin	interleukin	NOUN
chd-116	147	11	6	6	NUM
chd-116	147	12	on	on	ADP
chd-116	147	13	the	the	DET
chd-116	147	14	hypothalamicpituitary	hypothalamicpituitary	ADJ
chd-116	147	15	-	-	PUNCT
chd-116	147	16	adrenal	adrenal	ADJ
chd-116	147	17	axis	axis	NOUN
chd-116	147	18	(	(	PUNCT
chd-116	147	19	zhou	zhou	PROPN
chd-116	147	20	et	et	PROPN
chd-116	147	21	al	al	PROPN
chd-116	147	22	.	.	PROPN
chd-116	147	23	,	,	PUNCT
chd-116	147	24	1993	1993	NUM
chd-116	147	25	)	)	PUNCT
chd-116	147	26	which	which	PRON
chd-116	147	27	may	may	AUX
chd-116	147	28	result	result	VERB
chd-116	147	29	to	to	ADP
chd-116	147	30	fluctuation	fluctuation	NOUN
chd-116	147	31	in	in	ADP
chd-116	147	32	the	the	DET
chd-116	147	33	body	body	NOUN
chd-116	147	34	cortisol	cortisol	NOUN
chd-116	147	35	level	level	NOUN
chd-116	147	36	.	.	PUNCT
chd-116	148	1	the	the	DET
chd-116	148	2	t877a	t877a	PROPN
chd-116	148	3	androgen	androgen	NOUN
chd-116	148	4	receptor	receptor	NOUN
chd-116	148	5	mutation	mutation	NOUN
chd-116	148	6	in	in	ADP
chd-116	148	7	the	the	DET
chd-116	148	8	cap	cap	NOUN
chd-116	148	9	microenvironment	microenvironment	NOUN
chd-116	148	10	increases	increase	VERB
chd-116	148	11	the	the	DET
chd-116	148	12	binding	bind	VERB
chd-116	148	13	affinity	affinity	NOUN
chd-116	148	14	of	of	ADP
chd-116	148	15	the	the	DET
chd-116	148	16	androgen	androgen	NOUN
chd-116	148	17	receptor	receptor	NOUN
chd-116	148	18	to	to	ADP
chd-116	148	19	cortisol	cortisol	NOUN
chd-116	148	20	and	and	CCONJ
chd-116	148	21	its	its	PRON
chd-116	148	22	metabolite	metabolite	NOUN
chd-116	148	23	,	,	PUNCT
chd-116	148	24	cortisone	cortisone	NOUN
chd-116	148	25	,	,	PUNCT
chd-116	148	26	creating	create	VERB
chd-116	148	27	a	a	DET
chd-116	148	28	cortisol	cortisol	ADJ
chd-116	148	29	responsive	responsive	ADJ
chd-116	148	30	cap	cap	NOUN
chd-116	148	31	cells	cell	NOUN
chd-116	148	32	leading	lead	VERB
chd-116	148	33	to	to	ADP
chd-116	148	34	androgen	androgen	NOUN
chd-116	148	35	independent	independent	ADJ
chd-116	148	36	growth	growth	NOUN
chd-116	148	37	and	and	CCONJ
chd-116	148	38	higher	high	ADJ
chd-116	148	39	tumour	tumour	NOUN
chd-116	148	40	grade	grade	NOUN
chd-116	148	41	(	(	PUNCT
chd-116	148	42	zhao	zhao	PROPN
chd-116	148	43	et	et	PROPN
chd-116	148	44	al	al	PROPN
chd-116	148	45	.	.	PROPN
chd-116	148	46	,	,	PUNCT
chd-116	148	47	2000	2000	NUM
chd-116	148	48	)	)	PUNCT
chd-116	148	49	.	.	PUNCT
chd-116	149	1	interestingly	interestingly	ADV
chd-116	149	2	,	,	PUNCT
chd-116	149	3	the	the	DET
chd-116	149	4	abnormal	abnormal	ADJ
chd-116	149	5	mutations	mutation	NOUN
chd-116	149	6	of	of	ADP
chd-116	149	7	the	the	DET
chd-116	149	8	androgen	androgen	NOUN
chd-116	149	9	receptor	receptor	NOUN
chd-116	149	10	molecule	molecule	NOUN
chd-116	149	11	results	result	NOUN
chd-116	149	12	in	in	ADP
chd-116	149	13	the	the	DET
chd-116	149	14	ability	ability	NOUN
chd-116	149	15	of	of	ADP
chd-116	149	16	cortisol	cortisol	NOUN
chd-116	149	17	to	to	PART
chd-116	149	18	bind	bind	VERB
chd-116	149	19	to	to	ADP
chd-116	149	20	the	the	DET
chd-116	149	21	androgen	androgen	NOUN
chd-116	149	22	molecule	molecule	NOUN
chd-116	149	23	thereby	thereby	ADV
chd-116	149	24	functioning	function	VERB
chd-116	149	25	as	as	ADP
chd-116	149	26	a	a	DET
chd-116	149	27	“	"	PUNCT
chd-116	149	28	pseudo	pseudo	NOUN
chd-116	149	29	-	-	NOUN
chd-116	149	30	androgen	androgen	NOUN
chd-116	149	31	”	"	PUNCT
chd-116	149	32	,	,	PUNCT
chd-116	149	33	promoting	promote	VERB
chd-116	149	34	the	the	DET
chd-116	149	35	increase	increase	NOUN
chd-116	149	36	in	in	ADP
chd-116	149	37	secretion	secretion	NOUN
chd-116	149	38	of	of	ADP
chd-116	149	39	psa	psa	NOUN
chd-116	149	40	and	and	CCONJ
chd-116	149	41	making	make	VERB
chd-116	149	42	cap	cap	NOUN
chd-116	149	43	cells	cell	NOUN
chd-116	149	44	more	more	ADV
chd-116	149	45	aggressive	aggressive	ADJ
chd-116	149	46	(	(	PUNCT
chd-116	149	47	gaddipati	gaddipati	PROPN
chd-116	149	48	et	et	PROPN
chd-116	149	49	al	al	PROPN
chd-116	149	50	.	.	PROPN
chd-116	149	51	,	,	PUNCT
chd-116	149	52	1994	1994	NUM
chd-116	149	53	;	;	PUNCT
chd-116	149	54	zhao	zhao	PROPN
chd-116	149	55	et	et	PROPN
chd-116	149	56	al	al	PROPN
chd-116	149	57	.	.	PROPN
chd-116	149	58	,	,	PUNCT
chd-116	149	59	2000	2000	NUM
chd-116	149	60	)	)	PUNCT
chd-116	149	61	.	.	PUNCT
chd-116	150	1	these	these	DET
chd-116	150	2	factors	factor	NOUN
chd-116	150	3	explain	explain	VERB
chd-116	150	4	the	the	DET
chd-116	150	5	potential	potential	ADJ
chd-116	150	6	source	source	NOUN
chd-116	150	7	and	and	CCONJ
chd-116	150	8	role	role	NOUN
chd-116	150	9	of	of	ADP
chd-116	150	10	cortisol	cortisol	NOUN
chd-116	150	11	in	in	ADP
chd-116	150	12	cap	cap	NOUN
chd-116	150	13	.	.	PUNCT
chd-116	151	1	cap	cap	NOUN
chd-116	151	2	cells	cell	NOUN
chd-116	151	3	with	with	ADP
chd-116	151	4	metastatic	metastatic	ADJ
chd-116	151	5	features	feature	NOUN
chd-116	151	6	including	include	VERB
chd-116	151	7	metastatic	metastatic	ADJ
chd-116	151	8	castrationresistant	castrationresistant	ADJ
chd-116	151	9	phenotypes	phenotype	NOUN
chd-116	151	10	have	have	AUX
chd-116	151	11	been	be	AUX
chd-116	151	12	reported	report	VERB
chd-116	151	13	to	to	PART
chd-116	151	14	be	be	AUX
chd-116	151	15	highly	highly	ADV
chd-116	151	16	dependent	dependent	ADJ
chd-116	151	17	on	on	ADP
chd-116	151	18	amino	amino	NOUN
chd-116	151	19	acid	acid	NOUN
chd-116	151	20	uptake	uptake	ADJ
chd-116	151	21	through	through	ADP
chd-116	151	22	the	the	DET
chd-116	151	23	l	l	ADJ
chd-116	151	24	-	-	ADJ
chd-116	151	25	amino	amino	ADJ
chd-116	151	26	acid	acid	NOUN
chd-116	151	27	transporters	transporter	NOUN
chd-116	151	28	(	(	PUNCT
chd-116	151	29	lats	lat	NOUN
chd-116	151	30	)	)	PUNCT
chd-116	151	31	for	for	ADP
chd-116	151	32	cellular	cellular	ADJ
chd-116	151	33	growth	growth	NOUN
chd-116	151	34	and	and	CCONJ
chd-116	151	35	proliferation	proliferation	NOUN
chd-116	151	36	,	,	PUNCT
chd-116	151	37	as	as	ADV
chd-116	151	38	well	well	ADV
chd-116	151	39	as	as	ADP
chd-116	151	40	malignant	malignant	ADJ
chd-116	151	41	transformation	transformation	NOUN
chd-116	151	42	(	(	PUNCT
chd-116	151	43	wang	wang	PROPN
chd-116	151	44	et	et	PROPN
chd-116	151	45	al	al	PROPN
chd-116	151	46	.	.	PROPN
chd-116	151	47	,	,	PUNCT
chd-116	151	48	2013	2013	NUM
chd-116	151	49	)	)	PUNCT
chd-116	151	50	.	.	PUNCT
chd-116	152	1	the	the	DET
chd-116	152	2	lats	lat	NOUN
chd-116	152	3	are	be	AUX
chd-116	152	4	part	part	NOUN
chd-116	152	5	of	of	ADP
chd-116	152	6	atf4	atf4	NOUN
chd-116	152	7	genes	gene	NOUN
chd-116	152	8	that	that	PRON
chd-116	152	9	function	function	VERB
chd-116	152	10	in	in	ADP
chd-116	152	11	the	the	DET
chd-116	152	12	exchange	exchange	NOUN
chd-116	152	13	of	of	ADP
chd-116	152	14	branch	branch	NOUN
chd-116	152	15	chain	chain	NOUN
chd-116	152	16	amino	amino	NOUN
chd-116	152	17	acids	acid	NOUN
chd-116	152	18	for	for	ADP
chd-116	152	19	intracellular	intracellular	ADJ
chd-116	152	20	amino	amino	ADJ
chd-116	152	21	acids	acid	NOUN
chd-116	152	22	(	(	PUNCT
chd-116	152	23	tee	tee	NOUN
chd-116	152	24	,	,	PUNCT
chd-116	152	25	2013	2013	NUM
chd-116	152	26	)	)	PUNCT
chd-116	152	27	.	.	PUNCT
chd-116	153	1	amino	amino	ADJ
chd-116	153	2	acids	acid	NOUN
chd-116	153	3	via	via	ADP
chd-116	153	4	anabolic	anabolic	NOUN
chd-116	153	5	pathways	pathway	NOUN
chd-116	153	6	have	have	AUX
chd-116	153	7	been	be	AUX
chd-116	153	8	reported	report	VERB
chd-116	153	9	to	to	PART
chd-116	153	10	generate	generate	VERB
chd-116	153	11	nucleotide	nucleotide	NOUN
chd-116	153	12	and	and	CCONJ
chd-116	153	13	membrane	membrane	NOUN
chd-116	153	14	biomolecule	biomolecule	NOUN
chd-116	153	15	precursors	precursor	NOUN
chd-116	153	16	for	for	ADP
chd-116	153	17	aggressive	aggressive	ADJ
chd-116	153	18	cap	cap	NOUN
chd-116	153	19	cells	cell	NOUN
chd-116	153	20	(	(	PUNCT
chd-116	153	21	tee	tee	NOUN
chd-116	153	22	,	,	PUNCT
chd-116	153	23	2013	2013	NUM
chd-116	153	24	)	)	PUNCT
chd-116	153	25	.	.	PUNCT
chd-116	154	1	perhaps	perhaps	ADV
chd-116	154	2	this	this	PRON
chd-116	154	3	explains	explain	VERB
chd-116	154	4	why	why	SCONJ
chd-116	154	5	leucine	leucine	NOUN
chd-116	154	6	may	may	AUX
chd-116	154	7	serve	serve	VERB
chd-116	154	8	as	as	ADP
chd-116	154	9	a	a	DET
chd-116	154	10	source	source	NOUN
chd-116	154	11	of	of	ADP
chd-116	154	12	fuel	fuel	NOUN
chd-116	154	13	for	for	ADP
chd-116	154	14	aggressive	aggressive	ADJ
chd-116	154	15	prostate	prostate	NOUN
chd-116	154	16	cancer	cancer	NOUN
chd-116	154	17	cells	cell	NOUN
chd-116	154	18	.	.	PUNCT
chd-116	155	1	the	the	DET
chd-116	155	2	study	study	NOUN
chd-116	155	3	also	also	ADV
chd-116	155	4	shows	show	VERB
chd-116	155	5	increased	increase	VERB
chd-116	155	6	tissue	tissue	NOUN
chd-116	155	7	expression	expression	NOUN
chd-116	155	8	of	of	ADP
chd-116	155	9	annexin	annexin	NOUN
chd-116	155	10	v	v	ADP
chd-116	155	11	protein	protein	NOUN
chd-116	155	12	in	in	ADP
chd-116	155	13	the	the	DET
chd-116	155	14	cap	cap	NOUN
chd-116	155	15	cells	cell	NOUN
chd-116	155	16	.	.	PUNCT
chd-116	156	1	annexin	annexin	NOUN
chd-116	156	2	v	v	PROPN
chd-116	156	3	have	have	AUX
chd-116	156	4	been	be	AUX
chd-116	156	5	reported	report	VERB
chd-116	156	6	to	to	PART
chd-116	156	7	regulate	regulate	VERB
chd-116	156	8	immunological	immunological	ADJ
chd-116	156	9	and	and	CCONJ
chd-116	156	10	inflammatory	inflammatory	ADJ
chd-116	156	11	processes	process	NOUN
chd-116	156	12	and	and	CCONJ
chd-116	156	13	commonly	commonly	ADV
chd-116	156	14	expressed	express	VERB
chd-116	156	15	on	on	ADP
chd-116	156	16	the	the	DET
chd-116	156	17	surface	surface	NOUN
chd-116	156	18	of	of	ADP
chd-116	156	19	stressed	stress	VERB
chd-116	156	20	cells	cell	NOUN
chd-116	156	21	for	for	ADP
chd-116	156	22	inhibition	inhibition	NOUN
chd-116	156	23	of	of	ADP
chd-116	156	24	malignant	malignant	ADJ
chd-116	156	25	tumour	tumour	NOUN
chd-116	156	26	angiogenesis	angiogenesis	NOUN
chd-116	156	27	(	(	PUNCT
chd-116	156	28	desantis	desantis	PROPN
chd-116	156	29	et	et	PROPN
chd-116	156	30	al	al	PROPN
chd-116	156	31	.	.	PROPN
chd-116	156	32	,	,	PUNCT
chd-116	156	33	2012	2012	NUM
chd-116	156	34	)	)	PUNCT
chd-116	156	35	.	.	PUNCT
chd-116	157	1	previous	previous	ADJ
chd-116	157	2	findings	finding	NOUN
chd-116	157	3	have	have	AUX
chd-116	157	4	shown	show	VERB
chd-116	157	5	that	that	SCONJ
chd-116	157	6	abnormal	abnormal	ADJ
chd-116	157	7	increase	increase	NOUN
chd-116	157	8	in	in	ADP
chd-116	157	9	stress	stress	NOUN
chd-116	157	10	contributes	contribute	VERB
chd-116	157	11	to	to	PART
chd-116	157	12	increase	increase	VERB
chd-116	157	13	in	in	ADP
chd-116	157	14	cortisol	cortisol	NOUN
chd-116	157	15	,	,	PUNCT
chd-116	157	16	inflammation	inflammation	NOUN
chd-116	157	17	and	and	CCONJ
chd-116	157	18	immune	immune	ADJ
chd-116	157	19	dysfunction	dysfunction	NOUN
chd-116	157	20	via	via	ADP
chd-116	157	21	activation	activation	NOUN
chd-116	157	22	of	of	ADP
chd-116	157	23	the	the	DET
chd-116	157	24	hypothalamic	hypothalamic	ADJ
chd-116	157	25	-	-	PUNCT
chd-116	157	26	pituitary	pituitary	ADJ
chd-116	157	27	-	-	PUNCT
chd-116	157	28	adrenal	adrenal	ADJ
chd-116	157	29	axis	axis	NOUN
chd-116	157	30	(	(	PUNCT
chd-116	157	31	blankenberg	blankenberg	PROPN
chd-116	157	32	,	,	PUNCT
chd-116	157	33	2009	2009	NUM
chd-116	157	34	)	)	PUNCT
chd-116	157	35	.	.	PUNCT
chd-116	158	1	these	these	DET
chd-116	158	2	underlining	underline	VERB
chd-116	158	3	mechanisms	mechanism	NOUN
chd-116	158	4	have	have	AUX
chd-116	158	5	been	be	AUX
chd-116	158	6	proposed	propose	VERB
chd-116	158	7	to	to	PART
chd-116	158	8	play	play	VERB
chd-116	158	9	significant	significant	ADJ
chd-116	158	10	role	role	NOUN
chd-116	158	11	in	in	ADP
chd-116	158	12	prostate	prostate	NOUN
chd-116	158	13	cancer	cancer	NOUN
chd-116	158	14	pathology	pathology	NOUN
chd-116	158	15	and	and	CCONJ
chd-116	158	16	poor	poor	ADJ
chd-116	158	17	prognosis	prognosis	NOUN
chd-116	158	18	(	(	PUNCT
chd-116	158	19	touitou	touitou	PROPN
chd-116	158	20	et	et	PROPN
chd-116	158	21	al	al	PROPN
chd-116	158	22	.	.	PROPN
chd-116	158	23	,	,	PUNCT
chd-116	158	24	1983	1983	NUM
chd-116	158	25	;	;	PUNCT
chd-116	158	26	gidron	gidron	PROPN
chd-116	158	27	et	et	PROPN
chd-116	158	28	al	al	PROPN
chd-116	158	29	.	.	PROPN
chd-116	158	30	,	,	PUNCT
chd-116	158	31	2011	2011	NUM
chd-116	158	32	;	;	PUNCT
chd-116	158	33	coussens	coussen	NOUN
chd-116	158	34	and	and	CCONJ
chd-116	158	35	werb	werb	VERB
chd-116	158	36	2002	2002	NUM
chd-116	158	37	;	;	PUNCT
chd-116	158	38	desantis	desantis	PROPN
chd-116	158	39	et	et	PROPN
chd-116	158	40	al	al	PROPN
chd-116	158	41	.	.	PROPN
chd-116	158	42	,	,	PUNCT
chd-116	158	43	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-116	158	44	e15	e15	PROPN
chd-116	158	45	cancer	cancer	NOUN
chd-116	158	46	health	health	NOUN
chd-116	158	47	disparities	disparity	NOUN
chd-116	158	48	research	research	NOUN
chd-116	158	49	2012	2012	NUM
chd-116	158	50	;	;	PUNCT
chd-116	158	51	tai	tai	PROPN
chd-116	158	52	et	et	PROPN
chd-116	158	53	al	al	PROPN
chd-116	158	54	.	.	PROPN
chd-116	158	55	,	,	PUNCT
chd-116	158	56	2016	2016	NUM
chd-116	158	57	)	)	PUNCT
chd-116	158	58	.	.	PUNCT
chd-116	159	1	the	the	DET
chd-116	159	2	limitation	limitation	NOUN
chd-116	159	3	of	of	ADP
chd-116	159	4	our	our	PRON
chd-116	159	5	pilot	pilot	NOUN
chd-116	159	6	study	study	NOUN
chd-116	159	7	includes	include	VERB
chd-116	159	8	the	the	DET
chd-116	159	9	small	small	ADJ
chd-116	159	10	sample	sample	NOUN
chd-116	159	11	size	size	NOUN
chd-116	159	12	of	of	ADP
chd-116	159	13	participants	participant	NOUN
chd-116	159	14	with	with	ADP
chd-116	159	15	cap	cap	NOUN
chd-116	159	16	compared	compare	VERB
chd-116	159	17	to	to	ADP
chd-116	159	18	cap	cap	NOUN
chd-116	159	19	-	-	PUNCT
chd-116	159	20	free	free	ADJ
chd-116	159	21	participants	participant	NOUN
chd-116	159	22	.	.	PUNCT
chd-116	160	1	additional	additional	ADJ
chd-116	160	2	research	research	NOUN
chd-116	160	3	parameters	parameter	NOUN
chd-116	160	4	which	which	PRON
chd-116	160	5	include	include	VERB
chd-116	160	6	but	but	CCONJ
chd-116	160	7	not	not	PART
chd-116	160	8	limited	limit	VERB
chd-116	160	9	to	to	ADP
chd-116	160	10	inflammatory	inflammatory	ADJ
chd-116	160	11	markers	marker	NOUN
chd-116	160	12	are	be	AUX
chd-116	160	13	necessary	necessary	ADJ
chd-116	160	14	to	to	PART
chd-116	160	15	increase	increase	VERB
chd-116	160	16	our	our	PRON
chd-116	160	17	understanding	understanding	NOUN
chd-116	160	18	of	of	ADP
chd-116	160	19	the	the	DET
chd-116	160	20	role	role	NOUN
chd-116	160	21	of	of	ADP
chd-116	160	22	cortisol	cortisol	NOUN
chd-116	160	23	in	in	ADP
chd-116	160	24	the	the	DET
chd-116	160	25	development	development	NOUN
chd-116	160	26	and	and	CCONJ
chd-116	160	27	prognosis	prognosis	NOUN
chd-116	160	28	of	of	ADP
chd-116	160	29	cap	cap	NOUN
chd-116	160	30	in	in	ADP
chd-116	160	31	black	black	ADJ
chd-116	160	32	african	african	ADJ
chd-116	160	33	men	man	NOUN
chd-116	160	34	.	.	PUNCT
chd-116	161	1	further	far	ADV
chd-116	161	2	in	in	ADP
chd-116	161	3	-	-	PUNCT
chd-116	161	4	depth	depth	NOUN
chd-116	161	5	studies	study	NOUN
chd-116	161	6	that	that	PRON
chd-116	161	7	take	take	VERB
chd-116	161	8	into	into	ADP
chd-116	161	9	consideration	consideration	NOUN
chd-116	161	10	all	all	DET
chd-116	161	11	the	the	DET
chd-116	161	12	necessary	necessary	ADJ
chd-116	161	13	parameters	parameter	NOUN
chd-116	161	14	are	be	AUX
chd-116	161	15	required	require	VERB
chd-116	161	16	.	.	PUNCT
chd-116	162	1	conclusion	conclusion	NOUN
chd-116	162	2	in	in	ADP
chd-116	162	3	conclusion	conclusion	NOUN
chd-116	162	4	,	,	PUNCT
chd-116	162	5	this	this	DET
chd-116	162	6	study	study	NOUN
chd-116	162	7	to	to	ADP
chd-116	162	8	a	a	DET
chd-116	162	9	large	large	ADJ
chd-116	162	10	extent	extent	NOUN
chd-116	162	11	has	have	AUX
chd-116	162	12	demonstrated	demonstrate	VERB
chd-116	162	13	associations	association	NOUN
chd-116	162	14	of	of	ADP
chd-116	162	15	salivary	salivary	ADJ
chd-116	162	16	cortisol	cortisol	ADJ
chd-116	162	17	level	level	NOUN
chd-116	162	18	,	,	PUNCT
chd-116	162	19	tissue	tissue	NOUN
chd-116	162	20	cortisol	cortisol	ADJ
chd-116	162	21	expression	expression	NOUN
chd-116	162	22	activity	activity	NOUN
chd-116	162	23	and	and	CCONJ
chd-116	162	24	hrqol	hrqol	NOUN
chd-116	162	25	of	of	ADP
chd-116	162	26	life	life	NOUN
chd-116	162	27	in	in	ADP
chd-116	162	28	west	west	ADJ
chd-116	162	29	african	african	ADJ
chd-116	162	30	black	black	ADJ
chd-116	162	31	men	man	NOUN
chd-116	162	32	in	in	ADP
chd-116	162	33	nigeria	nigeria	PROPN
chd-116	162	34	,	,	PUNCT
chd-116	162	35	cameroon	cameroon	PROPN
chd-116	162	36	and	and	CCONJ
chd-116	162	37	the	the	DET
chd-116	162	38	usa	usa	PROPN
chd-116	162	39	with	with	ADP
chd-116	162	40	or	or	CCONJ
chd-116	162	41	without	without	ADP
chd-116	162	42	cap	cap	NOUN
chd-116	162	43	.	.	PUNCT
chd-116	163	1	the	the	DET
chd-116	163	2	study	study	NOUN
chd-116	163	3	show	show	VERB
chd-116	163	4	that	that	SCONJ
chd-116	163	5	salivary	salivary	VERB
chd-116	163	6	and	and	CCONJ
chd-116	163	7	tissue	tissue	NOUN
chd-116	163	8	cortisol	cortisol	NOUN
chd-116	163	9	levels	level	NOUN
chd-116	163	10	with	with	ADP
chd-116	163	11	an	an	DET
chd-116	163	12	accompanying	accompany	VERB
chd-116	163	13	annexin	annexin	NOUN
chd-116	163	14	v	v	ADP
chd-116	163	15	expression	expression	NOUN
chd-116	163	16	may	may	AUX
chd-116	163	17	serve	serve	VERB
chd-116	163	18	as	as	ADP
chd-116	163	19	important	important	ADJ
chd-116	163	20	biomarkers	biomarker	NOUN
chd-116	163	21	for	for	ADP
chd-116	163	22	prostate	prostate	NOUN
chd-116	163	23	cancer	cancer	NOUN
chd-116	163	24	diagnosis	diagnosis	NOUN
chd-116	163	25	and	and	CCONJ
chd-116	163	26	prognosis	prognosis	NOUN
chd-116	163	27	in	in	ADP
chd-116	163	28	west	west	ADJ
chd-116	163	29	african	african	ADJ
chd-116	163	30	black	black	ADJ
chd-116	163	31	men	man	NOUN
chd-116	163	32	.	.	PUNCT
chd-116	164	1	the	the	DET
chd-116	164	2	findings	finding	NOUN
chd-116	164	3	further	far	ADV
chd-116	164	4	suggest	suggest	VERB
chd-116	164	5	the	the	DET
chd-116	164	6	possibility	possibility	NOUN
chd-116	164	7	that	that	SCONJ
chd-116	164	8	tissue	tissue	NOUN
chd-116	164	9	and	and	CCONJ
chd-116	164	10	salivary	salivary	ADJ
chd-116	164	11	cortisol	cortisol	NOUN
chd-116	164	12	in	in	ADP
chd-116	164	13	combination	combination	NOUN
chd-116	164	14	with	with	ADP
chd-116	164	15	indicators	indicator	NOUN
chd-116	164	16	of	of	ADP
chd-116	164	17	hrqol	hrqol	NOUN
chd-116	164	18	may	may	AUX
chd-116	164	19	mediate	mediate	VERB
chd-116	164	20	prostate	prostate	NOUN
chd-116	164	21	cancer	cancer	NOUN
chd-116	164	22	risk	risk	NOUN
chd-116	164	23	in	in	ADP
chd-116	164	24	west	west	ADJ
chd-116	164	25	african	african	ADJ
chd-116	164	26	balck	balck	ADJ
chd-116	164	27	men	man	NOUN
chd-116	164	28	.	.	PUNCT
chd-116	165	1	acknowledgements	acknowledgement	NOUN
chd-116	165	2	we	we	PRON
chd-116	165	3	acknowledge	acknowledge	VERB
chd-116	165	4	the	the	DET
chd-116	165	5	support	support	NOUN
chd-116	165	6	of	of	ADP
chd-116	165	7	mrs	mrs	PROPN
chd-116	165	8	.	.	PROPN
chd-116	165	9	nike	nike	PROPN
chd-116	165	10	obafemi	obafemi	ADV
chd-116	165	11	who	who	PRON
chd-116	165	12	assisted	assist	VERB
chd-116	165	13	with	with	ADP
chd-116	165	14	data	datum	NOUN
chd-116	165	15	collection	collection	NOUN
chd-116	165	16	and	and	CCONJ
chd-116	165	17	our	our	PRON
chd-116	165	18	participants	participant	NOUN
chd-116	165	19	who	who	PRON
chd-116	165	20	took	take	VERB
chd-116	165	21	the	the	DET
chd-116	165	22	time	time	NOUN
chd-116	165	23	to	to	PART
chd-116	165	24	participate	participate	VERB
chd-116	165	25	in	in	ADP
chd-116	165	26	this	this	DET
chd-116	165	27	study	study	NOUN
chd-116	165	28	.	.	PUNCT
chd-116	166	1	in	in	ADP
chd-116	166	2	addition	addition	NOUN
chd-116	166	3	,	,	PUNCT
chd-116	166	4	ms	ms	PROPN
chd-116	166	5	.	.	PROPN
chd-116	166	6	kimberly	kimberly	PROPN
chd-116	166	7	meza	meza	PROPN
chd-116	166	8	is	be	AUX
chd-116	166	9	acknowledged	acknowledge	VERB
chd-116	166	10	for	for	ADP
chd-116	166	11	providing	provide	VERB
chd-116	166	12	editorial	editorial	ADJ
chd-116	166	13	review	review	NOUN
chd-116	166	14	for	for	ADP
chd-116	166	15	the	the	DET
chd-116	166	16	manuscript	manuscript	NOUN
chd-116	166	17	.	.	PUNCT
chd-116	167	1	funding	funding	NOUN
chd-116	167	2	support	support	NOUN
chd-116	167	3	funding	funding	NOUN
chd-116	167	4	support	support	NOUN
chd-116	167	5	for	for	ADP
chd-116	167	6	this	this	DET
chd-116	167	7	project	project	NOUN
chd-116	167	8	was	be	AUX
chd-116	167	9	provided	provide	VERB
chd-116	167	10	by	by	ADP
chd-116	167	11	the	the	DET
chd-116	167	12	prostate	prostate	NOUN
chd-116	167	13	cancer	cancer	NOUN
chd-116	167	14	transatlantic	transatlantic	ADJ
chd-116	167	15	consortium	consortium	NOUN
chd-116	167	16	(	(	PUNCT
chd-116	167	17	captc	captc	NOUN
chd-116	167	18	)	)	PUNCT
chd-116	167	19	.	.	PUNCT
chd-116	168	1	conflict	conflict	NOUN
chd-116	168	2	of	of	ADP
chd-116	168	3	interest	interest	NOUN
chd-116	168	4	the	the	DET
chd-116	168	5	authors	author	NOUN
chd-116	168	6	declare	declare	VERB
chd-116	168	7	that	that	SCONJ
chd-116	168	8	no	no	DET
chd-116	168	9	competing	compete	VERB
chd-116	168	10	or	or	CCONJ
chd-116	168	11	conflict	conflict	NOUN
chd-116	168	12	of	of	ADP
chd-116	168	13	interests	interest	NOUN
chd-116	168	14	exist	exist	VERB
chd-116	168	15	.	.	PUNCT
chd-116	169	1	the	the	DET
chd-116	169	2	funders	funder	NOUN
chd-116	169	3	had	have	VERB
chd-116	169	4	no	no	DET
chd-116	169	5	role	role	NOUN
chd-116	169	6	in	in	ADP
chd-116	169	7	study	study	NOUN
chd-116	169	8	design	design	NOUN
chd-116	169	9	,	,	PUNCT
chd-116	169	10	writing	writing	NOUN
chd-116	169	11	of	of	ADP
chd-116	169	12	the	the	DET
chd-116	169	13	manuscript	manuscript	NOUN
chd-116	169	14	,	,	PUNCT
chd-116	169	15	or	or	CCONJ
chd-116	169	16	decision	decision	NOUN
chd-116	169	17	to	to	PART
chd-116	169	18	publish	publish	VERB
chd-116	169	19	.	.	PUNCT
chd-116	170	1	authors	author	NOUN
chd-116	170	2	’	’	PART
chd-116	170	3	contributions	contribution	NOUN
chd-116	170	4	conception	conception	NOUN
chd-116	170	5	and	and	CCONJ
chd-116	170	6	design	design	NOUN
chd-116	170	7	:	:	PUNCT
chd-116	170	8	mf	mf	X
chd-116	170	9	,	,	PUNCT
chd-116	170	10	fto	fto	PROPN
chd-116	170	11	,	,	PUNCT
chd-116	170	12	sa	sa	PROPN
chd-116	170	13	,	,	PUNCT
chd-116	170	14	aa	aa	INTJ
chd-116	170	15	,	,	PUNCT
chd-116	170	16	sma	sma	PROPN
chd-116	170	17	,	,	PUNCT
chd-116	170	18	abdullahi	abdullahi	PROPN
chd-116	170	19	adamu	adamu	PROPN
chd-116	170	20	,	,	PUNCT
chd-116	170	21	ab	ab	PROPN
chd-116	170	22	,	,	PUNCT
chd-116	170	23	ji	ji	PROPN
chd-116	170	24	,	,	PUNCT
chd-116	170	25	ams	ams	PROPN
chd-116	170	26	,	,	PUNCT
chd-116	170	27	ek	ek	PROPN
chd-116	170	28	,	,	PUNCT
chd-116	170	29	ccy	ccy	PROPN
chd-116	170	30	,	,	PUNCT
chd-116	170	31	rrr	rrr	NOUN
chd-116	170	32	,	,	PUNCT
chd-116	170	33	development	development	NOUN
chd-116	170	34	of	of	ADP
chd-116	170	35	methodology	methodology	NOUN
chd-116	170	36	:	:	PUNCT
chd-116	170	37	mf	mf	X
chd-116	170	38	,	,	PUNCT
chd-116	170	39	fto	fto	PROPN
chd-116	170	40	,	,	PUNCT
chd-116	170	41	rrr	rrr	PROPN
chd-116	170	42	,	,	PUNCT
chd-116	170	43	cy	cy	PROPN
chd-116	170	44	,	,	PUNCT
chd-116	170	45	fc	fc	INTJ
chd-116	170	46	,	,	PUNCT
chd-116	170	47	so	so	ADV
chd-116	170	48	acquisition	acquisition	NOUN
chd-116	170	49	of	of	ADP
chd-116	170	50	data	data	PROPN
chd-116	170	51	:	:	PUNCT
chd-116	170	52	mf	mf	X
chd-116	170	53	,	,	PUNCT
chd-116	170	54	na	na	NOUN
chd-116	170	55	,	,	PUNCT
chd-116	170	56	sa	sa	PROPN
chd-116	170	57	,	,	PUNCT
chd-116	170	58	ams	am	NOUN
chd-116	170	59	,	,	PUNCT
chd-116	170	60	ra	ra	PROPN
chd-116	170	61	,	,	PUNCT
chd-116	170	62	km	km	VERB
chd-116	170	63	analysis	analysis	NOUN
chd-116	170	64	and	and	CCONJ
chd-116	170	65	interpretation	interpretation	NOUN
chd-116	170	66	of	of	ADP
chd-116	170	67	data	data	PROPN
chd-116	170	68	:	:	PUNCT
chd-116	170	69	mf	mf	PROPN
chd-116	170	70	,	,	PUNCT
chd-116	170	71	gad	gad	PROPN
chd-116	170	72	,	,	PUNCT
chd-116	170	73	na	na	ADP
chd-116	170	74	writing	writing	NOUN
chd-116	170	75	,	,	PUNCT
chd-116	170	76	review	review	NOUN
chd-116	170	77	,	,	PUNCT
chd-116	170	78	and/or	and/or	CCONJ
chd-116	170	79	revision	revision	NOUN
chd-116	170	80	of	of	ADP
chd-116	170	81	the	the	DET
chd-116	170	82	manuscript	manuscript	NOUN
chd-116	170	83	:	:	PUNCT
chd-116	170	84	mf	mf	X
chd-116	170	85	,	,	PUNCT
chd-116	170	86	fto	fto	PROPN
chd-116	170	87	,	,	PUNCT
chd-116	170	88	si	si	PROPN
chd-116	170	89	,	,	PUNCT
chd-116	170	90	ahr	ahr	PROPN
chd-116	170	91	,	,	PUNCT
chd-116	170	92	aa	aa	INTJ
chd-116	170	93	,	,	PUNCT
chd-116	170	94	daa	daa	PROPN
chd-116	170	95	,	,	PUNCT
chd-116	170	96	sma	sma	PROPN
chd-116	170	97	,	,	PUNCT
chd-116	170	98	abdullahi	abdullahi	PROPN
chd-116	170	99	adamu	adamu	PROPN
chd-116	170	100	,	,	PUNCT
chd-116	170	101	ab	ab	PROPN
chd-116	170	102	,	,	PUNCT
chd-116	170	103	ek	ek	PROPN
chd-116	170	104	,	,	PUNCT
chd-116	170	105	ji	ji	PROPN
chd-116	170	106	,	,	PUNCT
chd-116	170	107	ams	am	NOUN
chd-116	170	108	,	,	PUNCT
chd-116	170	109	sor	sor	NOUN
chd-116	170	110	,	,	PUNCT
chd-116	170	111	gad	gad	PROPN
chd-116	170	112	,	,	PUNCT
chd-116	170	113	na	na	NOUN
chd-116	170	114	,	,	PUNCT
chd-116	170	115	ccy	ccy	PROPN
chd-116	170	116	,	,	PUNCT
chd-116	170	117	eji	eji	PROPN
chd-116	170	118	,	,	PUNCT
chd-116	170	119	yi	yi	PROPN
chd-116	170	120	,	,	PUNCT
chd-116	170	121	ieb	ieb	PROPN
chd-116	170	122	,	,	PUNCT
chd-116	170	123	rrr	rrr	PROPN
chd-116	170	124	,	,	PUNCT
chd-116	170	125	am	be	AUX
chd-116	170	126	,	,	PUNCT
chd-116	170	127	mss	mss	PROPN
chd-116	170	128	,	,	PUNCT
chd-116	170	129	ajr	ajr	PROPN
chd-116	170	130	,	,	PUNCT
chd-116	170	131	hym	hym	PROPN
chd-116	170	132	,	,	PUNCT
chd-116	170	133	dmm	dmm	PROPN
chd-116	170	134	,	,	PUNCT
chd-116	170	135	alr	alr	PROPN
chd-116	170	136	,	,	PUNCT
chd-116	170	137	abk	abk	PROPN
chd-116	170	138	,	,	PUNCT
chd-116	170	139	han	han	PROPN
chd-116	170	140	,	,	PUNCT
chd-116	170	141	rg	rg	PROPN
chd-116	170	142	,	,	PUNCT
chd-116	170	143	hmd	hmd	PROPN
chd-116	170	144	,	,	PUNCT
chd-116	170	145	ap	ap	PROPN
chd-116	170	146	,	,	PUNCT
chd-116	170	147	sa	sa	PROPN
chd-116	170	148	,	,	PUNCT
chd-116	170	149	ra	ra	PROPN
chd-116	170	150	,	,	PUNCT
chd-116	170	151	km	km	PROPN
chd-116	170	152	,	,	PUNCT
chd-116	170	153	nb	nb	PROPN
chd-116	170	154	,	,	PUNCT
chd-116	170	155	pj	pj	PROPN
chd-116	170	156	,	,	PUNCT
chd-116	170	157	rs	rs	PROPN
chd-116	170	158	,	,	PUNCT
chd-116	170	159	hmm	hmm	INTJ
chd-116	170	160	,	,	PUNCT
chd-116	170	161	ahmad	ahmad	PROPN
chd-116	170	162	mai	mai	PROPN
chd-116	170	163	,	,	PUNCT
chd-116	170	164	ta	ta	PROPN
chd-116	170	165	,	,	PUNCT
chd-116	170	166	sea	sea	PROPN
chd-116	170	167	,	,	PUNCT
chd-116	170	168	saa	saa	PROPN
chd-116	170	169	,	,	PUNCT
chd-116	170	170	aliyu	aliyu	NOUN
chd-116	170	171	muhammad	muhammad	PROPN
chd-116	170	172	,	,	PUNCT
chd-116	170	173	kua	kua	PROPN
chd-116	170	174	,	,	PUNCT
chd-116	170	175	atl	atl	PROPN
chd-116	170	176	,	,	PUNCT
chd-116	170	177	jy	jy	PROPN
chd-116	170	178	,	,	PUNCT
chd-116	170	179	ahmad	ahmad	PROPN
chd-116	170	180	muhammad	muhammad	PROPN
chd-116	170	181	,	,	PUNCT
chd-116	170	182	mst	mst	PROPN
chd-116	170	183	,	,	PUNCT
chd-116	170	184	ot	ot	INTJ
chd-116	170	185	,	,	PUNCT
chd-116	170	186	aab	aab	PROPN
chd-116	170	187	,	,	PUNCT
chd-116	170	188	shehu	shehu	NOUN
chd-116	170	189	akuya	akuya	PROPN
chd-116	170	190	yr	yr	PROPN
chd-116	170	191	,	,	PUNCT
chd-116	170	192	mll	mll	PROPN
chd-116	170	193	,	,	PUNCT
chd-116	170	194	aeo	aeo	PROPN
chd-116	170	195	,	,	PUNCT
chd-116	170	196	as	as	ADP
chd-116	170	197	,	,	PUNCT
chd-116	170	198	jdy	jdy	NOUN
chd-116	170	199	,	,	PUNCT
chd-116	170	200	cao	cao	PROPN
chd-116	170	201	,	,	PUNCT
chd-116	170	202	fas	fas	PROPN
chd-116	170	203	,	,	PUNCT
chd-116	170	204	ocn	ocn	PROPN
chd-116	170	205	,	,	PUNCT
chd-116	170	206	aa	aa	INTJ
chd-116	170	207	,	,	PUNCT
chd-116	170	208	ooo	ooo	INTJ
chd-116	170	209	,	,	PUNCT
chd-116	170	210	aas	aas	PROPN
chd-116	170	211	,	,	PUNCT
chd-116	170	212	fc	fc	PROPN
chd-116	170	213	,	,	PUNCT
chd-116	170	214	wk	wk	PROPN
chd-116	170	215	,	,	PUNCT
chd-116	170	216	ei	ei	PROPN
chd-116	170	217	,	,	PUNCT
chd-116	170	218	ao	ao	PROPN
chd-116	170	219	,	,	PUNCT
chd-116	170	220	is	be	AUX
chd-116	170	221	,	,	PUNCT
chd-116	170	222	meo	meo	PROPN
chd-116	170	223	,	,	PUNCT
chd-116	170	224	fu	fu	ADJ
chd-116	170	225	,	,	PUNCT
chd-116	170	226	om	om	PROPN
chd-116	170	227	,	,	PUNCT
chd-116	170	228	ka	ka	PROPN
chd-116	170	229	,	,	PUNCT
chd-116	170	230	aok	aok	PROPN
chd-116	170	231	,	,	PUNCT
chd-116	170	232	sak	sak	PROPN
chd-116	170	233	,	,	PUNCT
chd-116	170	234	io	io	PROPN
chd-116	170	235	.	.	PROPN
chd-116	170	236	administrative	administrative	ADJ
chd-116	170	237	,	,	PUNCT
chd-116	170	238	technical	technical	ADJ
chd-116	170	239	,	,	PUNCT
chd-116	170	240	or	or	CCONJ
chd-116	170	241	material	material	NOUN
chd-116	170	242	support	support	NOUN
chd-116	170	243	:	:	PUNCT
chd-116	171	1	na	na	NOUN
chd-116	171	2	,	,	PUNCT
chd-116	171	3	sa	sa	PROPN
chd-116	171	4	,	,	PUNCT
chd-116	171	5	ra	ra	PROPN
chd-116	171	6	,	,	PUNCT
chd-116	171	7	km	km	PROPN
chd-116	171	8	study	study	NOUN
chd-116	171	9	supervision	supervision	NOUN
chd-116	171	10	:	:	PUNCT
chd-116	171	11	mf	mf	PROPN
chd-116	171	12	references	reference	NOUN
chd-116	171	13	akinremi	akinremi	ADV
chd-116	171	14	,	,	PUNCT
chd-116	171	15	t.o	t.o	PROPN
chd-116	171	16	.	.	PROPN
chd-116	171	17	,	,	PUNCT
chd-116	171	18	ogo	ogo	PROPN
chd-116	171	19	,	,	PUNCT
chd-116	171	20	c.n	c.n	PROPN
chd-116	171	21	.	.	PROPN
chd-116	171	22	,	,	PUNCT
chd-116	171	23	and	and	CCONJ
chd-116	171	24	olutunde	olutunde	PROPN
chd-116	171	25	,	,	PUNCT
chd-116	171	26	a.o	a.o	PROPN
chd-116	171	27	.	.	PROPN
chd-116	171	28	(	(	PUNCT
chd-116	171	29	2011	2011	NUM
chd-116	171	30	)	)	PUNCT
chd-116	171	31	.	.	PUNCT
chd-116	172	1	review	review	NOUN
chd-116	172	2	of	of	ADP
chd-116	172	3	prostate	prostate	NOUN
chd-116	172	4	cancer	cancer	NOUN
chd-116	172	5	research	research	NOUN
chd-116	172	6	in	in	ADP
chd-116	172	7	nigeria	nigeria	PROPN
chd-116	172	8	.	.	PUNCT
chd-116	173	1	infectious	infectious	ADJ
chd-116	173	2	agent	agent	NOUN
chd-116	173	3	cancer	cancer	NOUN
chd-116	173	4	2011	2011	NUM
chd-116	173	5	:	:	PUNCT
chd-116	173	6	6	6	NUM
chd-116	173	7	;	;	PUNCT
chd-116	173	8	(	(	PUNCT
chd-116	173	9	suppl	suppl	PROPN
chd-116	173	10	2):s8	2):s8	NUM
chd-116	173	11	.	.	PUNCT
chd-116	174	1	american	american	ADJ
chd-116	174	2	cancer	cancer	NOUN
chd-116	174	3	society	society	NOUN
chd-116	174	4	:	:	PUNCT
chd-116	174	5	cancer	cancer	NOUN
chd-116	174	6	facts	fact	NOUN
chd-116	174	7	&	&	CCONJ
chd-116	174	8	figures	figure	NOUN
chd-116	174	9	for	for	ADP
chd-116	174	10	african	african	ADJ
chd-116	174	11	americans	americans	PROPN
chd-116	174	12	2013–2014	2013–2014	NUM
chd-116	174	13	atlanta	atlanta	PROPN
chd-116	174	14	,	,	PUNCT
chd-116	174	15	american	american	ADJ
chd-116	174	16	cancer	cancer	NOUN
chd-116	174	17	society	society	NOUN
chd-116	174	18	;	;	PUNCT
chd-116	174	19	20013	20013	NUM
chd-116	174	20	https://www.cancer.org/content/dam/cancerorg/research/cancer-facts-and-statistics/cancer-factsand-figures-for-african-americans/cancer-facts-andfigures-for-african-americans-2013-2014.pdf	https://www.cancer.org/content/dam/cancerorg/research/cancer-facts-and-statistics/cancer-factsand-figures-for-african-americans/cancer-facts-andfigures-for-african-americans-2013-2014.pdf	PROPN
chd-116	174	21	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	PROPN
chd-116	174	22	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	PROPN
chd-116	174	23	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	PROPN
chd-116	174	24	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-african-americans/cancer-facts-and-figures-for-african-americans-2013-2014.pdf	PROPN
chd-116	174	25	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-116	174	26	e16	e16	PROPN
chd-116	174	27	cancer	cancer	NOUN
chd-116	174	28	health	health	NOUN
chd-116	174	29	disparities	disparity	NOUN
chd-116	174	30	research	research	NOUN
chd-116	174	31	bray	bray	PROPN
chd-116	174	32	,	,	PUNCT
chd-116	174	33	f.	f.	PROPN
chd-116	174	34	,	,	PUNCT
chd-116	174	35	ren	ren	PROPN
chd-116	174	36	,	,	PUNCT
chd-116	174	37	j.s	j.s	PROPN
chd-116	174	38	.	.	PROPN
chd-116	174	39	,	,	PUNCT
chd-116	174	40	masuyer	masuyer	PROPN
chd-116	174	41	,	,	PUNCT
chd-116	174	42	e.	e.	PROPN
chd-116	174	43	,	,	PUNCT
chd-116	174	44	and	and	CCONJ
chd-116	174	45	ferlay	ferlay	NOUN
chd-116	174	46	,	,	PUNCT
chd-116	174	47	j.	j.	PROPN
chd-116	174	48	(	(	PUNCT
chd-116	174	49	2013	2013	NUM
chd-116	174	50	)	)	PUNCT
chd-116	174	51	.	.	PUNCT
chd-116	175	1	global	global	ADJ
chd-116	175	2	estimates	estimate	NOUN
chd-116	175	3	of	of	ADP
chd-116	175	4	cancer	cancer	NOUN
chd-116	175	5	prevalence	prevalence	NOUN
chd-116	175	6	for	for	ADP
chd-116	175	7	27	27	NUM
chd-116	175	8	sites	site	NOUN
chd-116	175	9	in	in	ADP
chd-116	175	10	the	the	DET
chd-116	175	11	adult	adult	NOUN
chd-116	175	12	population	population	NOUN
chd-116	175	13	in	in	ADP
chd-116	175	14	2008	2008	NUM
chd-116	175	15	.	.	PUNCT
chd-116	176	1	international	international	ADJ
chd-116	176	2	journal	journal	PROPN
chd-116	176	3	of	of	ADP
chd-116	176	4	cancer	cancer	NOUN
chd-116	176	5	132	132	NUM
chd-116	176	6	,	,	PUNCT
chd-116	176	7	1133–1145	1133–1145	NUM
chd-116	176	8	.	.	PUNCT
chd-116	177	1	blankenberg	blankenberg	PROPN
chd-116	177	2	,	,	PUNCT
chd-116	177	3	f.g	f.g	NOUN
chd-116	177	4	.	.	PROPN
chd-116	177	5	(	(	PUNCT
chd-116	177	6	2009	2009	NUM
chd-116	177	7	)	)	PUNCT
chd-116	177	8	.	.	PUNCT
chd-116	178	1	imaging	image	VERB
chd-116	178	2	the	the	DET
chd-116	178	3	molecular	molecular	ADJ
chd-116	178	4	signatures	signature	NOUN
chd-116	178	5	of	of	ADP
chd-116	178	6	apoptosis	apoptosis	NOUN
chd-116	178	7	and	and	CCONJ
chd-116	178	8	injury	injury	NOUN
chd-116	178	9	with	with	ADP
chd-116	178	10	radiolabeled	radiolabele	VERB
chd-116	178	11	annexin	annexin	NOUN
chd-116	178	12	v.	v.	ADP
chd-116	178	13	proceeding	proceeding	NOUN
chd-116	178	14	of	of	ADP
chd-116	178	15	the	the	DET
chd-116	178	16	american	american	PROPN
chd-116	178	17	thoracic	thoracic	PROPN
chd-116	178	18	society	society	PROPN
chd-116	178	19	6	6	NUM
chd-116	178	20	,	,	PUNCT
chd-116	178	21	469–476	469–476	NUM
chd-116	178	22	.	.	PUNCT
chd-116	179	1	chida	chida	PROPN
chd-116	179	2	,	,	PUNCT
chd-116	179	3	y.	y.	PROPN
chd-116	179	4	,	,	PUNCT
chd-116	179	5	hamer	hamer	NOUN
chd-116	179	6	,	,	PUNCT
chd-116	179	7	m.	m.	NOUN
chd-116	179	8	,	,	PUNCT
chd-116	179	9	wardle	wardle	PROPN
chd-116	179	10	,	,	PUNCT
chd-116	179	11	j.	j.	PROPN
chd-116	179	12	,	,	PUNCT
chd-116	179	13	and	and	CCONJ
chd-116	179	14	steptoe	steptoe	PROPN
chd-116	179	15	,	,	PUNCT
chd-116	179	16	a.	a.	NOUN
chd-116	179	17	(	(	PUNCT
chd-116	179	18	2008	2008	NUM
chd-116	179	19	)	)	PUNCT
chd-116	179	20	.	.	PUNCT
chd-116	180	1	do	do	AUX
chd-116	180	2	stress	stress	NOUN
chd-116	180	3	-	-	PUNCT
chd-116	180	4	related	relate	VERB
chd-116	180	5	psychosocial	psychosocial	ADJ
chd-116	180	6	factors	factor	NOUN
chd-116	180	7	contribute	contribute	VERB
chd-116	180	8	to	to	ADP
chd-116	180	9	cancer	cancer	NOUN
chd-116	180	10	incidence	incidence	NOUN
chd-116	180	11	and	and	CCONJ
chd-116	180	12	survival	survival	NOUN
chd-116	180	13	?	?	PUNCT
chd-116	181	1	nature	nature	NOUN
chd-116	181	2	clinical	clinical	ADJ
chd-116	181	3	practice	practice	NOUN
chd-116	181	4	oncology	oncology	NOUN
chd-116	181	5	5	5	NUM
chd-116	181	6	,	,	PUNCT
chd-116	181	7	466	466	NUM
chd-116	181	8	-	-	SYM
chd-116	181	9	475	475	NUM
chd-116	181	10	.	.	PUNCT
chd-116	181	11	coussens	coussens	PROPN
chd-116	181	12	,	,	PUNCT
chd-116	181	13	l.	l.	PROPN
chd-116	181	14	m.	m.	PROPN
chd-116	181	15	and	and	CCONJ
chd-116	181	16	werb	werb	ADJ
chd-116	181	17	,	,	PUNCT
chd-116	181	18	z.	z.	PROPN
chd-116	181	19	(	(	PUNCT
chd-116	181	20	2002	2002	NUM
chd-116	181	21	)	)	PUNCT
chd-116	181	22	.	.	PUNCT
chd-116	182	1	inflammation	inflammation	NOUN
chd-116	182	2	and	and	CCONJ
chd-116	182	3	cancer	cancer	NOUN
chd-116	182	4	.	.	PUNCT
chd-116	183	1	nature	nature	NOUN
chd-116	183	2	420	420	NUM
chd-116	183	3	,	,	PUNCT
chd-116	183	4	860–867	860–867	NUM
chd-116	183	5	.	.	PUNCT
chd-116	184	1	desantis	desantis	PROPN
chd-116	184	2	,	,	PUNCT
chd-116	184	3	a.s	a.s	PROPN
chd-116	184	4	.	.	PROPN
chd-116	184	5	,	,	PUNCT
chd-116	184	6	diezroux	diezroux	NOUN
chd-116	184	7	,	,	PUNCT
chd-116	184	8	a.v	a.v	PROPN
chd-116	184	9	.	.	PROPN
chd-116	184	10	,	,	PUNCT
chd-116	184	11	hajat	hajat	PROPN
chd-116	184	12	,	,	PUNCT
chd-116	184	13	a.	a.	PROPN
chd-116	184	14	,	,	PUNCT
chd-116	184	15	aiello	aiello	PROPN
chd-116	184	16	,	,	PUNCT
chd-116	184	17	a.e	a.e	PROPN
chd-116	184	18	.	.	PROPN
chd-116	184	19	,	,	PUNCT
chd-116	184	20	golden	golden	ADJ
chd-116	184	21	,	,	PUNCT
chd-116	184	22	s.h	s.h	PROPN
chd-116	184	23	.	.	PROPN
chd-116	184	24	,	,	PUNCT
chd-116	184	25	jenny	jenny	PROPN
chd-116	184	26	,	,	PUNCT
chd-116	184	27	n.s	n.s	PROPN
chd-116	184	28	.	.	PROPN
chd-116	184	29	,	,	PUNCT
chd-116	184	30	seeman	seeman	PROPN
chd-116	184	31	,	,	PUNCT
chd-116	184	32	t.e	t.e	PROPN
chd-116	184	33	.	.	PROPN
chd-116	184	34	,	,	PUNCT
chd-116	184	35	and	and	CCONJ
chd-116	184	36	shea	shea	PROPN
chd-116	184	37	,	,	PUNCT
chd-116	184	38	s.	s.	PROPN
chd-116	184	39	(	(	PUNCT
chd-116	184	40	2012	2012	NUM
chd-116	184	41	)	)	PUNCT
chd-116	184	42	.	.	PUNCT
chd-116	185	1	associations	association	NOUN
chd-116	185	2	of	of	ADP
chd-116	185	3	salivary	salivary	ADJ
chd-116	185	4	cortisol	cortisol	ADJ
chd-116	185	5	levels	level	NOUN
chd-116	185	6	with	with	ADP
chd-116	185	7	inflammatory	inflammatory	ADJ
chd-116	185	8	markers	marker	NOUN
chd-116	185	9	:	:	PUNCT
chd-116	185	10	the	the	DET
chd-116	185	11	multi	multi	ADJ
chd-116	185	12	-	-	ADJ
chd-116	185	13	ethnic	ethnic	ADJ
chd-116	185	14	study	study	NOUN
chd-116	185	15	of	of	ADP
chd-116	185	16	atherosclerosis	atherosclerosis	NOUN
chd-116	185	17	.	.	PUNCT
chd-116	186	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
chd-116	186	2	37	37	NUM
chd-116	186	3	,	,	PUNCT
chd-116	186	4	1009–1018	1009–1018	NUM
chd-116	186	5	.	.	PUNCT
chd-116	187	1	ekins	ekin	NOUN
chd-116	187	2	,	,	PUNCT
chd-116	187	3	r.	r.	PROPN
chd-116	187	4	(	(	PUNCT
chd-116	187	5	1990	1990	NUM
chd-116	187	6	)	)	PUNCT
chd-116	187	7	.	.	PUNCT
chd-116	188	1	measurement	measurement	NOUN
chd-116	188	2	of	of	ADP
chd-116	188	3	free	free	ADJ
chd-116	188	4	hormones	hormone	NOUN
chd-116	188	5	in	in	ADP
chd-116	188	6	blood	blood	NOUN
chd-116	188	7	.	.	PUNCT
chd-116	189	1	endocrine	endocrine	ADJ
chd-116	189	2	reviews	review	NOUN
chd-116	189	3	11	11	NUM
chd-116	189	4	,	,	PUNCT
chd-116	189	5	5	5	NUM
chd-116	189	6	-	-	SYM
chd-116	189	7	46	46	NUM
chd-116	189	8	.	.	PUNCT
chd-116	190	1	enow	enow	PROPN
chd-116	190	2	orock	orock	PROPN
chd-116	190	3	,	,	PUNCT
chd-116	190	4	g.e	g.e	NOUN
chd-116	190	5	,	,	PUNCT
chd-116	190	6	ndom	ndom	NOUN
chd-116	190	7	,	,	PUNCT
chd-116	190	8	p.	p.	NOUN
chd-116	190	9	,	,	PUNCT
chd-116	190	10	and	and	CCONJ
chd-116	190	11	doh	doh	PROPN
chd-116	190	12	,	,	PUNCT
chd-116	190	13	a.s	a.s	PROPN
chd-116	190	14	.	.	PROPN
chd-116	190	15	(	(	PUNCT
chd-116	190	16	2012	2012	NUM
chd-116	190	17	)	)	PUNCT
chd-116	190	18	.	.	PUNCT
chd-116	191	1	current	current	ADJ
chd-116	191	2	cancer	cancer	NOUN
chd-116	191	3	incidence	incidence	NOUN
chd-116	191	4	and	and	CCONJ
chd-116	191	5	trends	trend	NOUN
chd-116	191	6	in	in	ADP
chd-116	191	7	yaounde	yaounde	PROPN
chd-116	191	8	,	,	PUNCT
chd-116	191	9	cameroon	cameroon	PROPN
chd-116	191	10	.	.	PUNCT
chd-116	192	1	oncology	oncology	NOUN
chd-116	192	2	,	,	PUNCT
chd-116	192	3	gastroenterology	gastroenterology	NOUN
chd-116	192	4	and	and	CCONJ
chd-116	192	5	hepatology	hepatology	NOUN
chd-116	192	6	reports	report	VERB
chd-116	192	7	1	1	NUM
chd-116	192	8	,	,	PUNCT
chd-116	192	9	58	58	NUM
chd-116	192	10	-	-	SYM
chd-116	192	11	63	63	NUM
chd-116	192	12	.	.	PUNCT
chd-116	193	1	farran	farran	PROPN
chd-116	193	2	,	,	PUNCT
chd-116	193	3	b.	b.	PROPN
chd-116	193	4	,	,	PUNCT
chd-116	193	5	dyson	dyson	PROPN
chd-116	193	6	,	,	PUNCT
chd-116	193	7	g.	g.	PROPN
chd-116	193	8	,	,	PUNCT
chd-116	193	9	craig	craig	PROPN
chd-116	193	10	,	,	PUNCT
chd-116	193	11	d.	d.	PROPN
chd-116	193	12	,	,	PUNCT
chd-116	193	13	dombkowski	dombkowski	PROPN
chd-116	193	14	,	,	PUNCT
chd-116	193	15	a.	a.	NOUN
chd-116	193	16	,	,	PUNCT
chd-116	193	17	beebedimmer	beebedimmer	PROPN
chd-116	193	18	,	,	PUNCT
chd-116	193	19	j.l	j.l	PROPN
chd-116	193	20	.	.	PROPN
chd-116	193	21	,	,	PUNCT
chd-116	193	22	powell	powell	PROPN
chd-116	193	23	,	,	PUNCT
chd-116	193	24	i.j	i.j	PROPN
chd-116	193	25	.	.	PROPN
chd-116	193	26	,	,	PUNCT
chd-116	193	27	podgorski	podgorski	ADJ
chd-116	193	28	,	,	PUNCT
chd-116	193	29	i.	i.	NOUN
chd-116	193	30	,	,	PUNCT
chd-116	193	31	heilbrun	heilbrun	PROPN
chd-116	193	32	l.	l.	PROPN
chd-116	193	33	,	,	PUNCT
chd-116	193	34	bolton	bolton	PROPN
chd-116	193	35	,	,	PUNCT
chd-116	193	36	s.	s.	PROPN
chd-116	193	37	,	,	PUNCT
chd-116	193	38	and	and	CCONJ
chd-116	193	39	bock	bock	NOUN
chd-116	193	40	,	,	PUNCT
chd-116	193	41	c.h	c.h	PROPN
chd-116	193	42	.	.	PROPN
chd-116	193	43	(	(	PUNCT
chd-116	193	44	2018	2018	NUM
chd-116	193	45	)	)	PUNCT
chd-116	193	46	.	.	PUNCT
chd-116	194	1	a	a	DET
chd-116	194	2	study	study	NOUN
chd-116	194	3	of	of	ADP
chd-116	194	4	circulating	circulate	VERB
chd-116	194	5	micrornas	microrna	NOUN
chd-116	194	6	identifies	identify	VERB
chd-116	194	7	a	a	DET
chd-116	194	8	new	new	ADJ
chd-116	194	9	potential	potential	ADJ
chd-116	194	10	biomarker	biomarker	NOUN
chd-116	194	11	panel	panel	NOUN
chd-116	194	12	to	to	PART
chd-116	194	13	distinguish	distinguish	VERB
chd-116	194	14	aggressive	aggressive	ADJ
chd-116	194	15	prostate	prostate	NOUN
chd-116	194	16	cancer	cancer	NOUN
chd-116	194	17	.	.	PUNCT
chd-116	195	1	carcinogenesis	carcinogenesis	NOUN
chd-116	195	2	39	39	NUM
chd-116	195	3	,	,	PUNCT
chd-116	195	4	556–561	556–561	NUM
chd-116	195	5	farré	farré	NOUN
chd-116	195	6	,	,	PUNCT
chd-116	195	7	x.	x.	NOUN
chd-116	195	8	,	,	PUNCT
chd-116	195	9	and	and	CCONJ
chd-116	195	10	kibera	kibera	PROPN
chd-116	195	11	j.	j.	PROPN
chd-116	195	12	(	(	PUNCT
chd-116	195	13	2018	2018	NUM
chd-116	195	14	)	)	PUNCT
chd-116	195	15	.	.	PUNCT
chd-116	196	1	the	the	DET
chd-116	196	2	untapped	untapped	ADJ
chd-116	196	3	potential	potential	NOUN
chd-116	196	4	of	of	ADP
chd-116	196	5	digital	digital	ADJ
chd-116	196	6	pathology	pathology	NOUN
chd-116	196	7	in	in	ADP
chd-116	196	8	prostate	prostate	NOUN
chd-116	196	9	cancer	cancer	NOUN
chd-116	196	10	diagnosis	diagnosis	NOUN
chd-116	196	11	and	and	CCONJ
chd-116	196	12	medical	medical	ADJ
chd-116	196	13	education	education	NOUN
chd-116	196	14	in	in	ADP
chd-116	196	15	sub	sub	ADJ
chd-116	196	16	-	-	ADJ
chd-116	196	17	saharan	saharan	ADJ
chd-116	196	18	africa	africa	PROPN
chd-116	196	19	.	.	PUNCT
chd-116	197	1	african	african	PROPN
chd-116	197	2	journal	journal	PROPN
chd-116	197	3	of	of	ADP
chd-116	197	4	urology	urology	NOUN
chd-116	197	5	24	24	NUM
chd-116	197	6	,	,	PUNCT
chd-116	197	7	54	54	NUM
chd-116	197	8	-	-	SYM
chd-116	197	9	55	55	NUM
chd-116	197	10	ferlay	ferlay	NOUN
chd-116	197	11	,	,	PUNCT
chd-116	197	12	j.	j.	PROPN
chd-116	197	13	,	,	PUNCT
chd-116	197	14	soerjomataram	soerjomataram	PROPN
chd-116	197	15	,	,	PUNCT
chd-116	197	16	i.	i.	PROPN
chd-116	197	17	,	,	PUNCT
chd-116	197	18	dikshit	dikshit	PROPN
chd-116	197	19	,	,	PUNCT
chd-116	197	20	r.	r.	PROPN
chd-116	197	21	,	,	PUNCT
chd-116	197	22	eser	eser	NOUN
chd-116	197	23	,	,	PUNCT
chd-116	197	24	s.	s.	PROPN
chd-116	197	25	,	,	PUNCT
chd-116	197	26	mathers	mathers	PROPN
chd-116	197	27	,	,	PUNCT
chd-116	197	28	c.	c.	PROPN
chd-116	197	29	,	,	PUNCT
chd-116	197	30	rebelo	rebelo	NOUN
chd-116	197	31	,	,	PUNCT
chd-116	197	32	m.	m.	NOUN
chd-116	197	33	,	,	PUNCT
chd-116	197	34	parkin	parkin	NOUN
chd-116	197	35	,	,	PUNCT
chd-116	197	36	d.m	d.m	PROPN
chd-116	197	37	,	,	PUNCT
chd-116	197	38	,	,	PUNCT
chd-116	197	39	forman	forman	NOUN
chd-116	197	40	,	,	PUNCT
chd-116	197	41	d.	d.	PROPN
chd-116	197	42	,	,	PUNCT
chd-116	197	43	and	and	CCONJ
chd-116	197	44	bray	bray	PROPN
chd-116	197	45	,	,	PUNCT
chd-116	197	46	f.	f.	PROPN
chd-116	197	47	(	(	PUNCT
chd-116	197	48	2015	2015	NUM
chd-116	197	49	)	)	PUNCT
chd-116	197	50	.	.	PUNCT
chd-116	198	1	cancer	cancer	NOUN
chd-116	198	2	incidence	incidence	NOUN
chd-116	198	3	and	and	CCONJ
chd-116	198	4	mortality	mortality	NOUN
chd-116	198	5	worldwide	worldwide	ADV
chd-116	198	6	:	:	PUNCT
chd-116	198	7	sources	source	NOUN
chd-116	198	8	,	,	PUNCT
chd-116	198	9	methods	method	NOUN
chd-116	198	10	and	and	CCONJ
chd-116	198	11	major	major	ADJ
chd-116	198	12	patterns	pattern	NOUN
chd-116	198	13	in	in	ADP
chd-116	198	14	globocan	globocan	PROPN
chd-116	198	15	2012	2012	NUM
chd-116	198	16	.	.	PUNCT
chd-116	199	1	international	international	ADJ
chd-116	199	2	journal	journal	PROPN
chd-116	199	3	of	of	ADP
chd-116	199	4	cancer	cancer	NOUN
chd-116	199	5	136	136	NUM
chd-116	199	6	,	,	PUNCT
chd-116	199	7	e359	e359	PROPN
chd-116	199	8	-	-	PUNCT
chd-116	199	9	e386	e386	PROPN
chd-116	199	10	fradet	fradet	NOUN
chd-116	199	11	,	,	PUNCT
chd-116	199	12	v.	v.	PROPN
chd-116	199	13	,	,	PUNCT
chd-116	199	14	cheng	cheng	PROPN
chd-116	199	15	,	,	PUNCT
chd-116	199	16	i.	i.	PROPN
chd-116	199	17	,	,	PUNCT
chd-116	199	18	casey	casey	PROPN
chd-116	199	19	,	,	PUNCT
chd-116	199	20	g.	g.	PROPN
chd-116	199	21	,	,	PUNCT
chd-116	199	22	and	and	CCONJ
chd-116	199	23	witte	witte	NOUN
chd-116	199	24	,	,	PUNCT
chd-116	199	25	j.s	j.s	PROPN
chd-116	199	26	.	.	PROPN
chd-116	199	27	(	(	PUNCT
chd-116	199	28	2009	2009	NUM
chd-116	199	29	)	)	PUNCT
chd-116	199	30	.	.	PUNCT
chd-116	200	1	dietary	dietary	ADJ
chd-116	200	2	omega-3	omega-3	PRON
chd-116	200	3	fatty	fatty	NOUN
chd-116	200	4	acids	acid	NOUN
chd-116	200	5	,	,	PUNCT
chd-116	200	6	cyclooxygenase-2	cyclooxygenase-2	NUM
chd-116	200	7	genetic	genetic	ADJ
chd-116	200	8	variation	variation	NOUN
chd-116	200	9	,	,	PUNCT
chd-116	200	10	and	and	CCONJ
chd-116	200	11	aggressive	aggressive	ADJ
chd-116	200	12	prostate	prostate	NOUN
chd-116	200	13	cancer	cancer	NOUN
chd-116	200	14	risk	risk	NOUN
chd-116	200	15	.	.	PUNCT
chd-116	201	1	clinical	clinical	ADJ
chd-116	201	2	cancer	cancer	NOUN
chd-116	201	3	research	research	NOUN
chd-116	201	4	15	15	NUM
chd-116	201	5	,	,	PUNCT
chd-116	201	6	2559	2559	NUM
chd-116	201	7	-	-	SYM
chd-116	201	8	2566	2566	NUM
chd-116	201	9	.	.	PUNCT
chd-116	202	1	freedland	freedland	PROPN
chd-116	202	2	,	,	PUNCT
chd-116	202	3	s.j	s.j	PROPN
chd-116	202	4	.	.	PROPN
chd-116	202	5	,	,	PUNCT
chd-116	202	6	and	and	CCONJ
chd-116	202	7	aronson	aronson	PROPN
chd-116	202	8	,	,	PUNCT
chd-116	202	9	w.j	w.j	PROPN
chd-116	202	10	.	.	PROPN
chd-116	202	11	(	(	PUNCT
chd-116	202	12	2009	2009	NUM
chd-116	202	13	)	)	PUNCT
chd-116	202	14	.	.	PUNCT
chd-116	203	1	dietary	dietary	ADJ
chd-116	203	2	intervention	intervention	NOUN
chd-116	203	3	strategies	strategy	NOUN
chd-116	203	4	to	to	PART
chd-116	203	5	modulate	modulate	VERB
chd-116	203	6	prostate	prostate	NOUN
chd-116	203	7	cancer	cancer	NOUN
chd-116	203	8	risk	risk	NOUN
chd-116	203	9	and	and	CCONJ
chd-116	203	10	prognosis	prognosis	NOUN
chd-116	203	11	.	.	PUNCT
chd-116	204	1	current	current	ADJ
chd-116	204	2	opinion	opinion	NOUN
chd-116	204	3	in	in	ADP
chd-116	204	4	urology	urology	NOUN
chd-116	204	5	19	19	NUM
chd-116	204	6	,	,	PUNCT
chd-116	204	7	263	263	NUM
chd-116	204	8	-	-	SYM
chd-116	204	9	267	267	NUM
chd-116	204	10	.	.	PUNCT
chd-116	205	1	gaddipati	gaddipati	PROPN
chd-116	205	2	,	,	PUNCT
chd-116	205	3	j.p	j.p	PROPN
chd-116	205	4	.	.	PROPN
chd-116	205	5	,	,	PUNCT
chd-116	205	6	mcleod	mcleod	PROPN
chd-116	205	7	,	,	PUNCT
chd-116	205	8	d.g	d.g	PROPN
chd-116	205	9	.	.	PROPN
chd-116	205	10	,	,	PUNCT
chd-116	205	11	heidenberg	heidenberg	PROPN
chd-116	205	12	,	,	PUNCT
chd-116	205	13	h.b	h.b	PROPN
chd-116	205	14	.	.	PROPN
chd-116	205	15	,	,	PUNCT
chd-116	205	16	sesterhenn	sesterhenn	PROPN
chd-116	205	17	,	,	PUNCT
chd-116	205	18	i.a	i.a	PROPN
chd-116	205	19	.	.	PROPN
chd-116	205	20	,	,	PUNCT
chd-116	205	21	finger	finger	NOUN
chd-116	205	22	,	,	PUNCT
chd-116	205	23	m.j	m.j	PROPN
chd-116	205	24	.	.	PROPN
chd-116	205	25	,	,	PUNCT
chd-116	205	26	moul	moul	PROPN
chd-116	205	27	,	,	PUNCT
chd-116	205	28	j.w	j.w	PROPN
chd-116	205	29	.	.	PROPN
chd-116	205	30	,	,	PUNCT
chd-116	205	31	srivastava	srivastava	PROPN
chd-116	205	32	,	,	PUNCT
chd-116	205	33	s.	s.	PROPN
chd-116	205	34	(	(	PUNCT
chd-116	205	35	1994	1994	NUM
chd-116	205	36	)	)	PUNCT
chd-116	205	37	.	.	PUNCT
chd-116	206	1	frequent	frequent	ADJ
chd-116	206	2	detection	detection	NOUN
chd-116	206	3	of	of	ADP
chd-116	206	4	codon	codon	ADJ
chd-116	206	5	877	877	NUM
chd-116	206	6	mutation	mutation	NOUN
chd-116	206	7	in	in	ADP
chd-116	206	8	the	the	DET
chd-116	206	9	androgen	androgen	NOUN
chd-116	206	10	receptor	receptor	NOUN
chd-116	206	11	gene	gene	NOUN
chd-116	206	12	in	in	ADP
chd-116	206	13	advanced	advanced	ADJ
chd-116	206	14	prostate	prostate	NOUN
chd-116	206	15	cancers	cancer	NOUN
chd-116	206	16	.	.	PUNCT
chd-116	207	1	cancer	cancer	NOUN
chd-116	207	2	research	research	NOUN
chd-116	207	3	54	54	NUM
chd-116	207	4	,	,	PUNCT
chd-116	207	5	2861–2866	2861–2866	PROPN
chd-116	207	6	.	.	PUNCT
chd-116	207	7	gidron	gidron	PROPN
chd-116	207	8	,	,	PUNCT
chd-116	207	9	y	y	PROPN
chd-116	207	10	,	,	PUNCT
chd-116	207	11	.	.	PUNCT
chd-116	208	1	fabre	fabre	PROPN
chd-116	208	2	,	,	PUNCT
chd-116	208	3	b.	b.	PROPN
chd-116	208	4	,	,	PUNCT
chd-116	208	5	grosman	grosman	NOUN
chd-116	208	6	,	,	PUNCT
chd-116	208	7	h.	h.	PROPN
chd-116	208	8	,	,	PUNCT
chd-116	208	9	nolazco	nolazco	PROPN
chd-116	208	10	,	,	PUNCT
chd-116	208	11	c.	c.	PROPN
chd-116	208	12	,	,	PUNCT
chd-116	208	13	mesch	mesch	PROPN
chd-116	208	14	,	,	PUNCT
chd-116	208	15	v.	v.	PROPN
chd-116	208	16	,	,	PUNCT
chd-116	208	17	mazza	mazza	PROPN
chd-116	208	18	,	,	PUNCT
chd-116	208	19	o.	o.	PROPN
chd-116	208	20	,	,	PUNCT
chd-116	208	21	and	and	CCONJ
chd-116	208	22	berg	berg	PROPN
chd-116	208	23	,	,	PUNCT
chd-116	208	24	g.	g.	PROPN
chd-116	208	25	(	(	PUNCT
chd-116	208	26	2011	2011	NUM
chd-116	208	27	)	)	PUNCT
chd-116	208	28	.	.	PUNCT
chd-116	209	1	life	life	NOUN
chd-116	209	2	events	event	NOUN
chd-116	209	3	,	,	PUNCT
chd-116	209	4	cortisol	cortisol	NOUN
chd-116	209	5	and	and	CCONJ
chd-116	209	6	levels	level	NOUN
chd-116	209	7	of	of	ADP
chd-116	209	8	prostate	prostate	NOUN
chd-116	209	9	specific	specific	ADJ
chd-116	209	10	antigen	antigen	NOUN
chd-116	209	11	:	:	PUNCT
chd-116	209	12	a	a	DET
chd-116	209	13	story	story	NOUN
chd-116	209	14	of	of	ADP
chd-116	209	15	synergism	synergism	NOUN
chd-116	209	16	.	.	PUNCT
chd-116	210	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
chd-116	210	2	36	36	NUM
chd-116	210	3	,	,	PUNCT
chd-116	210	4	874	874	NUM
chd-116	210	5	-	-	SYM
chd-116	210	6	880	880	NUM
chd-116	210	7	.	.	PUNCT
chd-116	211	1	huang	huang	PROPN
chd-116	211	2	,	,	PUNCT
chd-116	211	3	y.	y.	PROPN
chd-116	211	4	,	,	PUNCT
chd-116	211	5	jiang	jiang	PROPN
chd-116	211	6	,	,	PUNCT
chd-116	211	7	x.	x.	PROPN
chd-116	211	8	,	,	PUNCT
chd-116	211	9	liang	liang	PROPN
chd-116	211	10	,	,	PUNCT
chd-116	211	11	x.	x.	PROPN
chd-116	211	12	,	,	PUNCT
chd-116	211	13	and	and	CCONJ
chd-116	211	14	jiang	jiang	PROPN
chd-116	211	15	g.	g.	PROPN
chd-116	211	16	(	(	PUNCT
chd-116	211	17	2018	2018	NUM
chd-116	211	18	)	)	PUNCT
chd-116	211	19	.	.	PUNCT
chd-116	212	1	molecular	molecular	ADJ
chd-116	212	2	and	and	CCONJ
chd-116	212	3	cellular	cellular	ADJ
chd-116	212	4	mechanisms	mechanism	NOUN
chd-116	212	5	of	of	ADP
chd-116	212	6	castration	castration	NOUN
chd-116	212	7	resistant	resistant	ADJ
chd-116	212	8	prostate	prostate	NOUN
chd-116	212	9	cancer	cancer	NOUN
chd-116	212	10	.	.	PUNCT
chd-116	213	1	oncology	oncology	NOUN
chd-116	213	2	letters	letter	NOUN
chd-116	213	3	.	.	PUNCT
chd-116	214	1	15	15	NUM
chd-116	214	2	,	,	PUNCT
chd-116	214	3	6063	6063	NUM
chd-116	214	4	-	-	SYM
chd-116	214	5	6076	6076	NUM
chd-116	214	6	kaninjing	kaninjing	NOUN
chd-116	214	7	,	,	PUNCT
chd-116	214	8	e.	e.	PROPN
chd-116	214	9	,	,	PUNCT
chd-116	214	10	rahman	rahman	PROPN
chd-116	214	11	,	,	PUNCT
chd-116	214	12	s.	s.	PROPN
chd-116	214	13	,	,	PUNCT
chd-116	214	14	close	close	ADJ
chd-116	214	15	,	,	PUNCT
chd-116	214	16	f.	f.	PROPN
chd-116	214	17	,	,	PUNCT
chd-116	214	18	pierre	pierre	PROPN
chd-116	214	19	,	,	PUNCT
chd-116	214	20	r.	r.	PROPN
chd-116	214	21	,	,	PUNCT
chd-116	214	22	dutton	dutton	PROPN
chd-116	214	23	,	,	PUNCT
chd-116	214	24	m.	m.	NOUN
chd-116	214	25	,	,	PUNCT
chd-116	214	26	lamango	lamango	PROPN
chd-116	214	27	,	,	PUNCT
chd-116	214	28	n.	n.	NOUN
chd-116	214	29	and	and	CCONJ
chd-116	214	30	onokpise	onokpise	PROPN
chd-116	214	31	,	,	PUNCT
chd-116	214	32	o.	o.	PROPN
chd-116	214	33	(	(	PUNCT
chd-116	214	34	2017	2017	NUM
chd-116	214	35	)	)	PUNCT
chd-116	214	36	.	.	PUNCT
chd-116	215	1	prostate	prostate	NOUN
chd-116	215	2	cancer	cancer	NOUN
chd-116	215	3	screening	screen	VERB
chd-116	215	4	knowledge	knowledge	NOUN
chd-116	215	5	,	,	PUNCT
chd-116	215	6	attitudes	attitude	NOUN
chd-116	215	7	,	,	PUNCT
chd-116	215	8	and	and	CCONJ
chd-116	215	9	beliefs	belief	NOUN
chd-116	215	10	among	among	ADP
chd-116	215	11	men	man	NOUN
chd-116	215	12	in	in	ADP
chd-116	215	13	bamenda	bamenda	NOUN
chd-116	215	14	,	,	PUNCT
chd-116	215	15	cameroon	cameroon	PROPN
chd-116	215	16	.	.	PUNCT
chd-116	216	1	international	international	ADJ
chd-116	216	2	journal	journal	PROPN
chd-116	216	3	of	of	ADP
chd-116	216	4	public	public	ADJ
chd-116	216	5	health	health	NOUN
chd-116	216	6	and	and	CCONJ
chd-116	216	7	epidemiology	epidemiology	NOUN
chd-116	216	8	6	6	NUM
chd-116	216	9	,	,	PUNCT
chd-116	216	10	339	339	NUM
chd-116	216	11	–	–	PUNCT
chd-116	216	12	349	349	NUM
chd-116	216	13	.	.	PUNCT
chd-116	217	1	kirschbaum	kirschbaum	PROPN
chd-116	217	2	,	,	PUNCT
chd-116	217	3	c.	c.	PROPN
chd-116	217	4	,	,	PUNCT
chd-116	217	5	and	and	CCONJ
chd-116	217	6	hellhammer	hellhammer	PROPN
chd-116	217	7	,	,	PUNCT
chd-116	217	8	d.h	d.h	PROPN
chd-116	217	9	.	.	PROPN
chd-116	217	10	(	(	PUNCT
chd-116	217	11	1999	1999	NUM
chd-116	217	12	)	)	PUNCT
chd-116	217	13	.	.	PUNCT
chd-116	218	1	noise	noise	NOUN
chd-116	218	2	and	and	CCONJ
chd-116	218	3	stress	stress	NOUN
chd-116	218	4	salivary	salivary	ADJ
chd-116	218	5	cortisol	cortisol	NOUN
chd-116	218	6	as	as	ADP
chd-116	218	7	a	a	DET
chd-116	218	8	non	non	ADJ
chd-116	218	9	-	-	ADJ
chd-116	218	10	invasive	invasive	ADJ
chd-116	218	11	measure	measure	NOUN
chd-116	218	12	of	of	ADP
chd-116	218	13	allostatic	allostatic	ADJ
chd-116	218	14	load	load	NOUN
chd-116	218	15	.	.	PUNCT
chd-116	219	1	noise	noise	NOUN
chd-116	219	2	health	health	NOUN
chd-116	219	3	1	1	NUM
chd-116	219	4	,	,	PUNCT
chd-116	219	5	57	57	NUM
chd-116	219	6	-	-	SYM
chd-116	219	7	65	65	NUM
chd-116	219	8	.	.	PUNCT
chd-116	220	1	kumar	kumar	PROPN
chd-116	220	2	,	,	PUNCT
chd-116	220	3	n.b	n.b	PROPN
chd-116	220	4	.	.	PROPN
chd-116	220	5	,	,	PUNCT
chd-116	220	6	yu	yu	PROPN
chd-116	220	7	,	,	PUNCT
chd-116	220	8	d.	d.	PROPN
chd-116	220	9	,	,	PUNCT
chd-116	220	10	akinremi	akinremi	PROPN
chd-116	220	11	,	,	PUNCT
chd-116	220	12	t.o	t.o	PROPN
chd-116	220	13	.	.	PROPN
chd-116	220	14	,	,	PUNCT
chd-116	220	15	and	and	CCONJ
chd-116	220	16	odedina	odedina	PROPN
chd-116	220	17	,	,	PUNCT
chd-116	220	18	f.t	f.t	PROPN
chd-116	220	19	.	.	PUNCT
chd-116	220	20	(	(	PUNCT
chd-116	220	21	2009	2009	NUM
chd-116	220	22	)	)	PUNCT
chd-116	220	23	.	.	PUNCT
chd-116	221	1	comparing	compare	VERB
chd-116	221	2	dietary	dietary	ADJ
chd-116	221	3	and	and	CCONJ
chd-116	221	4	other	other	ADJ
chd-116	221	5	lifestyle	lifestyle	NOUN
chd-116	221	6	factors	factor	NOUN
chd-116	221	7	among	among	ADP
chd-116	221	8	immigrant	immigrant	ADJ
chd-116	221	9	nigerian	nigerian	ADJ
chd-116	221	10	men	man	NOUN
chd-116	221	11	living	live	VERB
chd-116	221	12	in	in	ADP
chd-116	221	13	the	the	DET
chd-116	221	14	us	us	PROPN
chd-116	221	15	and	and	CCONJ
chd-116	221	16	indigenous	indigenous	ADJ
chd-116	221	17	men	man	NOUN
chd-116	221	18	from	from	ADP
chd-116	221	19	nigeria	nigeria	PRON
chd-116	221	20	:	:	PUNCT
chd-116	221	21	potential	potential	ADJ
chd-116	221	22	implications	implication	NOUN
chd-116	221	23	for	for	ADP
chd-116	221	24	prostate	prostate	NOUN
chd-116	221	25	cancer	cancer	NOUN
chd-116	221	26	risk	risk	NOUN
chd-116	221	27	reduction	reduction	NOUN
chd-116	221	28	.	.	PUNCT
chd-116	222	1	journal	journal	NOUN
chd-116	222	2	of	of	ADP
chd-116	222	3	immigrant	immigrant	NOUN
chd-116	222	4	and	and	CCONJ
chd-116	222	5	minority	minority	NOUN
chd-116	222	6	health	health	NOUN
chd-116	222	7	.	.	PUNCT
chd-116	223	1	journal	journal	PROPN
chd-116	223	2	of	of	ADP
chd-116	223	3	immigrant	immigrant	NOUN
chd-116	223	4	and	and	CCONJ
chd-116	223	5	minority	minority	NOUN
chd-116	223	6	health	health	NOUN
chd-116	223	7	11	11	NUM
chd-116	223	8	,	,	PUNCT
chd-116	223	9	391399	391399	NUM
chd-116	223	10	.	.	PUNCT
chd-116	224	1	moul	moul	PROPN
chd-116	224	2	,	,	PUNCT
chd-116	224	3	j.w	j.w	PROPN
chd-116	224	4	.	.	PROPN
chd-116	224	5	,	,	PUNCT
chd-116	224	6	sesterhenn	sesterhenn	PROPN
chd-116	224	7	,	,	PUNCT
chd-116	224	8	i.a	i.a	PROPN
chd-116	224	9	.	.	PROPN
chd-116	224	10	,	,	PUNCT
chd-116	224	11	connelly	connelly	PROPN
chd-116	224	12	,	,	PUNCT
chd-116	224	13	r.r	r.r	PROPN
chd-116	224	14	.	.	PROPN
chd-116	224	15	,	,	PUNCT
chd-116	224	16	douglas	douglas	PROPN
chd-116	224	17	,	,	PUNCT
chd-116	224	18	t.	t.	PROPN
chd-116	224	19	,	,	PUNCT
chd-116	224	20	srivastava	srivastava	PROPN
chd-116	224	21	,	,	PUNCT
chd-116	224	22	s.	s.	PROPN
chd-116	224	23	,	,	PUNCT
chd-116	224	24	mostofi	mostofi	NOUN
chd-116	224	25	,	,	PUNCT
chd-116	224	26	f.k	f.k	PROPN
chd-116	224	27	.	.	PROPN
chd-116	224	28	,	,	PUNCT
chd-116	224	29	and	and	CCONJ
chd-116	224	30	mcleod	mcleod	PROPN
chd-116	224	31	,	,	PUNCT
chd-116	224	32	d.g	d.g	PROPN
chd-116	224	33	.	.	PROPN
chd-116	224	34	(	(	PUNCT
chd-116	224	35	1995	1995	NUM
chd-116	224	36	)	)	PUNCT
chd-116	224	37	.	.	PUNCT
chd-116	225	1	prostate	prostate	NOUN
chd-116	225	2	-	-	PUNCT
chd-116	225	3	specific	specific	ADJ
chd-116	225	4	antigen	antigen	ADJ
chd-116	225	5	values	value	NOUN
chd-116	225	6	at	at	ADP
chd-116	225	7	the	the	DET
chd-116	225	8	time	time	NOUN
chd-116	225	9	of	of	ADP
chd-116	225	10	prostate	prostate	NOUN
chd-116	225	11	cancer	cancer	NOUN
chd-116	225	12	diagnosis	diagnosis	NOUN
chd-116	225	13	in	in	ADP
chd-116	225	14	african	african	ADJ
chd-116	225	15	-	-	PUNCT
chd-116	225	16	american	american	ADJ
chd-116	225	17	men	man	NOUN
chd-116	225	18	.	.	PUNCT
chd-116	226	1	journal	journal	PROPN
chd-116	226	2	of	of	ADP
chd-116	226	3	the	the	DET
chd-116	226	4	american	american	PROPN
chd-116	226	5	medical	medical	PROPN
chd-116	226	6	association	association	PROPN
chd-116	226	7	274	274	NUM
chd-116	226	8	,	,	PUNCT
chd-116	226	9	1277	1277	NUM
chd-116	226	10	-	-	SYM
chd-116	226	11	1281	1281	NUM
chd-116	226	12	.	.	PUNCT
chd-116	227	1	munck	munck	NOUN
chd-116	227	2	,	,	PUNCT
chd-116	227	3	a	a	DET
chd-116	227	4	,	,	PUNCT
chd-116	227	5	naray	naray	ADJ
chd-116	227	6	-	-	PUNCT
chd-116	227	7	fejes	feje	NOUN
chd-116	227	8	-	-	PUNCT
chd-116	227	9	toth	toth	PROPN
chd-116	227	10	,	,	PUNCT
chd-116	227	11	a.	a.	NOUN
chd-116	227	12	glucocorticoid	glucocorticoid	PROPN
chd-116	227	13	action	action	NOUN
chd-116	227	14	in	in	ADP
chd-116	227	15	endocrinology	endocrinology	NOUN
chd-116	227	16	3rd	3rd	ADJ
chd-116	227	17	edn	edn	NOUN
chd-116	228	1	(	(	PUNCT
chd-116	228	2	ed	ed	NOUN
chd-116	228	3	.	.	PUNCT
chd-116	228	4	degroot	degroot	PROPN
chd-116	228	5	,	,	PUNCT
chd-116	228	6	l.	l.	PROPN
chd-116	228	7	)	)	PUNCT
chd-116	228	8	1642–1654	1642–1654	PROPN
chd-116	228	9	(	(	PUNCT
chd-116	228	10	w.b	w.b	PROPN
chd-116	228	11	.	.	PROPN
chd-116	228	12	saunders	saunders	PROPN
chd-116	228	13	co,1995	co,1995	PROPN
chd-116	228	14	)	)	PUNCT
chd-116	228	15	.	.	PUNCT
chd-116	229	1	odedina	odedina	PROPN
chd-116	229	2	,	,	PUNCT
chd-116	229	3	ft	ft	PROPN
chd-116	229	4	.	.	PROPN
chd-116	229	5	,	,	PUNCT
chd-116	229	6	yu	yu	PROPN
chd-116	229	7	,	,	PUNCT
chd-116	229	8	d.	d.	PROPN
chd-116	229	9	,	,	PUNCT
chd-116	229	10	akinremi	akinremi	PROPN
chd-116	229	11	,	,	PUNCT
chd-116	229	12	t.o	t.o	PROPN
chd-116	229	13	.	.	PROPN
chd-116	229	14	,	,	PUNCT
chd-116	229	15	reams	ream	NOUN
chd-116	229	16	,	,	PUNCT
chd-116	229	17	r.r	r.r	PROPN
chd-116	229	18	.	.	PROPN
chd-116	229	19	,	,	PUNCT
chd-116	229	20	freedman	freedman	PROPN
chd-116	229	21	,	,	PUNCT
chd-116	229	22	m.l	m.l	PROPN
chd-116	229	23	.	.	PROPN
chd-116	229	24	,	,	PUNCT
chd-116	229	25	and	and	CCONJ
chd-116	229	26	kumar	kumar	PROPN
chd-116	229	27	,	,	PUNCT
chd-116	229	28	n.	n.	PROPN
chd-116	229	29	(	(	PUNCT
chd-116	229	30	2009	2009	NUM
chd-116	229	31	)	)	PUNCT
chd-116	229	32	.	.	PUNCT
chd-116	230	1	(	(	PUNCT
chd-116	230	2	a	a	X
chd-116	230	3	)	)	PUNCT
chd-116	230	4	.	.	PUNCT
chd-116	231	1	prostate	prostate	NOUN
chd-116	231	2	cancer	cancer	NOUN
chd-116	231	3	cognitive	cognitive	ADJ
chd-116	231	4	-	-	PUNCT
chd-116	231	5	behavioral	behavioral	ADJ
chd-116	231	6	factors	factor	NOUN
chd-116	231	7	in	in	ADP
chd-116	231	8	a	a	DET
chd-116	231	9	west	west	ADJ
chd-116	231	10	african	african	ADJ
chd-116	231	11	population	population	NOUN
chd-116	231	12	.	.	PUNCT
chd-116	232	1	journal	journal	PROPN
chd-116	232	2	of	of	ADP
chd-116	232	3	immigrant	immigrant	NOUN
chd-116	232	4	and	and	CCONJ
chd-116	232	5	minority	minority	NOUN
chd-116	232	6	health	health	NOUN
chd-116	232	7	11	11	NUM
chd-116	232	8	,	,	PUNCT
chd-116	232	9	258	258	NUM
chd-116	232	10	-	-	SYM
chd-116	232	11	267	267	NUM
chd-116	232	12	.	.	PUNCT
chd-116	232	13	odedina	odedina	PROPN
chd-116	232	14	,	,	PUNCT
chd-116	232	15	f.t	f.t	PROPN
chd-116	232	16	.	.	PROPN
chd-116	232	17	,	,	PUNCT
chd-116	232	18	akinremi	akinremi	PROPN
chd-116	232	19	,	,	PUNCT
chd-116	232	20	t.o	t.o	PROPN
chd-116	232	21	.	.	PROPN
chd-116	232	22	,	,	PUNCT
chd-116	232	23	chinegwundoh	chinegwundoh	PROPN
chd-116	232	24	,	,	PUNCT
chd-116	232	25	f.	f.	PROPN
chd-116	232	26	,	,	PUNCT
chd-116	232	27	roberts	roberts	PROPN
chd-116	232	28	,	,	PUNCT
chd-116	232	29	r.	r.	PROPN
chd-116	232	30	,	,	PUNCT
chd-116	232	31	yu	yu	PROPN
chd-116	232	32	,	,	PUNCT
chd-116	232	33	d.	d.	PROPN
chd-116	232	34	,	,	PUNCT
chd-116	232	35	reams	ream	NOUN
chd-116	232	36	,	,	PUNCT
chd-116	232	37	r.r	r.r	PROPN
chd-116	232	38	.	.	PROPN
chd-116	232	39	,	,	PUNCT
chd-116	232	40	freedman	freedman	PROPN
chd-116	232	41	,	,	PUNCT
chd-116	232	42	m.l	m.l	PROPN
chd-116	232	43	.	.	PROPN
chd-116	232	44	,	,	PUNCT
chd-116	232	45	rivers	river	NOUN
chd-116	232	46	,	,	PUNCT
chd-116	232	47	b.	b.	PROPN
chd-116	232	48	,	,	PUNCT
chd-116	232	49	green	green	ADJ
chd-116	232	50	,	,	PUNCT
chd-116	232	51	l.b	l.b	PROPN
chd-116	232	52	.	.	PROPN
chd-116	232	53	,	,	PUNCT
chd-116	232	54	and	and	CCONJ
chd-116	232	55	kumar	kumar	PROPN
chd-116	232	56	n.	n.	PROPN
chd-116	232	57	(	(	PUNCT
chd-116	232	58	2009	2009	NUM
chd-116	232	59	)	)	PUNCT
chd-116	232	60	.	.	PUNCT
chd-116	233	1	(	(	PUNCT
chd-116	233	2	b	b	NOUN
chd-116	233	3	)	)	PUNCT
chd-116	233	4	.	.	PUNCT
chd-116	234	1	prostate	prostate	NOUN
chd-116	234	2	cancer	cancer	NOUN
chd-116	234	3	disparities	disparity	NOUN
chd-116	234	4	in	in	ADP
chd-116	234	5	black	black	ADJ
chd-116	234	6	men	man	NOUN
chd-116	234	7	of	of	ADP
chd-116	234	8	african	african	ADJ
chd-116	234	9	descent	descent	NOUN
chd-116	234	10	:	:	PUNCT
chd-116	234	11	a	a	DET
chd-116	234	12	comparative	comparative	ADJ
chd-116	234	13	literature	literature	NOUN
chd-116	234	14	review	review	NOUN
chd-116	234	15	of	of	ADP
chd-116	234	16	prostate	prostate	NOUN
chd-116	234	17	cancer	cancer	NOUN
chd-116	234	18	burden	burden	NOUN
chd-116	234	19	among	among	ADP
chd-116	234	20	black	black	ADJ
chd-116	234	21	men	man	NOUN
chd-116	234	22	in	in	ADP
chd-116	234	23	the	the	DET
chd-116	234	24	united	united	PROPN
chd-116	234	25	states	states	PROPN
chd-116	234	26	,	,	PUNCT
chd-116	234	27	caribbean	caribbean	PROPN
chd-116	234	28	,	,	PUNCT
chd-116	234	29	united	united	ADJ
chd-116	234	30	kingdom	kingdom	NOUN
chd-116	234	31	,	,	PUNCT
chd-116	234	32	and	and	CCONJ
chd-116	234	33	west	west	PROPN
chd-116	234	34	africa	africa	PROPN
chd-116	234	35	.	.	PUNCT
chd-116	235	1	infectious	infectious	ADJ
chd-116	235	2	agents	agent	NOUN
chd-116	235	3	and	and	CCONJ
chd-116	235	4	cancer	cancer	NOUN
chd-116	235	5	2009	2009	NUM
chd-116	235	6	,	,	PUNCT
chd-116	235	7	4	4	NUM
chd-116	235	8	(	(	PUNCT
chd-116	235	9	suppl	suppl	PROPN
chd-116	235	10	1):s2	1):s2	NUM
chd-116	235	11	.	.	PUNCT
chd-116	235	12	odedina	odedina	PROPN
chd-116	235	13	,	,	PUNCT
chd-116	235	14	f.t	f.t	PROPN
chd-116	235	15	.	.	PROPN
chd-116	235	16	,	,	PUNCT
chd-116	235	17	dagne	dagne	PROPN
chd-116	235	18	,	,	PUNCT
chd-116	235	19	g.	g.	PROPN
chd-116	235	20	,	,	PUNCT
chd-116	235	21	pressey	pressey	PROPN
chd-116	235	22	,	,	PUNCT
chd-116	235	23	s.	s.	PROPN
chd-116	235	24	,	,	PUNCT
chd-116	235	25	odedina	odedina	PROPN
chd-116	235	26	,	,	PUNCT
chd-116	235	27	o.	o.	PROPN
chd-116	235	28	,	,	PUNCT
chd-116	235	29	emanuel	emanuel	PROPN
chd-116	235	30	,	,	PUNCT
chd-116	235	31	f.	f.	PROPN
chd-116	235	32	,	,	PUNCT
chd-116	235	33	scrivens	scrivens	PROPN
chd-116	235	34	,	,	PUNCT
chd-116	235	35	j.	j.	PROPN
chd-116	235	36	,	,	PUNCT
chd-116	235	37	reams	ream	NOUN
chd-116	235	38	,	,	PUNCT
chd-116	235	39	r.r	r.r	PROPN
chd-116	235	40	,	,	PUNCT
chd-116	235	41	adams	adams	PROPN
chd-116	235	42	,	,	PUNCT
chd-116	235	43	a.	a.	NOUN
chd-116	235	44	,	,	PUNCT
chd-116	235	45	and	and	CCONJ
chd-116	235	46	larose	larose	NOUN
chd-116	235	47	-	-	PUNCT
chd-116	235	48	pierre	pierre	NOUN
chd-116	235	49	,	,	PUNCT
chd-116	235	50	m.	m.	NOUN
chd-116	235	51	(	(	PUNCT
chd-116	235	52	2011	2011	NUM
chd-116	235	53	)	)	PUNCT
chd-116	235	54	.	.	PUNCT
chd-116	236	1	(	(	PUNCT
chd-116	236	2	a	a	X
chd-116	236	3	)	)	PUNCT
chd-116	236	4	.	.	PUNCT
chd-116	237	1	prostate	prostate	NOUN
chd-116	237	2	cancer	cancer	NOUN
chd-116	237	3	health	health	PROPN
chd-116	237	4	and	and	CCONJ
chd-116	237	5	cultural	cultural	ADJ
chd-116	237	6	beliefs	belief	NOUN
chd-116	237	7	of	of	ADP
chd-116	237	8	black	black	ADJ
chd-116	237	9	men	man	NOUN
chd-116	237	10	:	:	PUNCT
chd-116	237	11	the	the	DET
chd-116	237	12	florida	florida	PROPN
chd-116	237	13	prostate	prostate	NOUN
chd-116	237	14	cancer	cancer	NOUN
chd-116	237	15	disparity	disparity	NOUN
chd-116	237	16	project	project	NOUN
chd-116	237	17	.	.	PUNCT
chd-116	238	1	infectious	infectious	ADJ
chd-116	238	2	agents	agent	NOUN
chd-116	238	3	and	and	CCONJ
chd-116	238	4	cancer	cancer	NOUN
chd-116	238	5	2011	2011	NUM
chd-116	238	6	,	,	PUNCT
chd-116	238	7	6(suppl	6(suppl	PROPN
chd-116	238	8	2):s10	2):s10	NUM
chd-116	238	9	.	.	PUNCT
chd-116	238	10	odedina	odedina	PROPN
chd-116	238	11	,	,	PUNCT
chd-116	238	12	f.t	f.t	PROPN
chd-116	238	13	.	.	PROPN
chd-116	238	14	,	,	PUNCT
chd-116	238	15	dagne	dagne	PROPN
chd-116	238	16	,	,	PUNCT
chd-116	238	17	g.	g.	PROPN
chd-116	238	18	,	,	PUNCT
chd-116	238	19	larose	larose	NOUN
chd-116	238	20	-	-	PUNCT
chd-116	238	21	pierre	pierre	NOUN
chd-116	238	22	,	,	PUNCT
chd-116	238	23	m.	m.	NOUN
chd-116	238	24	,	,	PUNCT
chd-116	238	25	emanuel	emanuel	PROPN
chd-116	238	26	,	,	PUNCT
chd-116	238	27	f.	f.	PROPN
chd-116	238	28	,	,	PUNCT
chd-116	238	29	scrivens	scrivens	PROPN
chd-116	238	30	,	,	PUNCT
chd-116	238	31	j.	j.	PROPN
chd-116	238	32	,	,	PUNCT
chd-116	238	33	adams	adams	PROPN
chd-116	238	34	,	,	PUNCT
chd-116	238	35	a.	a.	PROPN
chd-116	238	36	,	,	PUNCT
chd-116	238	37	pressey	pressey	PROPN
chd-116	238	38	,	,	PUNCT
chd-116	238	39	s.	s.	PROPN
chd-116	238	40	,	,	PUNCT
chd-116	238	41	odedina	odedina	PROPN
chd-116	238	42	,	,	PUNCT
chd-116	238	43	o.	o.	PROPN
chd-116	238	44	(	(	PUNCT
chd-116	238	45	2011	2011	NUM
chd-116	238	46	)	)	PUNCT
chd-116	238	47	.	.	PUNCT
chd-116	239	1	(	(	PUNCT
chd-116	239	2	b	b	NOUN
chd-116	239	3	)	)	PUNCT
chd-116	239	4	.	.	PUNCT
chd-116	240	1	within	within	ADP
chd-116	240	2	-	-	PUNCT
chd-116	240	3	group	group	NOUN
chd-116	240	4	differences	difference	NOUN
chd-116	240	5	between	between	ADP
chd-116	240	6	native	native	NOUN
chd-116	240	7	-	-	PUNCT
chd-116	240	8	born	bear	VERB
chd-116	240	9	and	and	CCONJ
chd-116	240	10	foreign	foreign	ADJ
chd-116	240	11	-	-	PUNCT
chd-116	240	12	born	bear	VERB
chd-116	240	13	black	black	ADJ
chd-116	240	14	men	man	NOUN
chd-116	240	15	on	on	ADP
chd-116	240	16	prostate	prostate	NOUN
chd-116	240	17	cancer	cancer	NOUN
chd-116	240	18	risk	risk	NOUN
chd-116	240	19	reduction	reduction	NOUN
chd-116	240	20	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-116	240	21	e17	e17	NOUN
chd-116	240	22	cancer	cancer	NOUN
chd-116	240	23	health	health	NOUN
chd-116	240	24	disparities	disparity	NOUN
chd-116	240	25	research	research	NOUN
chd-116	240	26	and	and	CCONJ
chd-116	240	27	early	early	ADJ
chd-116	240	28	detection	detection	NOUN
chd-116	240	29	practices	practice	NOUN
chd-116	240	30	.	.	PUNCT
chd-116	241	1	journal	journal	NOUN
chd-116	241	2	of	of	ADP
chd-116	241	3	immigrant	immigrant	NOUN
chd-116	241	4	and	and	CCONJ
chd-116	241	5	minority	minority	NOUN
chd-116	241	6	health	health	NOUN
chd-116	241	7	13	13	NUM
chd-116	241	8	,	,	PUNCT
chd-116	241	9	996	996	NUM
chd-116	241	10	-	-	SYM
chd-116	241	11	1004	1004	NUM
chd-116	241	12	.	.	PUNCT
chd-116	242	1	odedina	odedina	PROPN
chd-116	242	2	,	,	PUNCT
chd-116	242	3	f.t	f.t	PROPN
chd-116	242	4	.	.	PROPN
chd-116	242	5	,	,	PUNCT
chd-116	242	6	young	young	PROPN
chd-116	242	7	,	,	PUNCT
chd-116	242	8	m.e	m.e	PROPN
chd-116	242	9	.	.	PROPN
chd-116	242	10	,	,	PUNCT
chd-116	242	11	pereira	pereira	PROPN
chd-116	242	12	,	,	PUNCT
chd-116	242	13	d.	d.	PROPN
chd-116	242	14	,	,	PUNCT
chd-116	242	15	williams	williams	PROPN
chd-116	242	16	,	,	PUNCT
chd-116	242	17	c.	c.	PROPN
chd-116	242	18	,	,	PUNCT
chd-116	242	19	nguyen	nguyen	PROPN
chd-116	242	20	,	,	PUNCT
chd-116	242	21	j.	j.	PROPN
chd-116	242	22	,	,	PUNCT
chd-116	242	23	and	and	CCONJ
chd-116	242	24	dagne	dagne	PROPN
chd-116	242	25	g.	g.	PROPN
chd-116	242	26	(	(	PUNCT
chd-116	242	27	2017	2017	NUM
chd-116	242	28	)	)	PUNCT
chd-116	242	29	.	.	PUNCT
chd-116	243	1	point	point	NOUN
chd-116	243	2	of	of	ADP
chd-116	243	3	prostate	prostate	NOUN
chd-116	243	4	cancer	cancer	NOUN
chd-116	243	5	diagnosis	diagnosis	NOUN
chd-116	243	6	(	(	PUNCT
chd-116	243	7	ppcd	ppcd	NOUN
chd-116	243	8	)	)	PUNCT
chd-116	243	9	experiences	experience	NOUN
chd-116	243	10	of	of	ADP
chd-116	243	11	black	black	ADJ
chd-116	243	12	men	man	NOUN
chd-116	243	13	:	:	PUNCT
chd-116	243	14	the	the	DET
chd-116	243	15	florida	florida	PROPN
chd-116	243	16	capcas	capcas	PROPN
chd-116	243	17	study	study	NOUN
chd-116	243	18	.	.	PUNCT
chd-116	244	1	journal	journal	NOUN
chd-116	244	2	of	of	ADP
chd-116	244	3	community	community	NOUN
chd-116	244	4	and	and	CCONJ
chd-116	244	5	supportive	supportive	ADJ
chd-116	244	6	oncology	oncology	NOUN
chd-116	244	7	15	15	NUM
chd-116	244	8	,	,	PUNCT
chd-116	244	9	10	10	NUM
chd-116	244	10	-	-	SYM
chd-116	244	11	19	19	NUM
chd-116	244	12	.	.	PUNCT
chd-116	245	1	tai	tai	PROPN
chd-116	245	2	,	,	PUNCT
chd-116	245	3	s.y	s.y	PROPN
chd-116	245	4	.	.	PROPN
chd-116	245	5	,	,	PUNCT
chd-116	245	6	huang	huang	PROPN
chd-116	245	7	,	,	PUNCT
chd-116	245	8	s.p	s.p	PROPN
chd-116	245	9	.	.	PROPN
chd-116	245	10	,	,	PUNCT
chd-116	245	11	bao	bao	PROPN
chd-116	245	12	,	,	PUNCT
chd-116	245	13	b.y	b.y	PROPN
chd-116	245	14	.	.	PROPN
chd-116	245	15	,	,	PUNCT
chd-116	245	16	and	and	CCONJ
chd-116	245	17	wu	wu	PROPN
chd-116	245	18	,	,	PUNCT
chd-116	245	19	m.	m.	NOUN
chd-116	245	20	(	(	PUNCT
chd-116	245	21	2016	2016	NUM
chd-116	245	22	.	.	PUNCT
chd-116	245	23	)	)	PUNCT
chd-116	246	1	urinary	urinary	ADJ
chd-116	246	2	melatonin	melatonin	NOUN
chd-116	246	3	-	-	PUNCT
chd-116	246	4	sulfate	sulfate	NOUN
chd-116	246	5	/	/	SYM
chd-116	246	6	cortisol	cortisol	NOUN
chd-116	246	7	ratio	ratio	NOUN
chd-116	246	8	and	and	CCONJ
chd-116	246	9	the	the	DET
chd-116	246	10	presence	presence	NOUN
chd-116	246	11	of	of	ADP
chd-116	246	12	prostate	prostate	NOUN
chd-116	246	13	cancer	cancer	NOUN
chd-116	246	14	:	:	PUNCT
chd-116	246	15	a	a	DET
chd-116	246	16	case	case	NOUN
chd-116	246	17	-	-	PUNCT
chd-116	246	18	control	control	NOUN
chd-116	246	19	study	study	NOUN
chd-116	246	20	.	.	PUNCT
chd-116	247	1	scientific	scientific	ADJ
chd-116	247	2	reports	report	NOUN
chd-116	247	3	6	6	NUM
chd-116	247	4	,	,	PUNCT
chd-116	247	5	29606	29606	NUM
chd-116	247	6	.	.	PUNCT
chd-116	248	1	tee	tee	NOUN
chd-116	248	2	,	,	PUNCT
chd-116	248	3	a.r	a.r	PROPN
chd-116	248	4	.	.	PROPN
chd-116	248	5	(	(	PUNCT
chd-116	248	6	2013	2013	NUM
chd-116	248	7	)	)	PUNCT
chd-116	248	8	.	.	PUNCT
chd-116	249	1	metastatic	metastatic	ADJ
chd-116	249	2	castration	castration	NOUN
chd-116	249	3	-	-	PUNCT
chd-116	249	4	resistant	resistant	ADJ
chd-116	249	5	prostate	prostate	NOUN
chd-116	249	6	cancer	cancer	NOUN
chd-116	249	7	hungers	hunger	NOUN
chd-116	249	8	for	for	ADP
chd-116	249	9	leucine	leucine	NOUN
chd-116	249	10	.	.	PUNCT
chd-116	250	1	journal	journal	PROPN
chd-116	250	2	of	of	ADP
chd-116	250	3	the	the	DET
chd-116	250	4	national	national	PROPN
chd-116	250	5	cancer	cancer	PROPN
chd-116	250	6	institute	institute	PROPN
chd-116	250	7	105	105	NUM
chd-116	250	8	,	,	PUNCT
chd-116	250	9	1427–1428	1427–1428	NUM
chd-116	250	10	.	.	PUNCT
chd-116	251	1	touitou	touitou	PROPN
chd-116	251	2	,	,	PUNCT
chd-116	251	3	y.	y.	PROPN
chd-116	251	4	,	,	PUNCT
chd-116	251	5	sulon	sulon	PROPN
chd-116	251	6	,	,	PUNCT
chd-116	251	7	j.	j.	PROPN
chd-116	251	8	,	,	PUNCT
chd-116	251	9	bogdan	bogdan	PROPN
chd-116	251	10	,	,	PUNCT
chd-116	251	11	a.	a.	PROPN
chd-116	251	12	,	,	PUNCT
chd-116	251	13	reinberg	reinberg	PROPN
chd-116	251	14	,	,	PUNCT
chd-116	251	15	a.	a.	NOUN
chd-116	251	16	,	,	PUNCT
chd-116	251	17	sodoyez	sodoyez	NOUN
chd-116	251	18	,	,	PUNCT
chd-116	251	19	j.c	j.c	PROPN
chd-116	251	20	.	.	PROPN
chd-116	251	21	,	,	PUNCT
chd-116	251	22	and	and	CCONJ
chd-116	251	23	demey	demey	ADJ
chd-116	251	24	-	-	PUNCT
chd-116	251	25	ponsart	ponsart	NOUN
chd-116	251	26	,	,	PUNCT
chd-116	251	27	e.	e.	PROPN
chd-116	251	28	(	(	PUNCT
chd-116	251	29	1983	1983	NUM
chd-116	251	30	)	)	PUNCT
chd-116	251	31	.	.	PUNCT
chd-116	252	1	adrenocortical	adrenocortical	ADJ
chd-116	252	2	hormones	hormone	NOUN
chd-116	252	3	,	,	PUNCT
chd-116	252	4	ageing	age	VERB
chd-116	252	5	and	and	CCONJ
chd-116	252	6	mental	mental	ADJ
chd-116	252	7	condition	condition	NOUN
chd-116	252	8	:	:	PUNCT
chd-116	252	9	seasonal	seasonal	ADJ
chd-116	252	10	and	and	CCONJ
chd-116	252	11	circadian	circadian	ADJ
chd-116	252	12	rhythms	rhythm	NOUN
chd-116	252	13	of	of	ADP
chd-116	252	14	plasma	plasma	NOUN
chd-116	252	15	18	18	NUM
chd-116	252	16	-	-	PUNCT
chd-116	252	17	hydroxy-11	hydroxy-11	NOUN
chd-116	252	18	-	-	PUNCT
chd-116	252	19	deoxycorticosterone	deoxycorticosterone	ADJ
chd-116	252	20	,	,	PUNCT
chd-116	252	21	total	total	ADJ
chd-116	252	22	and	and	CCONJ
chd-116	252	23	free	free	ADJ
chd-116	252	24	cortisol	cortisol	NOUN
chd-116	252	25	and	and	CCONJ
chd-116	252	26	urinary	urinary	ADJ
chd-116	252	27	corticosteroids	corticosteroid	NOUN
chd-116	252	28	.	.	PUNCT
chd-116	253	1	journal	journal	NOUN
chd-116	253	2	of	of	ADP
chd-116	253	3	endocrinology	endocrinology	NOUN
chd-116	253	4	,	,	PUNCT
chd-116	253	5	96	96	NUM
chd-116	253	6	,	,	PUNCT
chd-116	253	7	53–64	53–64	NUM
chd-116	253	8	.	.	PUNCT
chd-116	254	1	us	us	PROPN
chd-116	254	2	preventive	preventive	ADJ
chd-116	254	3	services	service	NOUN
chd-116	254	4	task	task	PROPN
chd-116	254	5	force	force	PROPN
chd-116	254	6	recommendation	recommendation	NOUN
chd-116	254	7	statement	statement	NOUN
chd-116	254	8	.	.	PUNCT
chd-116	255	1	(	(	PUNCT
chd-116	255	2	2018	2018	NUM
chd-116	255	3	)	)	PUNCT
chd-116	255	4	.	.	PUNCT
chd-116	256	1	screening	screen	VERB
chd-116	256	2	for	for	ADP
chd-116	256	3	prostate	prostate	NOUN
chd-116	256	4	cancer	cancer	NOUN
chd-116	256	5	.	.	PUNCT
chd-116	257	1	journal	journal	NOUN
chd-116	257	2	of	of	ADP
chd-116	257	3	the	the	DET
chd-116	257	4	american	american	PROPN
chd-116	257	5	medical	medical	PROPN
chd-116	257	6	association	association	PROPN
chd-116	257	7	319	319	NUM
chd-116	257	8	,	,	PUNCT
chd-116	257	9	1901	1901	NUM
chd-116	257	10	-	-	SYM
chd-116	257	11	1913	1913	NUM
chd-116	257	12	.	.	PUNCT
chd-116	258	1	visakorpi	visakorpi	PROPN
chd-116	258	2	,	,	PUNCT
chd-116	258	3	t.	t.	PROPN
chd-116	258	4	,	,	PUNCT
chd-116	258	5	hyytinen	hyytinen	PROPN
chd-116	258	6	,	,	PUNCT
chd-116	258	7	e.	e.	PROPN
chd-116	258	8	,	,	PUNCT
chd-116	258	9	koivisto	koivisto	PROPN
chd-116	258	10	,	,	PUNCT
chd-116	258	11	p.	p.	NOUN
chd-116	258	12	,	,	PUNCT
chd-116	258	13	tanner	tanner	NOUN
chd-116	258	14	,	,	PUNCT
chd-116	258	15	m.	m.	NOUN
chd-116	258	16	,	,	PUNCT
chd-116	258	17	keinänen	keinänen	PROPN
chd-116	258	18	,	,	PUNCT
chd-116	258	19	r.	r.	PROPN
chd-116	258	20	,	,	PUNCT
chd-116	258	21	palmberg	palmberg	PROPN
chd-116	258	22	,	,	PUNCT
chd-116	258	23	c.	c.	PROPN
chd-116	258	24	,	,	PUNCT
chd-116	258	25	palotie	palotie	PROPN
chd-116	258	26	,	,	PUNCT
chd-116	258	27	a.	a.	NOUN
chd-116	258	28	,	,	PUNCT
chd-116	258	29	tammela	tammela	PROPN
chd-116	258	30	,	,	PUNCT
chd-116	258	31	t.	t.	PROPN
chd-116	258	32	,	,	PUNCT
chd-116	258	33	isola	isola	PROPN
chd-116	258	34	,	,	PUNCT
chd-116	258	35	j.	j.	PROPN
chd-116	258	36	,	,	PUNCT
chd-116	258	37	and	and	CCONJ
chd-116	258	38	kallioniemi	kallioniemi	PROPN
chd-116	258	39	,	,	PUNCT
chd-116	258	40	o.p	o.p	PROPN
chd-116	258	41	.	.	PROPN
chd-116	258	42	(	(	PUNCT
chd-116	258	43	1995	1995	NUM
chd-116	258	44	)	)	PUNCT
chd-116	258	45	.	.	PUNCT
chd-116	259	1	in	in	ADP
chd-116	259	2	vivo	vivo	ADJ
chd-116	259	3	amplification	amplification	NOUN
chd-116	259	4	of	of	ADP
chd-116	259	5	the	the	DET
chd-116	259	6	androgen	androgen	NOUN
chd-116	259	7	receptor	receptor	NOUN
chd-116	259	8	gene	gene	NOUN
chd-116	259	9	and	and	CCONJ
chd-116	259	10	progression	progression	NOUN
chd-116	259	11	of	of	ADP
chd-116	259	12	human	human	ADJ
chd-116	259	13	prostate	prostate	NOUN
chd-116	259	14	cancer	cancer	NOUN
chd-116	259	15	.	.	PUNCT
chd-116	260	1	nature	nature	NOUN
chd-116	260	2	genetics	genetic	NOUN
chd-116	260	3	9	9	NUM
chd-116	260	4	,	,	PUNCT
chd-116	260	5	401–406	401–406	NUM
chd-116	260	6	.	.	PUNCT
chd-116	260	7	walker	walker	PROPN
chd-116	260	8	,	,	PUNCT
chd-116	260	9	r.f	r.f	PROPN
chd-116	260	10	.	.	PROPN
chd-116	260	11	,	,	PUNCT
chd-116	260	12	riad	riad	PROPN
chd-116	260	13	-	-	PUNCT
chd-116	260	14	fahmy	fahmy	PROPN
chd-116	260	15	,	,	PUNCT
chd-116	260	16	d.	d.	PROPN
chd-116	260	17	and	and	CCONJ
chd-116	260	18	read	read	VERB
chd-116	260	19	,	,	PUNCT
chd-116	260	20	g.f	g.f	PROPN
chd-116	260	21	.	.	PROPN
chd-116	260	22	(	(	PUNCT
chd-116	260	23	1978	1978	NUM
chd-116	260	24	)	)	PUNCT
chd-116	260	25	.	.	PUNCT
chd-116	261	1	adrenal	adrenal	ADJ
chd-116	261	2	status	status	NOUN
chd-116	261	3	assessed	assess	VERB
chd-116	261	4	by	by	ADP
chd-116	261	5	direct	direct	ADJ
chd-116	261	6	radioimmunoassay	radioimmunoassay	NOUN
chd-116	261	7	of	of	ADP
chd-116	261	8	cortisol	cortisol	NOUN
chd-116	261	9	in	in	ADP
chd-116	261	10	whole	whole	ADJ
chd-116	261	11	saliva	saliva	NOUN
chd-116	261	12	or	or	CCONJ
chd-116	261	13	parotid	parotid	ADJ
chd-116	261	14	saliva	saliva	NOUN
chd-116	261	15	.	.	PUNCT
chd-116	262	1	clinical	clinical	ADJ
chd-116	262	2	chemistry	chemistry	NOUN
chd-116	262	3	24	24	NUM
chd-116	262	4	,	,	PUNCT
chd-116	262	5	14601463	14601463	NUM
chd-116	262	6	.	.	PUNCT
chd-116	263	1	wang	wang	PROPN
chd-116	263	2	,	,	PUNCT
chd-116	263	3	q.	q.	PROPN
chd-116	263	4	,	,	PUNCT
chd-116	263	5	tiffen	tiffen	PROPN
chd-116	263	6	,	,	PUNCT
chd-116	263	7	j.	j.	PROPN
chd-116	263	8	,	,	PUNCT
chd-116	263	9	bailey	bailey	PROPN
chd-116	263	10	.	.	PUNCT
chd-116	264	1	c.g	c.g	PROPN
chd-116	264	2	.	.	PROPN
chd-116	264	3	,	,	PUNCT
chd-116	264	4	lehman	lehman	PROPN
chd-116	264	5	.	.	PUNCT
chd-116	265	1	m.l	m.l	PROPN
chd-116	265	2	.	.	PROPN
chd-116	265	3	,	,	PUNCT
chd-116	265	4	ritchie	ritchie	PROPN
chd-116	265	5	.	.	PUNCT
chd-116	266	1	w.	w.	PROPN
chd-116	266	2	,	,	PUNCT
chd-116	266	3	fazli	fazli	PROPN
chd-116	266	4	.	.	PUNCT
chd-116	267	1	l.	l.	PROPN
chd-116	267	2	,	,	PUNCT
chd-116	267	3	metierre	metierre	PROPN
chd-116	267	4	.	.	PUNCT
chd-116	268	1	c.	c.	PROPN
chd-116	268	2	,	,	PUNCT
chd-116	268	3	feng	feng	PROPN
chd-116	268	4	,	,	PUNCT
chd-116	268	5	y.j	y.j	PROPN
chd-116	268	6	.	.	PROPN
chd-116	268	7	,	,	PUNCT
chd-116	268	8	li	li	PROPN
chd-116	268	9	,	,	PUNCT
chd-116	268	10	e.	e.	PROPN
chd-116	268	11	,	,	PUNCT
chd-116	268	12	gleave	gleave	PROPN
chd-116	268	13	,	,	PUNCT
chd-116	268	14	m.	m.	NOUN
chd-116	268	15	,	,	PUNCT
chd-116	268	16	buchanan	buchanan	PROPN
chd-116	268	17	,	,	PUNCT
chd-116	268	18	g.	g.	PROPN
chd-116	268	19	,	,	PUNCT
chd-116	268	20	nelson	nelson	PROPN
chd-116	268	21	,	,	PUNCT
chd-116	268	22	c.c	c.c	PROPN
chd-116	268	23	.	.	PROPN
chd-116	268	24	,	,	PUNCT
chd-116	268	25	rasko	rasko	ADV
chd-116	268	26	,	,	PUNCT
chd-116	268	27	j.e	j.e	PROPN
chd-116	268	28	.	.	PROPN
chd-116	268	29	,	,	PUNCT
chd-116	268	30	and	and	CCONJ
chd-116	268	31	holst	holst	NOUN
chd-116	268	32	,	,	PUNCT
chd-116	268	33	j.	j.	PROPN
chd-116	268	34	(	(	PUNCT
chd-116	268	35	2013	2013	NUM
chd-116	268	36	)	)	PUNCT
chd-116	268	37	.	.	PUNCT
chd-116	269	1	targeting	target	VERB
chd-116	269	2	amino	amino	NOUN
chd-116	269	3	acid	acid	NOUN
chd-116	269	4	transport	transport	NOUN
chd-116	269	5	in	in	ADP
chd-116	269	6	metastatic	metastatic	ADJ
chd-116	269	7	castration	castration	NOUN
chd-116	269	8	-	-	PUNCT
chd-116	269	9	resistant	resistant	ADJ
chd-116	269	10	prostate	prostate	NOUN
chd-116	269	11	cancer	cancer	NOUN
chd-116	269	12	:	:	PUNCT
chd-116	269	13	effects	effect	NOUN
chd-116	269	14	on	on	ADP
chd-116	269	15	cell	cell	NOUN
chd-116	269	16	cyle	cyle	NOUN
chd-116	269	17	,	,	PUNCT
chd-116	269	18	cell	cell	NOUN
chd-116	269	19	growth	growth	NOUN
chd-116	269	20	,	,	PUNCT
chd-116	269	21	and	and	CCONJ
chd-116	269	22	tumor	tumor	NOUN
chd-116	269	23	development	development	NOUN
chd-116	269	24	.	.	PUNCT
chd-116	270	1	journal	journal	PROPN
chd-116	270	2	of	of	ADP
chd-116	270	3	the	the	DET
chd-116	270	4	national	national	PROPN
chd-116	270	5	cancer	cancer	PROPN
chd-116	270	6	institute	institute	PROPN
chd-116	270	7	105	105	NUM
chd-116	270	8	,	,	PUNCT
chd-116	270	9	1463	1463	NUM
chd-116	270	10	-	-	SYM
chd-116	270	11	1473	1473	NUM
chd-116	270	12	.	.	PUNCT
chd-116	271	1	zhao	zhao	PROPN
chd-116	271	2	,	,	PUNCT
chd-116	271	3	x.y	x.y	PROPN
chd-116	271	4	.	.	PROPN
chd-116	271	5	,	,	PUNCT
chd-116	271	6	malloy	malloy	PROPN
chd-116	271	7	,	,	PUNCT
chd-116	271	8	p.j	p.j	PROPN
chd-116	271	9	.	.	PROPN
chd-116	271	10	,	,	PUNCT
chd-116	271	11	krishnan	krishnan	PROPN
chd-116	271	12	,	,	PUNCT
chd-116	271	13	a.v	a.v	PROPN
chd-116	271	14	.	.	PROPN
chd-116	271	15	,	,	PUNCT
chd-116	271	16	swami	swami	PROPN
chd-116	271	17	,	,	PUNCT
chd-116	271	18	s.	s.	PROPN
chd-116	271	19	,	,	PUNCT
chd-116	271	20	navone	navone	NOUN
chd-116	271	21	,	,	PUNCT
chd-116	271	22	n.m	n.m	PROPN
chd-116	271	23	.	.	PROPN
chd-116	271	24	,	,	PUNCT
chd-116	271	25	peehl	peehl	PROPN
chd-116	271	26	,	,	PUNCT
chd-116	271	27	d.m	d.m	PROPN
chd-116	271	28	.	.	PROPN
chd-116	271	29	,	,	PUNCT
chd-116	271	30	and	and	CCONJ
chd-116	271	31	feldman	feldman	PROPN
chd-116	271	32	d.	d.	PROPN
chd-116	271	33	(	(	PUNCT
chd-116	271	34	2000	2000	NUM
chd-116	271	35	)	)	PUNCT
chd-116	271	36	.	.	PUNCT
chd-116	272	1	glucocorticoids	glucocorticoid	NOUN
chd-116	272	2	can	can	AUX
chd-116	272	3	promote	promote	VERB
chd-116	272	4	androgen	androgen	NOUN
chd-116	272	5	-	-	PUNCT
chd-116	272	6	independent	independent	ADJ
chd-116	272	7	growth	growth	NOUN
chd-116	272	8	of	of	ADP
chd-116	272	9	prostate	prostate	NOUN
chd-116	272	10	cancer	cancer	NOUN
chd-116	272	11	cells	cell	NOUN
chd-116	272	12	through	through	ADP
chd-116	272	13	a	a	DET
chd-116	272	14	mutated	mutate	VERB
chd-116	272	15	androgen	androgen	NOUN
chd-116	272	16	receptor	receptor	NOUN
chd-116	272	17	.	.	PUNCT
chd-116	273	1	nature	nature	NOUN
chd-116	273	2	medicine	medicine	PROPN
chd-116	273	3	6	6	NUM
chd-116	273	4	,	,	PUNCT
chd-116	273	5	703–706	703–706	NUM
chd-116	273	6	zhou	zhou	PROPN
chd-116	273	7	,	,	PUNCT
chd-116	273	8	d.	d.	PROPN
chd-116	273	9	,	,	PUNCT
chd-116	273	10	kusnecov	kusnecov	PROPN
chd-116	273	11	,	,	PUNCT
chd-116	273	12	a.w	a.w	PROPN
chd-116	273	13	.	.	PROPN
chd-116	273	14	,	,	PUNCT
chd-116	273	15	shurin	shurin	NOUN
chd-116	273	16	,	,	PUNCT
chd-116	273	17	m.r	m.r	PROPN
chd-116	273	18	.	.	PROPN
chd-116	273	19	,	,	PUNCT
chd-116	273	20	depaoli	depaoli	PROPN
chd-116	273	21	,	,	PUNCT
chd-116	273	22	m.	m.	NOUN
chd-116	273	23	,	,	PUNCT
chd-116	273	24	ans	ans	X
chd-116	273	25	rabin	rabin	PROPN
chd-116	273	26	,	,	PUNCT
chd-116	273	27	b.s	b.s	PROPN
chd-116	273	28	.	.	PROPN
chd-116	273	29	(	(	PUNCT
chd-116	273	30	1993	1993	NUM
chd-116	273	31	)	)	PUNCT
chd-116	273	32	.	.	PUNCT
chd-116	274	1	exposure	exposure	NOUN
chd-116	274	2	to	to	ADP
chd-116	274	3	physical	physical	ADJ
chd-116	274	4	and	and	CCONJ
chd-116	274	5	psychological	psychological	ADJ
chd-116	274	6	stressors	stressor	NOUN
chd-116	274	7	elevates	elevate	VERB
chd-116	274	8	plasma	plasma	NOUN
chd-116	274	9	interleukin	interleukin	NOUN
chd-116	274	10	6	6	NUM
chd-116	274	11	:	:	PUNCT
chd-116	274	12	relationship	relationship	NOUN
chd-116	274	13	to	to	ADP
chd-116	274	14	the	the	DET
chd-116	274	15	activation	activation	NOUN
chd-116	274	16	of	of	ADP
chd-116	274	17	hypotha	hypotha	NOUN
chd-116	274	18	-	-	PUNCT
chd-116	274	19	lamic	lamic	ADJ
chd-116	274	20	-	-	PUNCT
chd-116	274	21	pituitary	pituitary	ADJ
chd-116	274	22	-	-	PUNCT
chd-116	274	23	adrenal	adrenal	ADJ
chd-116	274	24	axis	axis	NOUN
chd-116	274	25	.	.	PUNCT
chd-116	275	1	endocrinology	endocrinology	NOUN
chd-116	275	2	133	133	NUM
chd-116	275	3	,	,	PUNCT
chd-116	275	4	2523	2523	NUM
chd-116	275	5	-	-	SYM
chd-116	275	6	30	30	NUM
chd-116	275	7	.	.	PUNCT